<SEC-DOCUMENT>0001493152-24-025635.txt : 20240628
<SEC-HEADER>0001493152-24-025635.hdr.sgml : 20240628
<ACCEPTANCE-DATETIME>20240628164325
ACCESSION NUMBER:		0001493152-24-025635
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		23
CONFORMED PERIOD OF REPORT:	20240624
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240628
DATE AS OF CHANGE:		20240628

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DIGITAL ALLY, INC.
		CENTRAL INDEX KEY:			0001342958
		STANDARD INDUSTRIAL CLASSIFICATION:	RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				200064269
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33899
		FILM NUMBER:		241086415

	BUSINESS ADDRESS:	
		STREET 1:		14001 MARSHALL DRIVE
		CITY:			LENEXA
		STATE:			KS
		ZIP:			66215
		BUSINESS PHONE:		913-232-5349

	MAIL ADDRESS:	
		STREET 1:		14001 MARSHALL DRIVE
		CITY:			LENEXA
		STATE:			KS
		ZIP:			66215

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIGITAL ALLY INC
		DATE OF NAME CHANGE:	20051031
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:DGLY="http://digitalallyinc.com/20240624">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_DGLY_digitalallyinc.com_20240624 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20240624_20240624 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001342958 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000004" name="dei:EntityCentralIndexKey">0001342958</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="dgly-20240624.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-06-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001342958</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-24</xbrli:startDate>
        <xbrli:endDate>2024-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>Form
<span id="xdx_90E_edei--DocumentType_c20240624__20240624_zQGSVQPywNi7"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_905_edei--DocumentPeriodEndDate_c20240624__20240624_zZlSagBcoqy8"><ix:nonNumeric contextRef="AsOf2024-06-24" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 24, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_900_edei--EntityRegistrantName_c20240624__20240624_zCt1FWamIlh8"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000011" name="dei:EntityRegistrantName">DIGITAL
ALLY, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
Name of Registrant as Specified in Charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20240624__20240624_zYoWkSO7vxXg"><ix:nonNumeric contextRef="AsOf2024-06-24" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityFileNumber_c20240624__20240624_zNCBbBW7hg38"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000013" name="dei:EntityFileNumber">001-33899</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20240624__20240624_zprwBW430Ol2"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000014" name="dei:EntityTaxIdentificationNumber">20-0064269</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or other Jurisdiction</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS
    Employer</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
    Incorporation)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File
    Number)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressAddressLine1_c20240624__20240624_zHhsZUBuG3I3"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000015" name="dei:EntityAddressAddressLine1">14001
Marshall Drive</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressCityOrTown_c20240624__20240624_zAB47l8m7xv9"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000016" name="dei:EntityAddressCityOrTown">Lenexa</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20240624__20240624_zhDVgCpxcrNj"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000017" name="dei:EntityAddressStateOrProvince">KS</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20240624__20240624_zREd33iZ1Mga"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000018" name="dei:EntityAddressPostalZipCode">66215</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
of Principal Executive Offices) (Zip Code)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--CityAreaCode_c20240624__20240624_zGKLjfYuXdMc"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000019" name="dei:CityAreaCode">(913)</ix:nonNumeric></span>
<span id="xdx_909_edei--LocalPhoneNumber_c20240624__20240624_zWP53RwJBZga"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000020" name="dei:LocalPhoneNumber">814-7774</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Registrant&#8217;s
telephone number, including area code)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--Security12bTitle_c20240624__20240624_z6BZvBFRZUcf"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000021" name="dei:Security12bTitle">Common
    stock, $0.001 par value</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--TradingSymbol_c20240624__20240624_zGhqCOz4pKLa"><ix:nonNumeric contextRef="AsOf2024-06-24" id="Fact000022" name="dei:TradingSymbol">DGLY</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>The
    <span id="xdx_90D_edei--SecurityExchangeName_c20240624__20240624_zwatUAt1eX8e"><ix:nonNumeric contextRef="AsOf2024-06-24" format="ixt-sec:exchnameen" id="Fact000023" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--WrittenCommunications_c20240624__20240624_zs907KybMxl1"><ix:nonNumeric contextRef="AsOf2024-06-24" format="ixt:booleantrue" id="Fact000024" name="dei:WrittenCommunications">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--SolicitingMaterial_c20240624__20240624_zIsty7TuGWy8"><ix:nonNumeric contextRef="AsOf2024-06-24" format="ixt:booleanfalse" id="Fact000025" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20240624__20240624_zKCDiGealZwg"><ix:nonNumeric contextRef="AsOf2024-06-24" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20240624__20240624_zFMA1ArI7Toa"><ix:nonNumeric contextRef="AsOf2024-06-24" format="ixt:booleanfalse" id="Fact000027" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20240624__20240624_zuuRvwNQvNue"><ix:nonNumeric contextRef="AsOf2024-06-24" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry Into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placement Transaction</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 24, 2024, Digital Ally, Inc. (the &#8220;Company&#8221;) entered into a private placement transaction (the &#8220;Private Placement&#8221;),
pursuant to a Securities Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;) with certain institutional investors (the
&#8220;Purchasers&#8221;) for aggregate gross proceeds of approximately $2.9 million, before deducting fees to the placement agent and
other expenses payable by the Company in connection with the Private Placement. The Company intends to use the net proceeds from the
Private Placement for inventory purchases, artist costs for upcoming festivals, transaction cost, expanded sales, marketing, partial
prepayment of an outstanding note and general working capital. Aegis Capital Corp. (&#8220;Aegis&#8221;), acted as the exclusive placement
agent for the Private Placement, which closed on June 25, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the Private Placement, the Company issued an aggregate of 1,195,219 units and pre-funded units (collectively, the &#8220;Units&#8221;)
at a purchase price of $2.51 per unit (less $0.0001 per pre-funded unit). Each Unit consists of (i) one share of common stock,
par value $0.001 per share, of the Company (the &#8220;Common Stock&#8221;) (or one pre-funded warrant to purchase one share of Common
Stock (the &#8220;Pre-Funded Warrants&#8221;)), (ii) one Series A warrant to purchase one share of Common Stock (the &#8220;Series A
Warrant&#8221;) and (iii) one Series B warrant to purchase such number of shares of Common Stock as will be determined on the Reset Date
(as defined below) and in accordance with the terms therein (the &#8220;Series B Warrant&#8221;, and together with the Series A Warrant,
the &#8220;Warrants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pre-Funded Warrants are immediately exercisable at an exercise price of $0.0001 per share of Common Stock and will not expire until exercised
in full. The Series A Warrants will be exercisable at any time or times on or after the date Stockholder Approval (as defined in the
Series A Warrant) is obtained, have an initial exercise price of $2.51 per share of Common Stock and a term of 5 years after the later
of (a) the date that the Company obtains the Stockholder Approval and (b) the earlier of (i) the Resale Effective Date (as defined in
the Registration Rights Agreement (as defined below)) registering all of the Registerable Securities (as defined in the Registration
Rights Agreement) or (ii) the date that the Registerable Securities can be sold, assigned or transferred without restriction or limitation
pursuant to Rule 144 or Rule 144A promulgated under the Securities Act of 1933 (the &#8220;Securities Act&#8221;), as amended, (or a
successor rule thereto). The Series B Warrants will be exercisable at any time or times on or after the date Stockholder Approval is
obtained, have an initial exercise price of $0.001 per share of Common Stock and will not expire until exercised in full. The number
of shares of Common Stock issuable under the Series B Warrants will be determined following the earliest to occur of: (i) the
date on which a resale registration statement covering the resale of all Registrable Securities has been declared effective for 20 consecutive
trading days, (ii) the date on which the Purchasers may sell the Registrable Securities pursuant to Rule 144 under the Securities Act
for a period of 20 consecutive trading days, and (iii) twelve months and 20 days following the issuance date of the Series B Warrants
(the &#8220;Reset Date&#8221;), in each case, pursuant to the lowest daily weighted average trading price of the shares of Common Stock
during a period of 20 trading days, subject to a pricing floor of $0.502 per share of Common Stock (the &#8220;Floor Price&#8221;), such
that, assuming the Floor Price, the maximum number of shares of Common Stock underlying the Series A Warrants and Series B Warrants would
be an aggregate of approximately 5,976,095 shares and 4,780,877 shares, respectively. The Company has undertaken to file a resale registration
statement covering all of the Registrable Securities on behalf the Purchasers pursuant to a Registration Rights Agreement (the &#8220;Registration
Rights Agreement&#8221;), also entered into with the Purchasers in connection with the Private Placement. Pursuant to the Registration
Rights Agreement, the Company shall file the resale registration statement within twenty (20) trading days after the closing of the Private
Placement, and the resale registration statement shall be effective within thirty (30) calendar days following the filing date (or, in
the event of a full review by the United States Securities and Exchange Commission (the &#8220;SEC&#8221;), fifty (50) calendar days
following the filing date).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and number of shares of Common Stock issuable upon exercise of the Series A Warrants are subject to adjustment upon future
dilutive issuances and stock combination events. Whenever on or after the subscription date, as long as the Series A Warrant is outstanding,
the Company issues or sells any Common Stock for a consideration per share (the &#8220;New Issuance Price&#8221;) less than a price equal
to the exercise price in effect immediately prior to such issue or sale or deemed issuance or sale (the foregoing a &#8220;Dilutive Issuance&#8221;),
then immediately after such Dilutive Issuance, the exercise price then in effect shall be reduced to an amount equal to the lower of
(a) the New Issuance Price or (b) the lowest weighted average price during the 5 consecutive trading day period commencing on the date
of the Dilutive Issuance (such lower price, the &#8220;Base Share Price&#8221;), and the number of shares of Common Stock issuable upon
exercise of the Series A Warrant shall be proportionately adjusted such that the aggregate exercise price of the Series A Warrant on
the issuance date for the warrant shares then outstanding shall remain unchanged; provided that the Base Share Price shall not be less
than the Floor Price. In addition to the adjustments set forth above, if at any time on or after the issuance date there occurs any share
split, reverse share split, share dividend, share combination recapitalization or other similar transaction involving the Common Stock
(each, a &#8220;Share Combination Event&#8221;, and such date on which the Share Combination Event is effected, the &#8220;Share Combination
Event Date&#8221;) and the lowest weighted average price of the Common Stock during the period commencing on the trading day immediately
following the applicable Share Combination Event Date and ending on the fifth (5th) trading day immediately following the applicable
Share Combination Event Date (the &#8220;Event Market Price&#8221;) (provided if the Share Combination Event is effective prior to the
opening of trading on the principal market, then, commencing on the Share Combination Event Date and ending on the fourth (4th) trading
day immediately following the applicable Share Combination Event Date (such period, the &#8220;Share Combination Adjustment Period&#8221;))
is less than the exercise price then in effect, then, at the close of trading on the principal market on the last day of the Share Combination
Adjustment Period, the exercise price then in effect on such 5th trading day shall be reduced (but in no event increased) to the Event
Market Price and the number of warrant shares issuable upon exercise of the Series A Warrant shall be increased such that the aggregate
exercise price payable thereunder, after taking into account the decrease in the exercise price, shall be equal to the aggregate exercise
price on the issuance date for the warrant shares then outstanding; provided, however, that in no event shall the event market price
be lower than the Floor Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A Warrant also includes a reset feature, where, on the Reset Date, the exercise price shall be adjusted to equal the lower of
(i) the exercise price then in effect and (ii) the Reset Price (as defined in the Series A Warrant) determined as of the date of determination.
Upon such reset of the exercise price pursuant to the Series A Warrant, the number of warrant shares issuable upon exercise of the Series
A Warrant shall be increased such that the aggregate exercise price payable thereunder, after taking into account the decrease in the
exercise price, shall be equal to the aggregate exercise price on the issuance date for the warrant shares then outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also entered into a placement agent agreement (the &#8220;Placement Agent Agreement&#8221;) with Aegis, dated June 24, 2024,
pursuant to which Aegis agreed to serve as the exclusive placement agent for the Company in connection with the Private Placement. The
Company agreed to pay Aegis a cash placement fee equal to 8.00% of the gross cash proceeds received in the Private Placement and to pay
for expenses of the Aegis&#8217; legal counsel up to an aggregate amount of $50,000. Pursuant to the Placement Agent Agreement, without
the prior written consent of the Purchasers, the Company will not, for a period of sixty (60) days after the later of the Release Date
(as defined in the Securities Purchase Agreement) (a) offer, sell, issue, or otherwise transfer or dispose of, directly or indirectly,
any equity of the Company or any securities convertible into or exercisable or exchangeable for equity of the Company; (b) file or caused
to be filed any registration statement with the Commission relating to the offering of any equity of the Company or any securities convertible
into or exercisable or exchangeable for equity of the Company; or (c) enter into any agreement or announce the intention to effect any
of the actions described in subsections (a) or (b) hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Securities Purchase Agreement, the Company shall hold a special meeting of stockholders (which may also be at the annual meeting
of stockholders) at the earliest practicable date after the date of the Securities Purchase Agreement, but in no event later than sixty
(60) days after the closing date of the Private Placement for the purpose of obtaining Stockholder Approval, and the Company shall solicit
proxies from its stockholders in connection therewith in the same manner as all other management proposals in such proxy statement and
all management-appointed proxyholders shall vote their proxies in favor of such proposal. Within ten (10) business days following the
closing date of the Private Placement, the Company shall file with the SEC a preliminary proxy statement to request for the purpose
of obtaining Stockholder Approval. From the date of the Securities Purchase Agreement until six (6) months from the Release Date, the
Company and its subsidiaries shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or
any of its subsidiaries of shares of Common Stock or Common Stock Equivalents (as defined in the Securities Purchase Agreement) (or a
combination of units thereof) involving a Variable Rate Transaction (as defined in the Securities Purchase Agreement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Securities Purchase Agreement, Pre-Funded Warrant, Series A Warrant, Series B Warrant, Registration Rights
Agreement, and Placement Agent Agreement is qualified in its entirety by reference to the full text of the Form Securities Purchase Agreement,
Form of Pre-Funded Warrant, Form of Series A Warrant, Form of Series B Warrant, Form Registration Rights Agreement and Placement Agent
Agreement, a copy of each of which is filed as Exhibits 4.1, 4.2, 4.3, 10.1, 10.2 and 10.3, respectively, to this Current Report on Form
8-K (the &#8220;Report&#8221;), and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment
to Merger Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously disclosed, on June 1, 2023, Company&#8217;s wholly-owned subsidiary, Kustom Entertainment, Inc. (&#8220;Kustom Entertainment&#8221;),
entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), by and among Clover Leaf Capital Corp., a Delaware
corporation (together with its successors, &#8220;Clover Leaf&#8221;), CL Merger Sub, Inc., a Nevada corporation and a wholly-owned subsidiary
of the Purchaser, Yntegra Capital Investments LLC, a Delaware limited liability company (the &#8220;Purchaser Representative&#8221;),
Kustom Entertainment, and the Company. In connection with the transaction contemplated by the Merger Agreement, the Company,
Clover Leaf and the Purchaser Representative entered into a Lock-Up Agreement (the &#8220;Lock-Up Agreement&#8221;) as of June 1,
2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 24, 2024, Clover Leaf, the Purchaser Representative, and the Company entered into Amendment No. 1 to the Merger Agreement
(the &#8220;Merger Agreement Amendment&#8221;). Pursuant to the Merger Agreement Amendment, the parties agreed to extend the Outside
Date (as defined in the Merger Agreement) from July 22, 2024 to August 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Except
as stated above, the Merger Agreement Amendment does not make any other substantive changes to the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">A
copy of the Merger Agreement Amendment is filed with this Current Report on Form 8-K as Exhibit 2.1 and is incorporated herein
by reference, and the foregoing description of the Merger Agreement Amendment is qualified in its entirety by reference thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02 Unregistered Sales of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth above in Item 1.01 of this Report is incorporated by reference herein. The shares of Common Stock and Warrants
to be issued in connection with the Securities Purchase Agreement and the transactions contemplated thereby will not be registered under
the Securities Act, in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation
D promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01 Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 24, 2024, Clover Leaf, the Purchaser Representative, and the Company entered into Amendment No. 2 to the Lock-Up Agreement
(the &#8220;Lock-Up Agreement Amendment&#8221;). Pursuant to the Lock-Up Agreement Amendment, the parties agreed to reduce the percentage
of Restricted Securities (as defined in the Lock-up Agreement) from 80% to between 70% and 80%, which shall be set at the maximum amount
in such range that ensures the satisfaction of the closing condition set forth in Section 7.2(e) of the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Except
as stated above, the Lock-Up Agreement Amendment does not make any other substantive changes to the Lock-Up Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">A
copy of the Lock-Up Agreement Amendment is filed with this Current Report on Form 8-K as Exhibit 10.4 and is incorporated herein
by reference, and the foregoing description of the Lock-Up Agreement Amendment is qualified in its entirety by reference thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional
Information and Where to Find It</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the business combination between Clover Leaf and Kustom Entertainment (the &#8220;Business Combination&#8221;), Clover
Leaf has filed a proxy statement and registration statement on Form S-4 (the &#8220;Proxy/Registration Statement&#8221;) with the SEC
(as defined herein), which includes a preliminary proxy statement to be distributed to holders of Clover Leaf&#8217;s common stock in
connection with Clover Leaf&#8217;s solicitation of proxies for the vote by Clover Leaf&#8217;s stockholders with respect to the Business
Combination and other matters as described in the Proxy/Registration Statement, as well as, a prospectus relating to the offer of the
securities to be issued to Kustom Entertainment&#8217;s stockholder in connection with the Business Combination. After the Proxy/Registration
Statement has been declared effective by the SEC, Clover Leaf will mail a definitive proxy statement, to its stockholders. Before making
any voting or investment decision, investors and security holders of Clover Leaf and other interested parties are urged to read the proxy
statement and/or prospectus, any amendments thereto and any other documents filed with the SEC carefully and in their entirety when they
become available because they will contain important information about the Business Combination and the parties to the Business Combination.
Investors and security holders may obtain free copies of the preliminary proxy statement/prospectus and definitive proxy statement/prospectus
(when available) and other documents filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) by Clover Leaf through
the website maintained by the SEC at http://www.sec.gov, or by directing a request to: 1450 Brickell Avenue, Suite 1420, Miami, FL 33131.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Forward-Looking
Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report contains certain forward-looking statements within the meaning of the &#8220;safe harbor&#8221; provisions of the Private Securities
Litigation Reform Act of 1955. These forward-looking statements include, without limitation, the Company&#8217;s, Clover Leaf&#8217;s
and Kustom Entertainment&#8217;s expectations with respect to the proposed Business Combination between Clover Leaf and Kustom Entertainment,
including statements regarding the benefits of the Business Combination, the anticipated timing of the Business Combination, the implied
valuation of Kustom Entertainment, the products offered by Kustom Entertainment and the markets in which it operates, and Kustom Entertainment&#8217;s
projected future results. Words such as &#8220;believe,&#8221; &#8220;project,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221;
&#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;strategy,&#8221; &#8220;future,&#8221; &#8220;opportunity,&#8221; &#8220;plan,&#8221;
&#8220;may,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;will be,&#8221; &#8220;will continue,&#8221;
&#8220;will likely result,&#8221; and similar expressions are intended to indentify such forward-looking statements. Forward-looking
statements are predictions, projections and other statements about future events that are based on current expectations and assumptions
and, as a result, are subject to significant risks and uncertainties that could cause the actual results to differ materially from the
expected results. Most of these factors are outside of the Company&#8217;s, Clover Leaf&#8217;s and Kustom Entertainment&#8217;s
control and are difficult to predict. Factors that may cause actual future events to differ materially from the expected results, include,
but are not limited to: (i) the risk that the Business Combination may not be completed in a timely manner or at all, which may adversely
affect the price of the Company&#8217;s and Clover Leaf&#8217;s securities, (ii) the risk that the Business Combination may not
be completed by Clover Leaf&#8217;s business combination deadline, even if extended by its stockholders, (iii) the potential failure
to obtain an extension of the business combination deadline if sought by Clover Leaf; (iv) the failure to satisfy the conditions to the
consummation of the Business Combination, including the adoption of the agreement and plan of merger (&#8220;Merger Agreement&#8221;)
by the stockholders of Clover Leaf, (v) the occurrence of any event, change or other circumstance that could give rise to the termination
of the Merger Agreement, (vi) the failure to obtain any applicable regulatory approvals required to consummate the Business Combination,
(vii) the receipt of an unsolicited offer from another party for an alternative transaction that could interfere with the Business Combination,
(viii) the effect of the announcement or pendency of the Business Combination on Kustom Entertainment&#8217;s business relationships,
performance, and business generally, (ix) the inability to recognize the anticipated benefits of the Business Combination, which may
be affected by, among other things, competition and the ability of the post-combination company to grow and manage growth profitability
and retain its key employees, (x) costs related to the Business Combination, (xi) the outcome of any legal proceedings that may be instituted
against Kustom Entertainment or Clover Leaf following the announcement of the proposed Business Combination, (xii) the ability to maintain
the listing of Clover Leaf&#8217;s securities on the Nasdaq prior to the Business Combination, (xiii) the ability to implement business
plans, forecasts, and other expectations after the completion of the proposed Business Combination, and identify and realize additional
opportunities, (xiv) the risk of downturns and the possibility of rapid change in the highly competitive industry in which Kustom Entertainment
operates, (xv) the risk that demand for Kustom Entertainment&#8217;s services may be decreased due to a decrease in the number of large-scale
sporting events, concerts and theater shows, (xvi) the risk that any adverse changes in Kustom Entertainment&#8217;s relationships with
buyer, sellers and distribution partners may adversely affect the business, financial condition and results of operations, (xvii) the
risk that changes in Internet search engine algorithms and dynamics, or search engine disintermediation, or changes in marketplace rules
could have a negative impact on traffic for Kustom Entertainment&#8217;s sites and ultimately, its business and results of operations,
(xviii) the risk that any decrease in the willingness of artists, teams and promoters to continue to support the secondary ticket market
may result in decreased demand for Kustom Entertainment&#8217;s services, (xix) the risk that Kustom Entertainment is not able to maintain
and enhance its brand and reputation in its marketplace, adversely affecting Kustom Entertainment&#8217;s business, financial condition
and results of operations, (xx) the risk of the occurrence of extraordinary events, such as terrorist attacks, disease epidemics or pandemics,
severe weather events and natural disasters, (xxi) the risk that because Kustom Entertainment&#8217;s operations are seasonal and its
results of operations vary from quarter to quarter and year over year, its financial performance in certain financial quarters or years
may not be indicative of, or comparable to, Kustom Entertainment&#8217;s financial performance in subsequent financial quarters or years,
(xxii) the risk that periods of rapid growth and expansion could place a significant strain on Kustom Entertainment&#8217;s resources,
including its employee base, which could negatively impact Kustom Entertainment&#8217;s operating results, (xxiii) the risk that Kustom
Entertainment may never achieve or sustain profitability, (xxiv) the risk that Kustom Entertainment may need to raise additional capital
to execute its business plan, which many not be available on acceptable terms or at all; (xxv) the risk that third-parties suppliers
and manufacturers are not able to fully and timely meet their obligations, (xxvi) the risk that Kustom Entertainment is unable to secure
or protect its intellectual property, (xxvii) the risk that the post-combination company&#8217;s securities will not be approved for
listing on Nasdaq or if approved, maintain the listing and (xxviii) other risks and uncertainties indicated from time to time in the
proxy statement and/or prospectus to be filed relating to the Business Combination. There may be additional risks that the Company
and Kustom Entertainment presently do not know or that the Company and Kustom Entertainment currently believe are immaterial
that could also cause results to differ from those contained in any forward-looking statements. Forward-looking statements speak only
as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company,
Kustom Entertainment and Clover Leaf assume no obligation and do not intend to update or revise these forward-looking statements, whether
as a result of new information, future events, or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing list of factors is not exhaustive. Recipients should carefully consider such factors, with respect to the proposed Business
Combination, and the other risks and uncertainties described and to be described in the &#8220;Risk Factors&#8221; section of Clover
Leaf&#8217;s Annual Report on Form 10-K filed for the year ended December 31, 2023 filed with the SEC on April 1, 2024 and subsequent
periodic reports filed by Clover Leaf with the SEC, the Proxy Statement and Registration Statement and other documents filed or to be
filed by Clover Leaf from time to time with the SEC. These filings identify and address other important risks and uncertainties that
could cause actual events and results to differ materially from those contained in the forward-looking statements with respect to the
proposed Business Combination. Forward-looking statements speak only as of the date they are made. Recipients are cautioned not to put
undue reliance on forward-looking statements with respect to the proposed Business Combination, and neither Kustom Entertainment nor
Clover Leaf assume any obligation to, nor intend to, update or revise these forward-looking statements, whether as a result of new information,
future events, or otherwise, except as required by law. Neither Kustom Entertainment nor Clover Leaf gives any assurance that either
Kustom Entertainment or Clover Leaf, or the combined company, will achieve its expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Participants
in the Solicitation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clover
Leaf and Kustom Entertainment and their respective directors and certain of their respective executive officers and other members of
management and employees may be considered participants in the solicitation of proxies from the stockholders of Clover Leaf with respect
to the Business Combination. Information about the directors and executive officers of Clover Leaf is set forth in its Annual Report
on Form 10-K for the fiscal year ended December 31, 2023 filed with the SEC on April 1, 2024. Additional information regarding the participants
in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be included
in the proxy statement and/or prospectus and other relevant materials to be filed with the SEC regarding the Business Combination when
they become available. Stockholders, potential investors and other interested persons should read the proxy statement and/or prospectus
carefully when it becomes available before making any voting or investment decisions. When available, these documents can be obtained
free of charge from the sources indicated above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No
Offer or Solicitation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
communication shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of
the proposed Business Combination. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any
securities, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. No offering of securities
shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended,
or an exemption therefrom.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">2.1</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex2-1.htm">Amendment No. 1 to the Merger Agreement</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-1.htm">Form of Series A Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-2.htm">Form of Series B Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-3.htm">Form of Pre-Funded Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Form of Securities Purchase Agreement.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Form of Registration Rights Agreement.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-3.htm">Placement Agent Agreement.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment No. 2 to the Lock-Up Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
<span style="text-decoration: underline">June 28, 2024</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Digital
    Ally, Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    <span style="font-variant: small-caps">Stanton E. Ross</span></i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    E. Ross</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2WkqXfsDLxCKyCJHodtExlnRHZre/R+ot25RoGBiGc75zhAjFhta6RYbzqsihxK5vlUMosEFGU6F3pNtdAv4WeNHWsTJueH9gSp5Bz8wnUlZeGKx3bbFOIFpM5XIqZxDHSSThuBfBV0/JNLpG47RqQZkajkw9a3SKX2NCqZ5kqHsNVSdkq8kkEE+iUX6DjGIJB7qrB/HVQp6nIgiHCcSG6dZ7V/Z0aL4kZC12vs6O9H+DDwcySo0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>2
<FILENAME>ex2-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
2.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FIRST
AMENDMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MERGER
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
First Amendment (&ldquo;<B>First Amendment</B>&rdquo;) to the Merger Agreement (as defined below) is made and entered into as of June
24, 2024, by and among (i) Clover Leaf Capital Corp., a Delaware corporation (together with its successors, the &ldquo;<B>Purchaser</B>&rdquo;),
(ii) Yntegra Capital Investments LLC, a Delaware limited liability company, in the capacity as the representative from and after the
Effective Time (as defined below) for the stockholders of the Purchaser (other than the Company Stockholder (as defined below) as of
immediately prior to the Effective Time and its successors and assignees) in accordance with the terms and conditions of this Agreement
(the &ldquo;<B>Purchaser Representative</B>&rdquo;), (iii) <B>Kustom Entertainment, Inc.</B>, a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;),
and (iv) <B>Digital Ally, Inc.</B>, a Nevada corporation and the sole stockholder of the Company (the &ldquo;<B>Company Stockholder</B>&rdquo;).
Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Merger Agreement (defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Purchaser, Merger Sub, the Purchaser Representative, the Company and the Company Stockholder have entered into that certain Agreement
and Plan of Merger, dated as of June 1, 2023 (the &ldquo;<B>Original Agreement</B>,&rdquo; and as amended, including by this First Amendment,
the &ldquo;<B>Merger Agreement</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B><U>Section 10.9</U> of the Merger Agreement provides that the Merger Agreement may be amended, supplemented or modified only by execution
of a written instrument signed by the Purchaser, the Company, the Purchaser Representative and the Company Stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Parties now desire to amend the Original Agreement to extend the Outside Date from July 22, 2024 to August 30, 2024, as set forth
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, and in accordance with the terms of the Merger Agreement, the Parties hereto, intending to be legally bound,
do hereby acknowledge and agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Section 8.1(b)</U> of the Original Agreement is hereby amended by deleting the date &ldquo;July 22, 2024&rdquo; and replacing it with
the date &ldquo;August 30, 2024&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Miscellaneous</U>. Except as expressly provided in this First Amendment, all of the terms and provisions in the Original Agreement
and the Ancillary Documents are and shall remain unchanged and in full force and effect, on the terms and subject to the conditions set
forth therein. This First Amendment does not constitute, directly or by implication, an amendment or waiver of any provision of the Original
Agreement or any Ancillary Document, or any other right, remedy, power or privilege of any party, except as expressly set forth herein.
Any reference to the Merger Agreement in the Merger Agreement or any other agreement, document, instrument or certificate entered into
or issued in connection therewith shall hereinafter mean the Original Agreement, as amended by this First Amendment (or as the Merger
Agreement may be further amended or modified after the date hereof in accordance with the terms thereof). The Original Agreement, as
amended by this First Amendment, and the documents or instruments attached hereto or thereto or referenced herein or therein, constitutes
the entire agreement between the parties with respect to the subject matter of the Merger Agreement, and supersedes all prior agreements
and understandings, both oral and written, between the parties with respect to its subject matter. If any provision of the Original Agreement
is materially different from or inconsistent with any provision of this First Amendment, the provision of this First Amendment shall
control, and the provision of the Original Agreement shall, to the extent of such difference or inconsistency, be disregarded. Sections
10.1 through 10.8, and 10.10 through 10.16 of the Original Agreement are hereby incorporated herein by reference as if fully set forth
herein, and such provisions apply to this First Amendment as if all references to the &ldquo;Agreement&rdquo; contained therein were
instead references to this First Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>[Remainder
of Page Intentionally Left Blank; Signature Pages Follow]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each Party hereto has caused this First Amendment to be signed and delivered as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
    Purchaser:</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLOVER
    LEAF CAPITAL CORP.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Felipe MacLean</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Felipe
    MacLean</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
    Purchaser Representative:</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>YNTEGRA
    CAPITAL INVESTMENTS, LLC</B>,<BR>
    solely in the capacity as the Purchaser<BR>
    Representative hereunder</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Felipe MacLean</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Felipe
    MacLean</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manager</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
    Company:</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KUSTOM
    ENTERTAINMENT, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stanton E. Ross</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    E. Ross</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
    Company Stockholder:</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
    ALLY, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stanton E. Ross</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    E. Ross</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ex4-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL SELECTED BY THE HOLDER, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT
REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES
MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
ALLY, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Series
A Warrant To Purchase Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Warrant Shares: _____________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Issuance: June 25, 2024 (&ldquo;<B>Issuance Date</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Digital
Ally, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged<FONT STYLE="text-transform: uppercase">, __________</FONT>, the registered holder
hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set forth below, to purchase from
the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the date Stockholder Approval
is obtained, but not after 11:59 p.m., New York time, on the Expiration Date, (as defined below), ______________ (_____________) fully
paid nonassessable shares of Common Stock, subject to adjustment as provided herein (the &ldquo;<B>Warrant Shares</B>&rdquo;). Except
as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock
issued in exchange, transfer or replacement hereof, this &ldquo;<B>Warrant</B>&rdquo;), shall have the meanings set forth in Section
17. This Warrant is one of the Series A Warrants to purchase Common Stock (the &ldquo;<B>SPA Warrants</B>&rdquo;) issued pursuant to
that certain Securities Purchase Agreement, dated as of June 24, 2024 (the &ldquo;<B>Subscription Date</B>&rdquo;), by and among the
Company and the investors (the &ldquo;<B>Buyers</B>&rdquo;) referred to therein (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;).
Capitalized terms used herein and not otherwise defined shall have the definitions ascribed to such terms in the Securities Purchase
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <U>EXERCISE
OF WARRANT.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Mechanics
of Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(f)),
this Warrant may be exercised by the Holder at any time or times on or after the Stockholder Approval Date, in whole or in part, by (i)
delivery of a written notice, in the form attached hereto as <U>Exhibit A</U> (the &ldquo;<B>Exercise Notice</B>&rdquo;), of the Holder&rsquo;s
election to exercise this Warrant and (ii) (A) payment to the Company of an amount equal to the applicable Exercise Price multiplied
by the number of Warrant Shares as to which this Warrant is being exercised (the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;) in cash
by wire transfer of immediately available funds or (B) if the provisions of Section 1(d) are applicable, by notifying the Company that
this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section 1(d)). The Holder shall not be required to deliver
the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice with respect to less than
all of the Warrant Shares shall have the same effect as cancellation of the original Warrant and issuance of a new Warrant evidencing
the right to purchase the remaining number of Warrant Shares. On or before the first (1<SUP>st</SUP>) Trading Day following the date
on which the Company has received the Exercise Notice, the Company shall transmit by electronic mail an acknowledgment of confirmation
of receipt of the Exercise Notice to the Holder and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;). On
or before the earlier of (i) the first (1<SUP>st</SUP> ) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period, in each case, following the date on which the Holder delivers the Exercise Notice to the Company, so long as the Holder delivers
the Aggregate Exercise Price (or notice of a Cashless Exercise) on or prior to the Trading Day following the date on which the Company
has received the Exercise Notice (the &ldquo;<B>Share Delivery Date</B>&rdquo;) (provided that if the Aggregate Exercise Price has not
been delivered by such date, the Share Delivery Date shall be one (1) Trading Day after the Aggregate Exercise Price (or notice of a
Cashless Exercise) is delivered), the Company shall (X) provided that the Transfer Agent is participating in The Depository Trust Company
(&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities Transfer Program and (A) the Warrant Shares are subject to an effective resale registration
statement in favor of the Holder or (B) if exercised via Cashless Exercise, at a time when Rule 144 would be available for resale of
the Warrant Shares by the Holder, credit such aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise
to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian system, or (Y) if
the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program or (A) the Warrant Shares are not subject
to an effective resale registration statement in favor of the Holder and (B) if exercised via Cashless Exercise, at a time when Rule
144 would not be available for resale of the Warrant Shares by the Holder, deliver to the Holder, book entry statements evidencing the
Warrant Shares, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to an Exercise Notice by the Share Delivery Date, the Company shall pay
to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based
on the VWAP of the Common Stock on the date of the applicable Exercise Notice), $10 per Trading Day (increasing to $20 per Trading Day
on the third (3rd) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Share Delivery Date until such
Warrant Shares are delivered or Holder rescinds such exercise. The Company shall be responsible for all fees and expenses of the Transfer
Agent and all fees and expenses with respect to the issuance of Warrant Shares via DTC, if any. Upon delivery of the Exercise Notice,
the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date such Warrant Shares are credited to the Holder&rsquo;s DTC account or the date
of delivery of the book entry statements evidencing such Warrant Shares, as the case may be. If this Warrant is submitted in connection
with any exercise pursuant to this Section 1(a) and the number of Warrant Shares represented by this Warrant submitted for exercise is
greater than the number of Warrant Shares being acquired upon an exercise, then the Company shall as soon as practicable and in no event
later than three (3) Trading Days after any exercise and at its own expense, issue a new Warrant (in accordance with Section 7(d)) representing
the right to purchase the number of Warrant Shares issuable immediately prior to such exercise under this Warrant, less the number of
Warrant Shares with respect to which this Warrant is exercised. No fractional Warrant Shares are to be issued upon the exercise of this
Warrant, but rather the number of Warrant Shares to be issued shall be rounded down to the nearest whole number. Issuance of Warrant
Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance
of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the
name of the Holder or in such name or names as may be directed by the Holder. The Company shall pay all Transfer Agent fees required
for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation
performing similar functions) required for same-day electronic delivery of the Warrant Shares. The Company&rsquo;s obligations to issue
and deliver Warrant Shares in accordance with the terms and subject to the conditions hereof are absolute and unconditional, irrespective
of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery
of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Exercise
Price</U>. For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $2.51 per share, subject to adjustment as provided
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 1(a) by
the Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Company&rsquo;s
Failure to Timely Deliver Securities</U>. In addition to any other rights available to the Holder, if the Company shall fail to cause
the Transfer Agent to transmit to the Holder on or prior to the Share Delivery Date, Warrant Shares pursuant to an exercise notice delivered
by the Holder and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or
the Holder&rsquo;s brokerage firm otherwise purchases, Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant
Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company shall, within three
(3) Trading Days after the Holder&rsquo;s request (a) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total
purchase price (including brokerage commissions, if any) for the Common Stock so purchased exceeds (y) the amount obtained by multiplying
(1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times
(2) the price at which the sell order giving rise to such purchase obligation was executed, and (b) at the option of the Holder, either
reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such
exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the
Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Common Stock with an aggregate sale price
giving rise to such purchase obligation of $10,000, under clause (a) of the immediately preceding sentence the Company shall be required
to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect
of the Buy-In and evidence of the amount of such loss. Nothing herein shall limit the Holder&rsquo;s right to pursue any other remedies
available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief
with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon the exercise of this Warrant as required pursuant
to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Cashless
Exercise. If at any time after the Release Date, if there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, the Holder may, in its sole discretion, exercise this
Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise
in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the &ldquo;Net Number&rdquo; of shares of Common
Stock determined according to the following formula (a &ldquo;<B>Cashless Exercise</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 1.5in">&nbsp;</TD>
  <TD STYLE="white-space: nowrap; text-align: right; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
Number = </FONT></TD>
  <TD><U>(A x B) - (A x C)</U></TD>
  <TD STYLE="width: 1in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD STYLE="padding-left: 30pt">B</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the foregoing formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A=
the total number of shares with respect to which this Warrant is then being exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B=
as applicable: (i) the Weighted Average Price of the Common Stock on the Trading Day immediately preceding the date of the applicable
Exercise Notice if such Exercise Notice is (1) both executed and delivered pursuant to Section 1(a) hereof on a day that is not a Trading
Day or (2) both executed and delivered pursuant to Section 1(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the
bid price of the Common Stock on the principal Principal Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution
of the applicable Exercise Notice, if such Exercise Notice is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and
is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on
a Trading Day) pursuant to Section 1(a) hereof or (iii) the Weighted Average Price of the Common Stock on the date of the applicable
Exercise Notice if the date of such Exercise Notice is a Trading Day and such Exercise Notice is both executed and delivered pursuant
to Section 1(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C=
the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 94.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Common Stock is issued pursuant to this Section 1(e), the Company hereby acknowledges and agrees that the Warrant Shares issued in a
Cashless Exercise shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed
to have commenced, on the date this Warrant was originally issued pursuant to the Securities Purchase Agreement. The Company agrees not
to take any position contrary to this Section 1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Disputes</U>.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company
shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute in accordance with Section
12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Beneficial
Ownership Limitations on Exercises</U>. Notwithstanding anything to the contrary contained herein, the Company shall not effect the exercise
of any portion of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, pursuant to the terms
and conditions of this Warrant and any such exercise shall be null and void and treated as if never made, to the extent that after giving
effect to such exercise, the Holder together with the other Attribution Parties collectively would beneficially own in excess of 4.99%
(the &ldquo;<B>Maximum Percentage</B>&rdquo;) of the number of shares of Common Stock outstanding immediately after giving effect to
such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Holder
and the other Attribution Parties shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties
plus the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence
is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (A) exercise of the remaining, unexercised
portion of this Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise or conversion of the
unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible notes or convertible
preferred stock or warrants, including the Series B Warrants) and Pre-funded Warrants beneficially owned by the Holder or any other Attribution
Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 1(g). For purposes of this
Section 1(g), beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended
(the &ldquo;<B>1934 Act</B>&rdquo;). For purposes of this Warrant, in determining the number of outstanding shares of Common Stock the
Holder may acquire upon the exercise of this Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of outstanding
shares of Common Stock as reflected in (x) the Company&rsquo;s most recent Annual Report on Form 10-K, Current Report on Form 8-K or
other public filing with the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;), as the case may be, (y) a more recent
public announcement by the Company or (3) any other written notice by the Company or the Transfer Agent setting forth the number of shares
of Common Stock outstanding (the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). If the Company receives an Exercise Notice
from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number,
the Company shall (i) notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such
Exercise Notice would otherwise cause the Holder&rsquo;s beneficial ownership, as determined pursuant to this Section 1(g), to exceed
the Maximum Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to be purchased pursuant to such Exercise
Notice (the number of shares by which such purchase is reduced, the &ldquo;<B>Reduction Shares</B>&rdquo;) and (ii) as soon as reasonably
practicable, the Company shall return to the Holder any exercise price paid by the Holder for the Reduction Shares. For any reason at
any time, upon the written or oral request of the Holder, the Company shall within one (1) Trading Day confirm orally and in writing
or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares
of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant,
by the Holder and any other Attribution Party since the date as of which the Reported Outstanding Share Number was reported. In the event
that the issuance of shares of Common Stock to the Holder upon exercise of this Warrant results in the Holder and the other Attribution
Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common
Stock (as determined under Section 13(d) of the 1934 Act), the number of shares so issued by which the Holder&rsquo;s and the other Attribution
Parties&rsquo; aggregate beneficial ownership exceeds the Maximum Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed
null and void and shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer the Excess Shares. As
soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to the
Holder the exercise price paid by the Holder for the Excess Shares. Upon delivery of a written notice to the Company, the Holder may
from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified in such notice;
provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such notice
is delivered to the Company and (ii) any such increase or decrease will apply only to the Holder and the other Attribution Parties and
not to any other holder of SPA Warrants that is not an Attribution Party of the Holder. For purposes of clarity, the Common Stock issuable
pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder
for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. <FONT STYLE="background-color: white">No
</FONT>prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions
of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(g) to the extent necessary to correct
this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial ownership limitation
contained in this Section 1(g) or to make changes or supplements necessary or desirable to properly give effect to such limitation. The
limitation contained in this paragraph may not be waived and shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Insufficient
Authorized Shares</U>. If at any time while this Warrant remains outstanding the Company does not have a sufficient number of authorized
and unreserved shares of Common Stock to satisfy its obligation to reserve for issuance upon exercise of this Warrant at least a number
of shares of Common Stock equal to 100% of the number of shares of Common Stock as shall from time to time be necessary to effect the
exercise of all of this Warrant then outstanding without regard to any limitation on exercise included herein and assuming that the shares
underlying this Warrant are adjusted based on a Reset Price equal to $0.502 (as adjusted for stock splits, stock dividends, recapitalizations,
reorganizations, reclassification, combinations, reverse stock splits, or other similar events occurring after the Subscription Date)
(the &ldquo;<B>Required Reserve Amount</B>&rdquo; and the failure to have such sufficient number of authorized and unreserved Common
Stock, an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company shall immediately take all action necessary to increase the
number of the Company&rsquo;s shares of authorized Common Stock to an amount sufficient to allow the Company to reserve the Required
Reserve Amount for this Warrant then outstanding. Without limiting the generality of the foregoing sentence, as soon as practicable after
the date of the occurrence of an Authorized Share Failure, but in no event later than sixty (60) days after the occurrence of such Authorized
Share Failure, the Company shall hold a meeting of its shareholders for the approval of an increase in the number of authorized shares
of Common Stock. In connection with such meeting, the Company shall provide each shareholder with a proxy statement and shall use its
best efforts to solicit its shareholders&rsquo; approval of such increase in the number of authorized shares of Common Stock and to cause
its board of directors to recommend to the shareholders that they approve such proposal. Notwithstanding the foregoing, if any such time
of an Authorized Share Failure, the Company is able to obtain the approval of holders of a majority of the shares of Common Stock voting
at a general meeting to approve the increase in the number of authorized shares of Common Stock, the Company may satisfy this obligation
by obtaining such approval. In the event that upon any exercise of this Warrant, the Company does not have sufficient authorized shares
to deliver in satisfaction of such exercise, then unless the Holder elects to void such attempted exercise, the Holder may require the
Company to pay to the Holder within three (3) Trading Days of the applicable exercise, cash in an amount equal to the product of (i)
the quotient determined by dividing (x) the number of Warrant Shares that the Company is unable to deliver pursuant to this Section 1(h),
by (y) the total number of Warrant Shares issuable upon exercise of this Warrant (without regard to any limitations or restrictions on
exercise of this Warrant) and (ii) the Black Scholes Value; provided, that (x) references to &ldquo;the day immediately following the
public announcement of the applicable Fundamental Transaction&rdquo; in the definition of &ldquo;Black Scholes Value&rdquo; shall instead
refer to &ldquo;the date the Holder exercises this Warrant and the Company cannot deliver the required number of Warrant Shares because
of an Authorized Share Failure&rdquo; and (y) clause (iii) of the definition of &ldquo;Black Scholes Value&rdquo; shall instead refer
to &ldquo;the underlying price per share used in such calculation shall be the highest Weighted Average Price during the period beginning
on the date of the applicable date of exercise and the date that the Company makes the applicable cash payment.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and the number of Warrant Shares shall be adjusted from time to
time as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Adjustment
Upon Issuance of Common Stock</U>. If and whenever on or after the Subscription Date, as long as this Warrant is outstanding, the Company
issues or sells, or in accordance with this Section 2 is deemed to have issued or sold, any Common Stock (including the issuance or sale
of Common Stock owned or held by or for the account of the Company, but excluding Common Stock deemed to have been issued or sold by
the Company in connection with any Excluded Securities) for a consideration per share (the &ldquo;<B>New Issuance Price</B>&rdquo;) less
than a price (the &ldquo;<B>Applicable Price</B>&rdquo;) equal to the Exercise Price in effect immediately prior to such issue or sale
or deemed issuance or sale (the foregoing a &ldquo;<B>Dilutive Issuance</B>&rdquo;), then immediately after such Dilutive Issuance, the
Exercise Price then in effect shall be reduced to an amount equal to the lower of (a) the New Issuance Price or (b) the lowest VWAP during
the 5 consecutive Trading Day period commencing on the date of the Dilutive Issuance (such lower price, the &ldquo;<B>Base Share Price</B>&rdquo;)
and the number of shares of Common Stock issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate
Exercise Price of this Warrant on the Issuance Date for the Warrant Shares then outstanding shall remain unchanged; provided that the
Base Share Price shall not be less than the Floor Price(subject to adjustment for reverse and forward stock splits, recapitalizations
and similar transactions following the date of the Securities Purchase Agreement). Notwithstanding the foregoing, if one or more Dilutive
Issuances occurred prior to the Stockholder Approval being obtained and the reduction of the Exercise Price was limited by clause (i)
of the definition of Floor Price, once the Stockholder Approval is obtained, the Exercise Price will automatically be reduced to equal
the greater of (x) the lowest Base Share Price with respect to any Dilutive Issuance that occurred prior to the Stockholder Approval
being obtained, and (y) the price determined by reference to clause (ii) of the definition of Floor Price. For the avoidance of doubt,
for the purposes of this Section 2(a), pre-funded warrants to purchase Common Stock shall be treated as Common Stock. For purposes of
determining the adjusted Exercise Price under this Section 2(a), the following shall be applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Issuance
of Options</U>. If the Company in any manner grants or sells any Options and the lowest price per share for which one share of Common
Stock is issuable upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible Securities issuable
upon exercise of any such Option is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding
and to have been issued and sold by the Company at the time of the granting or sale of such Option for such price per share. For purposes
of this Section 2(a)(i), the &ldquo;lowest price per share for which one share of Common Stock is issuable upon the exercise of any such
Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option&rdquo; shall
be equal to the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share
of Common Stock upon the granting or sale of the Option, upon exercise of the Option and upon conversion, exercise or exchange of any
Convertible Security issuable upon exercise of such Option less any consideration paid or payable by the Company with respect to such
one share of Common Stock upon the granting or sale of such Option, upon exercise of such Option and upon conversion exercise or exchange
of any Convertible Security issuable upon exercise of such Option. No further adjustment of the Exercise Price shall be made upon the
actual issuance of such Common Stock or of such Convertible Securities upon the exercise of such Options or upon the actual issuance
of such Common Stock upon conversion, exercise or exchange of such Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Issuance
of Convertible Securities</U>. If the Company in any manner issues or sells any Convertible Securities and the lowest price per share
for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof is less than the Applicable Price,
then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the
issuance or sale of such Convertible Securities for such price per share. For the purposes of this Section 2(a)(ii), the &ldquo;lowest
price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof&rdquo; shall be equal
to the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share of Common
Stock upon the issuance or sale of the Convertible Security and upon conversion, exercise or exchange of such Convertible Security less
any consideration paid or payable by the Company with respect to such one share of Common Stock upon the issuance or sale of such Convertible
Security and upon conversion, exercise or exchange of such Convertible Security. No further adjustment of the Exercise Price shall be
made upon the actual issuance of such Common Stock upon conversion, exercise or exchange of such Convertible Securities, and if any such
issue or sale of such Convertible Securities is made upon exercise of any Options for which adjustment of this Warrant has been or is
to be made pursuant to other provisions of this Section 2(a), no further adjustment of the Exercise Price shall be made by reason of
such issue or sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <U>Change
in Option Price or Rate of Conversion.</U> If the purchase price provided for in any Options, the additional consideration, if any, payable
upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible
into or exercisable or exchangeable for Common Stock increases or decreases at any time, the Exercise Price in effect at the time of
such increase or decrease shall be adjusted to the Exercise Price, which would have been in effect at such time had such Options or Convertible
Securities provided for such increased or decreased purchase price, additional consideration or increased or decreased conversion rate,
as the case may be, at the time initially granted, issued or sold. For purposes of this Section 2(a)(iii), if the terms of any Option
or Convertible Security that was outstanding as of the Subscription Date are increased or decreased in the manner described in the immediately
preceding sentence, then such Option or Convertible Security and the Common Stock deemed issuable upon exercise, conversion or exchange
thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 2(a)
shall be made if such adjustment would result in an increase of the Exercise Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) <U>Calculation
of Consideration Received</U>. In case any Option is issued in connection with the issue or sale of other securities of the Company,
together comprising one integrated transaction, (x) the Options will be deemed to have been issued for the Option Value of the Options
and (y) the other securities issued or sold in such integrated transaction shall be deemed to have been issued or sold for the difference
of (I) the aggregate consideration received by the Company less any consideration paid or payable by the Company pursuant to the terms
of such other securities of the Company, less (II) the Option Value of such Options. If any Common Stock, Options or Convertible Securities
are issued or sold or deemed to have been issued or sold for cash, the consideration other than cash received therefor will be deemed
to be the net amount received by the Company therefor. If any Common Stock, Options or Convertible Securities are issued or sold for
a consideration other than cash, the amount of such consideration received by the Company will be the fair value of such consideration,
except where such consideration consists of publicly traded securities, in which case the amount of consideration received by the Company
will be the Closing Sale Price of such publicly traded securities on the date of receipt of such publicly traded securities. If any Common
Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger in which
the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion of the
net assets and business of the non-surviving entity as is attributable to such Common Stock, Options or Convertible Securities, as the
case may be. The fair value of any consideration other than cash or publicly traded securities will be determined jointly by the Company
and the Required Holders. If such parties are unable to reach agreement within ten (10) days after the occurrence of an event requiring
valuation (the &ldquo;<B>Valuation Event</B>&rdquo;), the fair value of such consideration will be determined within five (5) Business
Days after the tenth (10<SUP>th</SUP>) day following the Valuation Event by an independent, reputable appraiser jointly selected by the
Company and the Required Holders. The determination of such appraiser shall be final and binding upon all parties absent manifest error
and the fees and expenses of such appraiser shall be borne by the Company. Notwithstanding anything to the contrary contained herein,
if a calculation pursuant to this Section 2(a)(iv) would result in an Exercise Price that is lower than the par value of the Common Stock,
then the Exercise Price shall be deemed to equal the par value of the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <U>Record
Date</U>. If the Company takes a record of the holders of Common Stock for the purpose of entitling them (A) to receive a dividend or
other distribution payable in Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase Common Stock, Options
or Convertible Securities, then such record date will be deemed to be the date of the issue or sale of the Common Stock deemed to have
been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such
right of subscription or purchase, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) <U>No
Readjustment</U>. For the avoidance of doubt, in the event that following the consummation of a Dilutive Issuance and the Exercise Price
has been adjusted pursuant to this Section 2(a) and the Dilutive Issuance that triggered such adjustment is unwound, cancelled or expires
after the fact for any reason, the Exercise Price will not be readjusted to the Exercise Price that would have been in effect if such
Dilutive Issuance had not occurred or been consummated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Voluntary
Adjustment by Company.</U> Subject to the rules and regulations of the primary Principal Market, the Company may at any time during the
term of this Warrant, with the prior written consent of the Required Holders, reduce the then current Exercise Price to any amount and
for any period of time deemed appropriate by the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Adjustment
Upon Subdivision or Combination of Common Stock</U>. If the Company at any time on or after the Subscription Date subdivides (by any
stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding Common Stock into a greater number
of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant
Shares will be proportionately increased. If the Company at any time on or after the Subscription Date combines (by combination, reverse
stock split or otherwise) one or more classes of its outstanding Common Stock into a smaller number of shares, the Exercise Price in
effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately
decreased. Any adjustment under this Section 2(c) shall become effective at the close of business on the date the subdivision or combination
becomes effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Reset</U>.
On the Reset Date, the Exercise Price shall be adjusted to equal the lower of (i) the Exercise Price then in effect and (ii) the Reset
Price determined as of the date of determination. Upon such reset of the Exercise Price pursuant to this Section 2(d), the number of
Warrant Shares issuable upon exercise of this Warrant shall be increased such that the aggregate Exercise Price payable hereunder, after
taking into account the decrease in the Exercise Price, shall be equal to the aggregate Exercise Price on the Issuance Date (adjusted
for any Warrants exercised or sold by the Holder prior to such Reset Date) for the Warrant Shares then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Notwithstanding
the foregoing, if a Holder requests to exercise this Warrant in whole or in part on any given date prior to the Reset Date on which (i)
all Registrable Securities have become and remained registered pursuant to an effective Registration Statement that is available for
the resale of all Registrable Securities, provided, however, if less than all Registrable Securities have become registered for resale
on the date that a Registration Statement is declared effective, the Holder with respect to itself only, shall have the right in its
sole and absolute discretion to deem such condition satisfied, including with regard only to the Registrable Securities that have been
so registered, (ii) the Holder can sell all Registrable Securities pursuant to Rule 144 without restriction or limitation and the Company
has not had a Public Information Failure or (iii) twelve (12) months immediately following the Issuance Date (any such date, an &ldquo;<B>Exercise
Date</B>&rdquo;), solely with respect to such portion of this Warrant being exercised on such applicable Exercise Date, (a) such applicable
Reset Date shall be deemed to mean the Exercise Date, (b) such applicable Reset Period shall be deemed to have commenced on the applicable
date set forth in clause (i), (ii) or (iii) hereof and ended on the twenty-first (21st) Trading Day thereafter and (c) the applicable
Reset Price and Reset Share Amount for such exercised Warrants shall be calculated pursuant to this Section 2(d). For the avoidance of
doubt, following the calculation of the Reset Price and Reset Share Amount pursuant to this Section 2(d)(i), the Company&rsquo;s obligations
with regard to such exercised Warrants shall be deemed satisfied and no additional Reset Price and Reset Share Amount shall apply to
such exercised Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Partial
Reset</U>. If less than all of the Registrable Securities have been registered pursuant to the clause (i) of the definition of Reset
Date and a Holder has deemed the condition satisfied as to such Registrable Securities, then the Reset Date shall apply only to such
portion of the Registrable Securities, and the Company&rsquo;s obligations will continue to apply with regard to the Registrable
Securities for which the definition of Reset Date has not been not satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Share
Combination Event Adjustment</U>. In addition to the adjustments set forth in this Section 2, subject to Stockholder Approval, if at
any time on or after the Issuance Date there occurs any share split, reverse share split, share dividend, share combination recapitalization
or other similar transaction involving the Common Stock (each, a &ldquo;<B>Share Combination Event</B>&rdquo;, and such date on which
the Share Combination Event is effected, the &ldquo;<B>Share Combination Event Date</B>&rdquo;) and the lowest Weighted Average Price
of the Common Stock during the period commencing on the Trading Day immediately following the applicable Share Combination Event Date
and ending on the fifth (5<SUP>th</SUP>) Trading Day immediately following the applicable Share Combination Event Date (the &ldquo;<B>Event
Market Price</B>&rdquo;) (provided if the Share Combination Event is effective prior to the opening of trading on the Principal Market
(or if the Common Stock no longer trades on the Principal Market, on the primary Eligible Market on which the Common Stock then trades),
then, commencing on the Share Combination Event Date and ending on the fourth (4<SUP>th</SUP>) Trading Day immediately following the
applicable Share Combination Event Date (such period, the &ldquo;<B>Share Combination Adjustment Period</B>&rdquo;)) is less than the
Exercise Price then in effect (after giving effect to the adjustment in clause 2(c) above), then, at the close of trading on the Principal
Market (or if the Common Stock no longer trades on the Principal Market, on the primary Eligible Market on which the Common Stock then
trades) on the last day of the Share Combination Adjustment Period, the Exercise Price then in effect on such 5<SUP>th</SUP> Trading
Day shall be reduced (but in no event increased) to the Event Market Price and the number of Warrant Shares issuable upon exercise of
this Warrant hereunder (such resulting number, the &ldquo;<B>Share Combination Issuable Shares</B>&rdquo;) shall be increased such that
the aggregate Exercise Price payable hereunder, after taking into account the decrease in the Exercise Price, shall be equal to the aggregate
Exercise Price on the Issuance Date for the Warrant Shares then outstanding; provided, however, that in no event shall the Event Market
Price be lower than the Floor Price; and provided further that notwithstanding the foregoing, if one or more Share Combination Events
occurred prior to the Stockholder Approval being obtained and the reduction of the Exercise Price was limited by clause (i) of the definition
of Floor Price, once the Stockholder Approval is obtained, the Exercise Price will automatically be reduced to equal the greater of (x)
the lowest Event Market Price with respect to any Share Combination Event that occurred prior to the Stockholder Approval being obtained,
and (y) the price determined by reference to clause (ii) of the definition of Floor Price.. For the avoidance of doubt, if the adjustment
in this Section 2(e) would otherwise result in an increase in the Exercise Price hereunder, no adjustment shall be made, and if this
Warrant is exercised, on any date on which the Holder delivers an Exercise Notice to the Company (an &ldquo;<B>Exercise Date</B>&rdquo;)
during the Share Combination Adjustment Period, solely with respect to such portion of this Warrant exercised on such applicable Exercise
Date, such applicable Share Combination Adjustment Period shall be deemed to have ended on, and include, the Trading Day immediately
prior to such Exercise Date and the Event Market Price on such applicable Exercise Date will be the lowest VWAP of the Common Stock immediately
prior to the Share Combination Event Date and ending on, and including the Trading Day immediately prior to such Exercise Date. Notwithstanding
the foregoing, if one or more Share Combination Events occurs prior to the Stockholder Approval being obtained and the reduction of the
Exercise Price to the Event Market Price, once the Stockholder Approval is obtained, the Exercise Price will automatically be reduced
to the lowest Event Market Price with respect to any Share Combination Event that occurred prior to the Stockholder Approval being obtained
and the Share Combination Issuable Shares will automatically be adjusted to equal the highest such number with respect to any Share Combination
Event that occurred prior to the Stockholder Approval being obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Other
Events</U>. If any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for by such provisions
(including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features),
then the Company&rsquo;s Board of Directors will make an appropriate adjustment in the Exercise Price and the number of Warrant Shares,
as mutually determined by the Company&rsquo;s Board of Directors and the Required Holders, so as to protect the rights of the Holder;
<U>provided</U> that no such adjustment pursuant to this Section 2(f) will increase the Exercise Price or decrease the number of Warrant
Shares as otherwise determined pursuant to this Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Voluntary
Adjustment by Company</U>. Subject to the rules and regulations of the Principal Market and the consent of the Holder, the Company may
at any time during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate
by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>RIGHTS
UPON DISTRIBUTION OF ASSETS</U>. If the Company shall declare or make any dividend or other distribution of its assets (or rights to
acquire its assets) to holders of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution
of cash, stock or other securities, property, options, evidence of indebtedness or any other assets by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after
the issuance of this Warrant and while the Warrant is outstanding, then, in each such case, the Exercise Price shall be adjusted by multiplying
the Exercise Price in effect immediately prior to the record date fixed for determination of shareholders entitled to receive such distribution
by a fraction of which the denominator shall be the Weighted Average Price determined as of the record date mentioned above, and of which
the numerator shall be such Weighted Average Price on such record date less the then per share fair market value at such record date
of the portion of such assets or evidence of indebtedness or rights or warrants so distributed applicable to one outstanding share of
Common Stock as determined by the Board of Directors in good faith. In either case the adjustments shall be described in a statement
provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription rights applicable to
one share of Common Stock. Such adjustment shall be made whenever any such distribution is made and shall become effective immediately
after the record date mentioned above; provided that in no event shall such adjustment result in an Exercise Price less than the Floor
Price (subject to adjustment for reverse and forward stock splits, recapitalizations and similar transactions following the date of the
Securities Purchase Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Purchase
Rights</U>. In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells any Options,
Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class
of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to
such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares
of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this
Warrant, including without limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant,
issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock is
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (and shall not be entitled to beneficial ownership
of such Common Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and such Purchase Right to such extent
shall be held in abeyance for the benefit of the Holder until such time or times as its right thereto would not result in the Holder
and the other Attribution Parties exceeding the Maximum Percentage, at which time or times the Holder shall be granted such right (and
any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase Right held similarly in abeyance)
to the same extent as if there had been no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Fundamental
Transactions</U>. Except the Merger, the Company shall not enter into or be party to a Fundamental Transaction unless the Successor Entity
assumes in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the
provisions of this Section 4(b) pursuant to written agreements in form and substance satisfactory to the Required Holders, including
agreements, if so requested by the Holder, to deliver to each holder of the SPA Warrants in exchange for such SPA Warrants a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant, including, without
limitation, an adjusted exercise price equal to the value for the Common Stock reflected by the terms of such Fundamental Transaction,
and exercisable for a corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable
upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and satisfactory to the Required Holders, and with an exercise price which applies the exercise price hereunder to such shares of capital
stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value
of such shares of capital stock, such adjustments to the number of shares of capital stock and such exercise price being for the purpose
of protecting the economic value of this Warrant immediately prior to the occurrence or consummation of such Fundamental Transaction).
Any security issuable or potentially issuable to the Holder pursuant to the terms of this Warrant on the consummation of a Fundamental
Transaction that was within the Company&rsquo;s control to enter into or to avoid shall be registered and freely tradable by the Holder
without any restriction or limitation or the requirement to be subject to any holding period pursuant to any applicable securities laws.
<FONT STYLE="background-color: white">No later than (i) thirty (30) days prior to the occurrence or consummation of any Fundamental Transaction
or (ii) if later, the first Trading Day following the date the Company first becomes aware of the occurrence or potential occurrence
of a Fundamental Transaction, the Company shall deliver written notice thereof via facsimile or electronic mail and overnight courier
to the Holder. </FONT>Upon the occurrence or consummation of any Fundamental Transaction that was within the Company&rsquo;s control
to enter into or to avoid, it shall be a required condition to the occurrence or consummation of any Fundamental Transaction that, the
Company and the Successor Entity or Successor Entities, jointly and severally, shall succeed to, and the Company shall cause any Successor
Entity or Successor Entities to jointly and severally succeed to, and be added to the term &ldquo;Company&rdquo; under this Warrant (so
that from and after the date of such Fundamental Transaction, each and every provision of this Warrant referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Company and
the Successor Entity or Successor Entities, jointly and severally, may exercise every right and power of the Company prior thereto and
shall assume all of the obligations of the Company prior thereto under this Warrant with the same effect as if the Company and such Successor
Entity or Successor Entities, jointly and severally, had been named as the Company in this Warrant, and, solely at the request of the
Holder, if the Successor Entity and/or Successor Entities is a publicly traded corporation whose common stock is quoted on or listed
for trading on an Eligible Market, shall deliver (in addition to and without limiting any right under this Warrant) to the Holder in
exchange for this Warrant a security of the Successor Entity and/or Successor Entities evidenced by a written instrument substantially
similar in form and substance to this Warrant and exercisable for a corresponding number of shares of capital stock of the Successor
Entity and/or Successor Entities (the &ldquo;<B>Successor Capital Stock</B>&rdquo;) equivalent to the shares of Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction (such corresponding number of shares of Successor Capital Stock to be delivered to the Holder shall be equal to the greater
of (A) the quotient of (i) the aggregate dollar value of all consideration (including cash consideration and any consideration other
than cash (&ldquo;<B>Non-Cash Consideration</B>&rdquo;), in such Fundamental Transaction, as such values are set forth in any definitive
agreement for the Fundamental Transaction that has been executed at the time of the first public announcement of the Fundamental Transaction
or, if no such value is determinable from such definitive agreement, as determined in accordance with Section 12 with the term &ldquo;Non-Cash
Consideration&rdquo; being substituted for the term &ldquo;Exercise Price&rdquo;) that the Holder would have been entitled to receive
upon the happening of such Fundamental Transaction or the record, eligibility or other determination date for the event resulting in
such Fundamental Transaction, had this Warrant been exercised immediately prior to such Fundamental Transaction or the record, eligibility
or other determination date for the event resulting in such Fundamental Transaction (without regard to any limitations on the exercise
of this Warrant) (the &ldquo;<B>Aggregate Consideration</B>&rdquo;) divided by (ii) the per share Closing Sale Price of such Successor
Capital Stock on the Trading Day immediately prior to the consummation or occurrence of the Fundamental Transaction and (B) the product
of (i) the quotient obtained by dividing (x) the Aggregate Consideration, by (y) the Closing Sale Price of the Common Stock on the Trading
Day immediately prior to the consummation or occurrence of the Fundamental Transaction and (ii) the highest exchange ratio pursuant to
which any shareholder of the Company may exchange Common Stock for Successor Capital Stock) (<U>provided</U>, <U>however</U>, to the
extent that the Holder&rsquo;s right to receive any such shares of publicly traded common stock (or their equivalent) of the Successor
Entity would result in the Holder and its other Attribution Parties exceeding the Maximum Percentage, if applicable, then the Holder
shall not be entitled to receive such shares to such extent (and shall not be entitled to beneficial ownership of such shares of publicly
traded common stock (or their equivalent) of the Successor Entity as a result of such consideration to such extent) and the portion of
such shares shall be held in abeyance for the Holder until such time or times, as its right thereto would not result in the Holder and
its other Attribution Parties exceeding the Maximum Percentage, at which time or times the Holder shall be delivered such shares to the
extent as if there had been no such limitation), and such security shall be satisfactory to the Holder, and with an identical exercise
price to the Exercise Price hereunder (such adjustments to the number of shares of capital stock and such exercise price being for the
purpose of protecting after the consummation or occurrence of such Fundamental Transaction the economic value of this Warrant that was
in effect immediately prior to the consummation or occurrence of such Fundamental Transaction, as elected by the Holder solely at its
option). Upon occurrence or consummation of the Fundamental Transaction, and it shall be a required condition to the occurrence or consummation
of such Fundamental Transaction that, the Company and the Successor Entity or Successor Entities shall deliver to the Holder confirmation
that there shall be issued upon exercise of this Warrant at any time after the occurrence or consummation of the Fundamental Transaction,
as elected by the Holder solely at its option, Common Stock, Successor Capital Stock or, in lieu of the Common Stock or Successor Capital
Stock (or other securities, cash, assets or other property purchasable upon the exercise of this Warrant prior to such Fundamental Transaction),
such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription
rights), which for purposes of clarification may continue to be Common Stock, if any, that the Holder would have been entitled to receive
upon the happening of such Fundamental Transaction or the record, eligibility or other determination date for the event resulting in
such Fundamental Transaction, had this Warrant been exercised immediately prior to such Fundamental Transaction or the record, eligibility
or other determination date for the event resulting in such Fundamental Transaction (without regard to any limitations on the exercise
of this Warrant), as adjusted in accordance with the provisions of this Warrant. In addition to and not in substitution for any other
rights hereunder, prior to the occurrence or consummation of any Fundamental Transaction pursuant to which holders of shares of Common
Stock are entitled to receive securities, cash, assets or other property with respect to or in exchange for Common Stock (a &ldquo;<B>Corporate
Event</B>&rdquo;), the Company shall make appropriate provision to ensure that, and any applicable Successor Entity or Successor Entities
shall ensure that, and it shall be a required condition to the occurrence or consummation of such Corporate Event that, the Holder will
thereafter have the right to receive upon exercise of this Warrant at any time after the occurrence or consummation of the Corporate
Event, Common Stock or Successor Capital Stock or, if so elected by the Holder, in lieu of the Common Stock (or other securities, cash,
assets or other property) purchasable upon the exercise of this Warrant prior to such Corporate Event (but not in lieu of such items
still issuable under Sections 3 and 4(a), which shall continue to be receivable on the Common Stock or on the such shares of stock, securities,
cash, assets or any other property otherwise receivable with respect to or in exchange for Common Stock), such shares of stock, securities,
cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights and any Common Stock) which
the Holder would have been entitled to receive upon the occurrence or consummation of such Corporate Event or the record, eligibility
or other determination date for the event resulting in such Corporate Event, had this Warrant been exercised immediately prior to such
Corporate Event or the record, eligibility or other determination date for the event resulting in such Corporate Event (without regard
to any limitations on exercise of this Warrant). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably
satisfactory to the Holder. The provisions of this Section 4(b) shall apply similarly and equally to successive Fundamental Transactions
and Corporate Events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, in the event of Fundamental Transaction, at the request of the Holder delivered before the ninetieth (90<SUP>th</SUP>)
day after the occurrence or consummation of such Fundamental Transaction, the Company (or the Successor Entity) shall purchase this Warrant
from the Holder by paying to the Holder, within five (5) Business Days after such request (or, if later, on the effective date of the
Fundamental Transaction), cash in an amount equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on
the date of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if such Fundamental Transaction is not within the Company&rsquo;s
control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company
or any Successor Entity, as of the date of consummation of such Fundamental Transaction, the same type or form of consideration (and
in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the
holders of Common Stock of the Company in connection with such Fundamental Transaction, whether that consideration be in the form of
cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative
forms of consideration in connection with such Fundamental Transaction; <U>provided</U>, <U>further</U>, that if that if holders of Common
Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be
deemed to have received common stock of the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction)
in such Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>NON-CIRCUMVENTION</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its articles of incorporation or bylaws, or through
any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any
other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times
in good faith carry out all of the provisions of this Warrant and take all action as may be required to protect the rights of the Holder.
Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any Common Stock receivable upon
the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this
Warrant, and (iii) shall, so long as any of the SPA Warrants are outstanding, take all action necessary to reserve and keep available
out of its authorized and unissued Common Stock, solely for the purpose of effecting the exercise of the SPA Warrants, 100% of the number
of shares of Common Stock as shall from time to time be necessary to effect the exercise of the SPA Warrants then outstanding (without
regard to any limitations on exercise ).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <U>WARRANT
HOLDER NOT DEEMED A SHAREHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in such Person&rsquo;s capacity
as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company
for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person&rsquo;s capacity
as the Holder of this Warrant, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any
corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise),
receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant
Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant
shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise)
or as a shareholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding
this Section 6, the Company shall provide the Holder with copies of the same notices and other information given to the shareholders
of the Company generally, contemporaneously with the giving thereof to the shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. <U>REISSUANCE
OF WARRANTS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Transfer
of Warrant</U>. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will
forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may
request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total
number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder
representing the right to purchase the number of Warrant Shares not being transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Lost,
Stolen or Mutilated Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the
Company in customary form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute
and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant Shares then
underlying this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Exchangeable
for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company,
for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the number of Warrant
Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares
as is designated by the Holder at the time of such surrender; <U>provided</U>, <U>however</U>, that no SPA Warrants for fractional Warrant
Shares shall be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Issuance
of New Warrants</U>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant
(i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase
the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or Section 7(c),
the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Warrants
issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have
an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights
and conditions as this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <U>NOTICES</U>.
Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
with Section 5.4 of the Securities Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions
taken pursuant to this Warrant, including in reasonable detail a description of such action and the reason therefor. Without limiting
the generality of the foregoing, the Company will give written notice to the Holder (i) immediately upon any adjustment of the Exercise
Price, setting forth in reasonable detail, and certifying, the calculation of such adjustment and (ii) at least fifteen (15) days prior
to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Common
Stock, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities or rights to purchase stock, warrants,
securities or other property to holders of Common Stock or (C) for determining rights to vote with respect to any Fundamental Transaction,
dissolution or liquidation; <U>provided</U> in each case that such information shall be made known to the public prior to or in conjunction
with such notice being provided to the Holder. It is expressly understood and agreed that the time of exercise specified by the Holder
in each Exercise Notice shall be definitive and may not be disputed or challenged by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <U>AMENDMENT
AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant may be amended or waived and the Company may take
any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the
written consent of the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. <U>GOVERNING
LAW; JURISDICTION; JURY TRIAL</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions
concerning the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the
State of Nevada, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or
any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Nevada. The Company
hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of
Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue
of such suit, action or proceeding is improper. The Company hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof to the Company at the address set forth on the signature
page to the Securities Purchase Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing
contained herein shall be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the Company
in any other jurisdiction to collect on the Company&rsquo;s obligations to the Holder, to realize on any collateral or any other security
for such obligations, or to enforce a judgment or other court ruling in favor of the Holder. <B>THE COMPANY HEREBY IRREVOCABLY WAIVES
ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR
ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. <U>CONSTRUCTION;
HEADINGS</U>. This Warrant shall be deemed to be jointly drafted by the Company and all the Buyers and shall not be construed against
any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect
the interpretation of, this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12. <U>DISPUTE
RESOLUTION</U>. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares,
the Company shall submit the disputed determinations or arithmetic calculations via facsimile or electronic mail within two (2) Business
Days of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company
are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three (3) Business Days
of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two (2) Business
Days submit via facsimile or electronic mail (a) the disputed determination of the Exercise Price to an independent, reputable investment
bank selected by the Company and approved by the Holder or (b) the disputed arithmetic calculation of the Warrant Shares to the Company&rsquo;s
independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to
perform the determinations or calculations and notify the Company and the Holder of the results no later than ten (10) Business Days
from the time it receives the disputed determinations or calculations. Such investment bank&rsquo;s or accountant&rsquo;s determination
or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. <U>REMEDIES,
OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and in addition to all
other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree of specific
performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any
failure by the Company to comply with the terms of this Warrant. The Company acknowledges that a breach by it of its obligations hereunder
will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees
that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available
remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security
being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14. <U>TRANSFER</U>. This
Warrant and the Warrant Shares may be offered for sale, sold, transferred, pledged or assigned without the consent of the Company, except
as may otherwise be required by Section 4.1 of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15. <U>SEVERABILITY</U>. If
any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction,
the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that
it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining
provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions
of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question
does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited,
invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16. <U>DISCLOSURE</U>.
Upon receipt or delivery by the Company of any notice in accordance with the terms of this Warrant, unless the Company has in good faith
determined that the matters relating to such notice do not constitute material, nonpublic information relating to the Company or its
Subsidiaries (as defined in the Securities Purchase Agreement), the Company shall contemporaneously with any such receipt or delivery
publicly disclose such material, nonpublic information on a Form 8-K or otherwise. In the event that the Company believes that a notice
contains material, nonpublic information relating to the Company or its Subsidiaries, the Company so shall indicate to the Holder contemporaneously
with delivery of such notice, and in the absence of any such indication, the Holder shall be allowed to presume that all matters relating
to such notice do not constitute material, nonpublic information relating to the Company or its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17. <U>CERTAIN
DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &ldquo;<B>1933
Act</B>&rdquo; means the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &ldquo;<B>Affiliate</B>&rdquo;
shall have the meaning ascribed to such term in Rule 405 of the 1933 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &ldquo;<B>Approved
Stock Plan</B>&rdquo; means any employee benefit plan or share incentive plan which has been approved by the Board of Directors of the
Company, pursuant to which the Company&rsquo;s securities may be issued to any employee, officer or director or consultant for services
provided to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) &ldquo;<B>Attribution
Parties</B>&rdquo; means, collectively, the following Persons: (i) any investment vehicle, including, any funds, feeder funds or managed
accounts, currently, or from time to time after the Issuance Date, directly or indirectly managed or advised by the Holder&rsquo;s investment
manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder or any of the foregoing, (iii) any
Person acting or who could be deemed to be acting as a Group together with the Holder or any of the foregoing and (iv) any other Persons
whose beneficial ownership of the Common Stock would or could be aggregated with the Holder&rsquo;s and the other Attribution Parties
for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of the foregoing is to subject collectively the Holder and all
other Attribution Parties to the Maximum Percentage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) &ldquo;<B>Black
Scholes Value</B>&rdquo; means the value of this Warrant calculated using the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg determined as of the day immediately following the public announcement of the applicable Fundamental Transaction,
or, if the Fundamental Transaction is not publicly announced, the date the Fundamental Transaction is consummated, for pricing purposes
and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of this
Warrant as of such date of request, (ii) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from
the HVT function on Bloomberg as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction,
or, if the Fundamental Transaction is not publicly announced, the date the Fundamental Transaction is consummated, (iii) the underlying
price per share used in such calculation shall be the greater of (x) the highest Weighted Average Price of the Common Stock during the
period beginning on the Trading Day prior to the execution of definitive documentation relating to the applicable Fundamental Transaction
and ending on (A) the Trading Day immediately following the public announcement of such Fundamental Transaction, if the applicable Fundamental
Transaction is publicly announced or (B) the Trading Day immediately following the consummation of the applicable Fundamental Transaction
if the applicable Fundamental Transaction is not publicly announced and (y) the sum of the price per share being offered in cash, if
any, plus the value of any non-cash consideration, if any, being offered in the Fundamental Transaction, (iv) a zero cost of borrow and
(v) a 360 day annualization factor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) &ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg Financial Markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) &ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) &ldquo;<B>Closing
Bid Price</B>&rdquo; and &ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the last closing bid price and
last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market
begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price, as the case may
be, then the last bid price or the last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported
by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the last closing
bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where such security
is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively,
of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no
closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the
ask prices, respectively, of any market makers for such security as reported on the Pink Open Market. If the Closing Bid Price or the
Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the
Closing Sale Price, as the case may be, of such security on such date shall be the fair market value as mutually determined by the Company
and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall
be resolved pursuant to Section 12. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination,
reclassification or other similar transaction during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<B>Intentionally omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) &ldquo;<B>Convertible
Securities</B>&rdquo; means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable
for Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <B>&ldquo;Common
Stock&rdquo; </B>means (i) the Company&rsquo;s common stock, par value $0.00001, and (ii) any share capital into which such Common Stock
shall have been changed or any share capital resulting from a reclassification, reorganization or reclassification of such Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) &ldquo;<B>Eligible
Market</B>&rdquo; means the Principal Market, the NYSE American, The Nasdaq Global Select Market, The Nasdaq Global Market, The New York
Stock Exchange, Inc., the OTC QB or the OTC QX.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) &ldquo;<B>Excluded
Securities</B>&rdquo; means any Common Stock, restricted share units, warrants and/or Convertible Securities issued or issuable or deemed
to be issued in accordance with Section 2(a) hereof by the Company: (i) under any Approved Stock Plan, (ii) upon exercise of any SPA
Warrants, any Series B Warrants and any Pre-funded Warrants, in each case, issued pursuant to the Securities Purchase Agreement; provided,
that the terms of such SPA Warrants, Series B Warrants and Pre-funded Warrants are not amended, modified or changed on or after the Subscription
Date, (iii) upon conversion, exercise or exchange of any Options or Convertible Securities which are outstanding on the day immediately
preceding the Subscription Date; provided, that such issuance of Common Stock upon exercise of such Options or Convertible Securities
is made pursuant to the terms of such Options or Convertible Securities in effect on the date immediately preceding the Subscription
Date and such Options or Convertible Securities are not amended, modified or changed on or after the Subscription Date, (iv) upon a dividend
or distribution to all holders of Common Stock (including pursuant to a rights plan), (v) upon a stock split, reverse stock split, distribution
of bonus shares, combination or other recapitalization events, (vi) issued pursuant to acquisitions (whether by merger, consolidation,
purchase of equity, purchase of assets, reorganization or otherwise) mergers, consolidations, reorganizations or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that any such issuance shall only be to a Person (or to
the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business
complementary with the business of the Company and shall provide to the Company additional benefits in addition to the investment of
funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or
to an entity whose primary business is investing in securities, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith, or (vii) to which a majority-in-interest of Holders of the Warrants consent in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) &ldquo;<B>Expiration
Date</B>&rdquo; means five (5) years after the later of (a) the date that the Company obtains the Stockholder Approval and (b) the earlier
of (i) the Resale Effective Date registering all of the Registerable Securities or (ii) the date that the Registerable Securities can
be sold, assigned or transferred without restriction or limitation pursuant to Rule 144 or Rule 144A promulgated under the 1933 Act,
as amended, (or a successor rule thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) <B>Intentionally
omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) <FONT STYLE="background-color: white">&ldquo;<B>Floor
Price</B>&rdquo; means (i) prior to Stockholder Approval, a price equal to the Nasdaq Minimum Price on the Pricing Date, as defined in
Nasdaq Listing Rule 5635(d)(1)(A) (which price shall be appropriately adjusted for any stock dividend, stock split, stock combination,
reclassification or similar transaction), or (ii) following Stockholder Approval, a price equal to twenty percent (20%) of the Nasdaq
Minimum Price on the Pricing Date, as defined in Nasdaq Listing Rule 5635(d)(1)(A) (which price shall be appropriately adjusted for any
stock dividend, stock split, stock combination, reclassification or similar transaction.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) &ldquo;<B>Fundamental
Transaction</B>&rdquo; means (A) that the Company shall, directly or indirectly, including through Subsidiaries, Affiliates or otherwise,
in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the surviving corporation)
another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or
assets of the Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule 1-02 of Regulation S-X) to one or more
Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject to or have its Common
Stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the holders
of at least (x) 50% of the outstanding Common Stock, (y) 50% of the outstanding Common Stock calculated as if any Common Stock held by
all Subject Entities making or party to, or Affiliated with any Subject Entities making or party to, such purchase, tender or exchange
offer were not outstanding; or (z) such number of shares of Common Stock such that all Subject Entities making or party to, or Affiliated
with any Subject Entity making or party to, such purchase, tender or exchange offer, become collectively the beneficial owners (as defined
in Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding Common Stock, or (iv) consummate a stock purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with one
or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire, either (x) at least 50% of the
outstanding Common Stock, (y) at least 50% of the outstanding Common Stock calculated as if any Common Stock held by all the Subject
Entities making or party to, or Affiliated with any Subject Entity making or party to, such stock purchase agreement or other business
combination were not outstanding; or (z) such number of shares of Common Stock such that the Subject Entities become collectively the
beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding Common Stock, or (v) reorganize, recapitalize
or reclassify its Common Stock, (B) that the Company shall, directly or indirectly, including through Subsidiaries, Affiliates or otherwise,
in one or more related transactions, allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the
&ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition, purchase,
assignment, conveyance, tender, tender offer, exchange, reduction in outstanding Common Stock, merger, consolidation, business combination,
reorganization, recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification or otherwise
in any manner whatsoever, of either (x) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common
Stock, (y) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock not held by all such
Subject Entities as of the Subscription Date calculated as if any Common Stock held by all such Subject Entities were not outstanding,
or (z) a percentage of the aggregate ordinary voting power represented by issued and outstanding Common Stock or other equity securities
of the Company sufficient to allow such Subject Entities to effect a statutory short form merger or other transaction requiring other
shareholders of the Company to surrender their Common Stock without approval of the shareholders of the Company or (C) directly or indirectly,
including through Subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance of or the entering into any
other instrument or transaction structured in a manner to circumvent, or that circumvents, the intent of this definition in which case
this definition shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this definition
to the extent necessary to correct this definition or any portion of this definition which may be defective or inconsistent with the
intended treatment of such instrument or transaction; provided, however, that the Merger shall not constitute a Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) &ldquo;<B>Group</B>&rdquo;
means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5 thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
&ldquo;<B>Merger</B>&rdquo; means that certain merger, despac transaction and the following distribution of CLOE&rsquo;s (as defined
below) common stock as set out in the Merger Agreement, dated as of June 1, 2023, by and between the Company, Kustom Entertainment, Inc.,
a Delaware corporation, Clover Leaf Capital Corp., a Delaware corporation (&ldquo;CLOE&rdquo;), CL. Merger Sub, Inc., a Nevada corporation,
and Yntegra Capital Investments LLC, a Delaware limited liability company, as may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) <B>Intentionally
omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) &ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase (i) Common Stock or (ii) Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Option
Value&rdquo; </B>means the value of an Option based on the Black and Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg determined as of (A) the Trading Day prior to the public announcement of the issuance of the applicable Option,
if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option
if the issuance of such Option is not publicly announced, for pricing purposes and reflecting (i) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the remaining term of the applicable Option as of the applicable date of determination,
(ii) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg as of
(A) the Trading Day immediately following the public announcement of the applicable Option if the issuance of such Option is publicly
announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly
announced, (iii) the underlying price per share used in such calculation shall be the highest Weighted Average Price of the Common Stock
during the period beginning on the Trading Day prior to the execution of definitive documentation relating to the issuance of the applicable
Option and ending on (A) the Trading Day immediately following the public announcement of such issuance, if the issuance of such Option
is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option
is not publicly announced, (iv) a zero cost of borrow and (v) a 360 day annualization factor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) &ldquo;<B>Parent
Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person, including such entity whose
common capital or equivalent equity security is quoted or listed on an Eligible Market (or, if so elected by the Required Holders, any
other market, exchange or quotation system), or, if there is more than one such Person or such entity, the Person or such entity designated
by the Required Holders or in the absence of such designation, such Person or entity with the largest public market capitalization as
of the date of consummation of the Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) &ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) &ldquo;<B>Pre-funded
Warrants</B>&rdquo; shall have the meaning ascribed to such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) &ldquo;<B>Principal
Market</B>&rdquo; means The Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) <B>Intentionally
omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa) <B>Intentionally
omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) <B>Intentionally
omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) &ldquo;<B>Registrable
Securities</B>&rdquo; shall have the meaning ascribed to such term in the Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd) &ldquo;<B>Registration
Rights Agreement</B>&rdquo; means that certain Registration Rights Agreement dated as of the Subscription Date by and among the Company
and the Buyers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee) &ldquo;<B>Registration
Statement</B>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Buyers of the Registrable Securities (as defined in the Registration Rights Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff) &ldquo;<B>Required
Holders</B>&rdquo; means the holders of the SPA Warrants representing at least a majority of the shares of Common Stock underlying the
SPA Warrants then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg) <B>&ldquo;Resale
Effective Date&rdquo;</B> means the earliest of the date that (a) the initial Registration Statement registering for resale the Registerable
Securities (as defined in the Registration Rights Agreement) has been declared effective by the Commission, (b) all of the Registerable
Securities have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance
with the current public information required under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one
year anniversary of the Closing Date provided that a holder of Registerable Securities is not an Affiliate of the Company, or (d) all
of the Registerable Securities may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without
volume or manner-of-sale restrictions and Company Counsel has delivered to such holders a standing written unqualified opinion that resales
may then be made by such holders of the Registerable Securities pursuant to such exemption which opinion shall be in form and substance
reasonably acceptable to such holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh) &ldquo;<B>Reset
Date</B>&rdquo; means the date following Stockholder Approval that is the earliest of the following dates, (i) the date on which for
twenty (20) consecutive Trading Days all Registrable Securities have become and remained registered pursuant to an effective Registration
Statement that is available for the resale of all Registrable Securities, <U>provided</U>, <U>however</U>, if less than all Registrable
Securities have become registered for resale on the date that a Registration Statement is declared effective, the Holder with respect
to itself only, shall have the right in its sole and absolute discretion to deem such condition satisfied, including with regard only
to the Registrable Securities that have been so registered, (ii) the date on which the Holder, for twenty (20) consecutive Trading Days
can sell all Registrable Securities pursuant to Rule 144 without restriction or limitation and the Company has not had a Public Information
Failure or (iii) twelve (12) months and twenty (20) Trading Days immediately following the Issuance Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) &ldquo;<B>Reset
Period</B>&rdquo; means the period commencing on the twentieth- (20th) Trading Day immediately preceding the Reset Date and ending on
the Reset Date</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj) &ldquo;<B>Reset
Price</B>&rdquo; means the greater of (i) the lowest single day Weighted Average Price of the Common Stock during the Reset Period and
(ii) the Floor Price (as adjusted for stock splits, stock dividends, recapitalizations, reorganizations, reclassification, combinations,
reverse stock splits or other similar events occurring after the Subscription Date).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk) <B>&ldquo;Stockholder
Approval</B>&rdquo; means such approval as may be required by the applicable rules and regulations of The Nasdaq Stock Market LLC (or
any successor entity) from the shareholders of the Company or board of directors in lieu thereof: (a) to consent to the adjustments in
Section 2(a) hereof determined by reference to clause (ii) of the definition of Floor Price , thereby giving full effect to the adjustment
in the Exercise Price and/or number of shares of Common Stock underlying this Warrant following any Dilutive Issuance, (b) to consent
to any adjustment to the Exercise Price and/or number of shares of Common Stock underlying this Warrant in the event of Reset upon the
Reset Date pursuant to Section 2(d) hereof, (c) to consent to any adjustment to the Exercise Price and/or number of shares of Common
Stock underlying this Warrant in the event of a Share Combination Event in Section 2(e) hereof, (d) to consent to any adjustment to the
Exercise Price of this Warrant in the event of a voluntary adjustment pursuant to Section 2(b) hereof, and (e) to consent to any adjustment
of the Maximum Eligibility Number of the Series B Warrants pursuant to Section 2(a) of the Series B Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
&ldquo;<B>Stockholder Approval Date</B>&rdquo; means the date on which Stockholder Approval is received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm) &ldquo;<B>Series
B Warrants</B>&rdquo; shall have the meaning ascribed to such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn) &ldquo;<B>Standard
Settlement Period</B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Eligible Market with respect to the Common Stock as in effect on the date of delivery of the applicable Exercise Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo) &ldquo;<B>Subject
Entity</B>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp) &ldquo;<B>Successor
Entity</B>&rdquo; means one or more Person or Persons (or, if so elected by the Holder, the Company or Parent Entity) formed by, resulting
from or surviving any Fundamental Transaction or one or more Person or Persons (or, if so elected by the Holder, the Company or the Parent
Entity) with which such Fundamental Transaction shall have been entered into.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<B>Intentionally omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<FONT STYLE="background-color: white"><B> Intentionally omitted</B>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss) &ldquo;<B>Trading
Day</B>&rdquo; means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal
trading market for the Common Stock on such day, then on the principal securities exchange or securities market on which the Common Stock
is then traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt) &ldquo;<B>Weighted
Average Price</B>&rdquo; means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal
Market during the period beginning at 9:30:01 a.m., New York time (or such other time as the Principal Market publicly announces is the
official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as the Principal Market publicly announces is
the official close of trading), as reported by Bloomberg through its &ldquo;Volume at Price&rdquo; function or, if the foregoing does
not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board
for such security during the period beginning at 9:30:01 a.m., New York time (or such other time as such market publicly announces is
the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as such market publicly announces is the
official close of trading), as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by
Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for
such security as reported on the Pink Open Market. If the Weighted Average Price cannot be calculated for a security on a particular
date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually
determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security,
then such dispute shall be resolved pursuant to Section 12 with the term &ldquo;Weighted Average Price&rdquo; being substituted for the
term &ldquo;Exercise Price.&rdquo; All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock
combination, reclassification or other similar transaction during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Signature
Page Follows]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out
above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
    ALLY, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    E. Ross</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXERCISE
NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
TO PURCHASE ORDINARY SHARES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
ALLY, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder hereby exercises the right to purchase _________________ Common Stock (&ldquo;<B>Warrant Shares</B>&rdquo;) of Digital
Ally, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), evidenced by the attached Warrant to Purchase Common Stock (the
&ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in
the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Form of Exercise Price. The Holder intends that payment of the Exercise Price shall be made as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________
a &ldquo;<U>Cash Exercise</U>&rdquo; with respect to _________________ Warrant Shares; and/or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________
a &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to _______________ Warrant Shares, resulting in a delivery obligation of the Company
to the Holder of __________ Common Stock representing the applicable Net Number.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Payment of Exercise Price. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares
to be issued pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in
accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Delivery of Warrant Shares. The Company shall deliver to the holder __________ Warrant Shares in accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Date: </FONT></TD>
    <TD STYLE="width: 45%"><FONT STYLE="font-size: 10pt">_______________ __, ______</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">________________________</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name of Registered Holder</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACKNOWLEDGMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby acknowledges this Exercise Notice and hereby directs Securities Transfer Corporation to issue the above indicated number
of shares of Common Stock in accordance with the Transfer Agent Instructions dated ________ __, 2024 from the Company and acknowledged
and agreed to by Securities Transfer Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
    ALLY, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    E. Ross</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>4
<FILENAME>ex4-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL SELECTED BY THE HOLDER, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT
REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES
MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
ALLY, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Series
B Warrant To Purchase Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Warrant Shares: Up to the Maximum Eligibility Number</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Issuance: June 25, 2024 (&ldquo;<B>Issuance Date</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Digital
Ally, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged<FONT STYLE="text-transform: uppercase">, _____________</FONT>, the registered
holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set forth below, to purchase
from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the date Stockholder Approval
is obtained until the date this Warrant is exercised in full, up to the Maximum Eligibility Number of fully paid nonassessable shares
of Common Stock, subject to adjustment as provided herein (the &ldquo;<B>Warrant Shares</B>&rdquo;). Except as otherwise defined herein,
capitalized terms in this Series B Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange,
transfer or replacement hereof, this &ldquo;<B>Warrant</B>&rdquo;), shall have the meanings set forth in Section 17. This Warrant is
one of the Series B Warrants to purchase Common Stock (the &ldquo;<B>SPA Warrants</B>&rdquo;) issued pursuant to that certain Securities
Purchase Agreement, dated as of June 24, 2024 (the &ldquo;<B>Subscription Date</B>&rdquo;), by and among the Company and the investors
(the &ldquo;<B>Buyers</B>&rdquo;) referred to therein (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;). Capitalized terms used
herein and not otherwise defined shall have the definitions ascribed to such terms in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>EXERCISE OF WARRANT.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Mechanics of Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in
Section 1(f)), this Warrant may be exercised by the Holder at any time or times on or after the Stockholder Approval Date, in whole or
in part, by (i) delivery of a written notice, in the form attached hereto as <U>Exhibit A</U> (the &ldquo;<B>Exercise Notice</B>&rdquo;),
of the Holder&rsquo;s election to exercise this Warrant and (ii) (A) payment to the Company of an amount equal to the applicable Exercise
Price multiplied by the number of Warrant Shares as to which this Warrant is being exercised (the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;)
in cash by wire transfer of immediately available funds or (B) by notifying the Company that this Warrant is being exercised pursuant
to a Cashless Exercise (as defined in Section 1(d)). The Holder shall not be required to deliver the original Warrant in order to effect
an exercise hereunder. Execution and delivery of the Exercise Notice with respect to less than all of the Warrant Shares shall have the
same effect as cancellation of the original Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number
of Warrant Shares. On or before the first (1<SUP>st</SUP>) Trading Day following the date on which the Company has received the Exercise
Notice, the Company shall transmit by electronic mail an acknowledgment of confirmation of receipt of the Exercise Notice to the Holder
and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;). On or before the earlier of (i) the first (1<SUP>st</SUP>)
Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case, following the date on which
the Holder delivers the Exercise Notice to the Company, so long as the Holder delivers the Aggregate Exercise Price (or notice of a Cashless
Exercise) on or prior to the Trading Day following the date on which the Company has received the Exercise Notice (the &ldquo;<B>Share
Delivery Date</B>&rdquo;) (provided that if the Aggregate Exercise Price has not been delivered by such date, the Share Delivery Date
shall be one (1) Trading Day after the Aggregate Exercise Price (or notice of a Cashless Exercise) is delivered), the Company shall (X)
provided that the Transfer Agent is participating in The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities
Transfer Program and (A) the Warrant Shares are subject to an effective resale registration statement in favor of the Holder or (B) if
exercised via Cashless Exercise, at a time when Rule 144 would be available for resale of the Warrant Shares by the Holder, credit such
aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s
balance account with DTC through its Deposit / Withdrawal At Custodian system, or (Y) if the Transfer Agent is not participating in the
DTC Fast Automated Securities Transfer Program or (A) the Warrant Shares are not subject to an effective resale registration statement
in favor of the Holder and (B) if exercised via Cashless Exercise, at a time when Rule 144 would not be available for resale of the Warrant
Shares by the Holder, deliver to the Holder, book entry statements evidencing the Warrant Shares, for the number of Warrant Shares to
which the Holder is entitled pursuant to such exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares
subject to an Exercise Notice by the Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Exercise Notice), $10 per Trading Day (increasing to $20 per Trading Day on the third (3rd) Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The
Company shall be responsible for all fees and expenses of the Transfer Agent and all fees and expenses with respect to the issuance of
Warrant Shares via DTC, if any. Upon delivery of the Exercise Notice, the Holder shall be deemed for all corporate purposes to have become
the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such Warrant
Shares are credited to the Holder&rsquo;s DTC account or the date of delivery of the book entry statements evidencing such Warrant Shares,
as the case may be. If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a) and the number of Warrant
Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon an exercise,
then the Company shall as soon as practicable and in no event later than three (3) Trading Days after any exercise and at its own expense,
issue a new Warrant (in accordance with Section 7(d)) representing the right to purchase the number of Warrant Shares issuable immediately
prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised. No fractional
Warrant Shares are to be issued upon the exercise of this Warrant, but rather the number of Warrant Shares to be issued shall be rounded
down to the nearest whole number. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.
The Company&rsquo;s obligations to issue and deliver Warrant Shares in accordance with the terms and subject to the conditions hereof
are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with
respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim,
recoupment, limitation or termination. <FONT STYLE="text-transform: uppercase"><B>Notwithstanding any provision of this Warrant to the
contrary, no more than the Maximum Eligibility Number of Warrant Shares shall be exercisable hereunder.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise
Price</U>. For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $0.001 per share, subject to adjustment as provided
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
1(a) by the Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Company&rsquo;s Failure to Timely Deliver Securities</U>. In addition to any other rights available to the Holder, if the Company
shall fail to cause its Transfer Agent to transmit to the Holder on or prior to the Share Delivery Date, Warrant Shares pursuant to an
exercise notice delivered by the Holder and if after such date the Holder is required by its broker to purchase (in an open market transaction
or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, Common Stock to deliver in satisfaction of a sale by the Holder
of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;Buy-In&rdquo;), then the Company shall, within
three (3) Trading Days after the Holder&rsquo;s request, (a) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the Common Stock so purchased exceeds (y) the amount obtained by multiplying
(1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times
(2) the price at which the sell order giving rise to such purchase obligation was executed, and (b) at the option of the Holder, either
reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such
exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the
Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Common Stock with an aggregate sale price
giving rise to such purchase obligation of $10,000, under clause (a) of the immediately preceding sentence the Company shall be required
to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect
of the Buy-In and evidence of the amount of such loss. Nothing herein shall limit the Holder&rsquo;s right to pursue any other remedies
available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief
with respect to the Company&rsquo;s failure to timely deliver Common Stock upon the exercise of this Warrant as required pursuant to
the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Cashless Exercise. If at any time after the Release Date, there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, the Holder may, in its sole discretion, exercise
this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise
in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the &ldquo;Net Number&rdquo; of shares of Common
Stock determined according to the following formula (a &ldquo;<B>Cashless Exercise</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
Number = <U>(A x B) - (A x C)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.75in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the foregoing formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A=
the total number of shares with respect to which this Warrant is then being exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B=
as applicable: (i) the Weighted Average Price of the Common Stock on the Trading Day immediately preceding the date of the applicable
Exercise Notice if such Exercise Notice is (1) both executed and delivered pursuant to Section 1(a) hereof on a day that is not a Trading
Day or (2) both executed and delivered pursuant to Section 1(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the
bid price of the Common Stock on the principal Principal Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution
of the applicable Exercise Notice, if such Exercise Notice is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and
is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on
a Trading Day) pursuant to Section 1(a) hereof or (iii) the Weighted Average Price of the Common Stock on the date of the applicable
Exercise Notice if the date of such Exercise Notice is a Trading Day and such Exercise Notice is both executed and delivered pursuant
to Section 1(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 94.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C=
the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 94.5pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Common Stock is issued pursuant to this Section 1(e), the Company hereby acknowledges and agrees that the Warrant Shares issued in a
Cashless Exercise shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed
to have commenced, on the date this Warrant was originally issued pursuant to the Securities Purchase Agreement. The Company agrees not
to take any position contrary to this Section 1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Disputes</U>. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant
Shares, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute in
accordance with Section 12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Beneficial Ownership Limitations on Exercises</U>. Notwithstanding anything to the contrary contained herein, the Company shall not
effect the exercise of any portion of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant,
pursuant to the terms and conditions of this Warrant and any such exercise shall be null and void and treated as if never made, to the
extent that after giving effect to such exercise, the Holder together with the other Attribution Parties collectively would beneficially
own in excess of 4.99% (the &ldquo;<B>Maximum Percentage</B>&rdquo;) of the number of shares of Common Stock outstanding immediately
after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially
owned by the Holder and the other Attribution Parties shall include the number of shares of Common Stock held by the Holder and all other
Attribution Parties plus the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination
of such sentence is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (A) exercise of the
remaining, unexercised portion of this Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise
or conversion of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible
notes or convertible preferred stock or warrants, including the Series A Warrants) and Pre-funded Warrants beneficially owned by the
Holder or any other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained in this
Section 1(g). For purposes of this Section 1(g), beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities
Exchange Act of 1934, as amended (the &ldquo;<B>1934 Act</B>&rdquo;). For purposes of this Warrant, in determining the number of shares
outstanding Common Stock the Holder may acquire upon the exercise of this Warrant without exceeding the Maximum Percentage, the Holder
may rely on the number of shares outstanding Common Stock as reflected in (x) the Company&rsquo;s most recent Annual Report on Form 10-K,
Current Report on Form 8-K or other public filing with the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;), as the
case may be, (y) a more recent public announcement by the Company or (3) any other written notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding (the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). If the Company
receives an Exercise Notice from the Holder at a time when the actual number of shares of Common Stock outstanding is less than the Reported
Outstanding Share Number, the Company shall (i) notify the Holder in writing of the number of shares of Common Stock then outstanding
and, to the extent that such Exercise Notice would otherwise cause the Holder&rsquo;s beneficial ownership, as determined pursuant to
this Section 1(g), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to be purchased
pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the &ldquo;<B>Reduction Shares</B>&rdquo;)
and (ii) as soon as reasonably practicable, the Company shall return to the Holder any exercise price paid by the Holder for the Reduction
Shares. For any reason at any time, upon the written or oral request of the Holder, the Company shall within one (1) Trading Day confirm
orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder and any other Attribution Party since the date as of which the Reported Outstanding Share Number
was reported. In the event that the issuance of Common Stock to the Holder upon exercise of this Warrant results in the Holder and the
other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of shares
outstanding Common Stock (as determined under Section 13(d) of the 1934 Act), the number of shares so issued by which the Holder&rsquo;s
and the other Attribution Parties&rsquo; aggregate beneficial ownership exceeds the Maximum Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;)
shall be deemed null and void and shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer the Excess
Shares. As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return
to the Holder the exercise price paid by the Holder for the Excess Shares. Upon delivery of a written notice to the Company, the Holder
may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified in such
notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such
notice is delivered to the Company and (ii) any such increase or decrease will apply only to the Holder and the other Attribution Parties
and not to any other holder of SPA Warrants that is not an Attribution Party of the Holder. For purposes of clarity, the Common Stock
issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the
Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. <FONT STYLE="background-color: white">No
</FONT>prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions
of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(g) to the extent necessary to correct
this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial ownership limitation
contained in this Section 1(g) or to make changes or supplements necessary or desirable to properly give effect to such limitation. The
limitation contained in this paragraph may not be waived and shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Insufficient Authorized Shares</U>. If at any time while this Warrant remains outstanding the Company does not have a sufficient number
of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve for issuance upon exercise of this Warrant at
least a number of shares of Common Stock equal to 100% of the number of shares of Common Stock as shall from time to time be necessary
to effect the exercise of all of this Warrant then outstanding without regard to any limitation on exercise included herein and assuming
that the Maximum Eligibility Number is being determined based on a Reset Price equal to $0.502 (as adjusted for stock splits, stock dividends,
recapitalizations, reorganizations, reclassification, combinations, reverse stock splits or other similar events occurring after the
Subscription Date) (the &ldquo;<B>Required Reserve Amount</B>&rdquo; and the failure to have such sufficient number of authorized and
unreserved Common Stock, an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company shall immediately take all action necessary
to increase the Company&rsquo;s number of authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the
Required Reserve Amount for this Warrant then outstanding. Without limiting the generality of the foregoing sentence, as soon as practicable
after the date of the occurrence of an Authorized Share Failure, but in no event later than sixty (60) days after the occurrence of such
Authorized Share Failure, the Company shall hold a meeting of its shareholders for the approval of an increase in the number of authorized
shares of Common Stock. In connection with such meeting, the Company shall provide each shareholder with a proxy statement and shall
use its best efforts to solicit its shareholders&rsquo; approval of such increase in authorized shares of Common Stock and to cause its
board of directors to recommend to the shareholders that they approve such proposal. Notwithstanding the foregoing, if any such time
of an Authorized Share Failure, the Company is able to obtain the approval of holders of a majority of the shares voting at a general
meeting to approve the increase in the number of authorized shares of Common Stock, the Company may satisfy this obligation by obtaining
such approval. In the event that upon any exercise of this Warrant, the Company does not have sufficient authorized shares to deliver
in satisfaction of such exercise, then unless the Holder elects to void such attempted exercise, the Holder may require the Company to
pay to the Holder within three (3) Trading Days of the applicable exercise, cash in an amount equal to the product of (i) the quotient
determined by dividing (x) the number of Warrant Shares that the Company is unable to deliver pursuant to this Section 1(h), by (y) the
total number of Warrant Shares issuable upon exercise of this Warrant (without regard to any limitations or restrictions on exercise
of this Warrant) and (ii) the Black Scholes Value; provided, that (x) references to &ldquo;the day immediately following the public announcement
of the applicable Fundamental Transaction&rdquo; in the definition of &ldquo;Black Scholes Value&rdquo; shall instead refer to &ldquo;the
date the Holder exercises this Warrant and the Company cannot deliver the required number of Warrant Shares because of an Authorized
Share Failure&rdquo; and (y) clause (iii) of the definition of &ldquo;Black Scholes Value&rdquo; shall instead refer to &ldquo;the underlying
price per share used in such calculation shall be the highest Weighted Average Price during the period beginning on the date of the applicable
date of exercise and the date that the Company makes the applicable cash payment.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and the number of Warrant Shares shall be adjusted
from time to time as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Maximum Eligibility Number Reset</U>. The Maximum Eligibility Number shall be increased (but not decreased) on the Reset Date to equal
the Reset Share Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Notwithstanding the foregoing, if a Holder requests to exercise this Warrant in whole or in part, on any given date prior to the Reset
Date on which (i) all Registrable Securities have become and remained registered pursuant to an effective Registration Statement that
is available for the resale of all Registrable Securities, provided, however, if less than all Registrable Securities have become registered
for resale on the date that a Registration Statement is declared effective, the Holder with respect to itself only, shall have the right
in its sole and absolute discretion to deem such condition satisfied, including with regard only to the Registrable Securities that have
been so registered, (ii) the Holder can sell all Registrable Securities pursuant to Rule 144 without restriction or limitation and the
Company has not had a Public Information Failure or (iii) twelve (12) months immediately following the Issuance Date (any such date,
an &ldquo;<B>Exercise Date</B>&rdquo;), solely with respect to such portion of this Warrant being exercised on such applicable Exercise
Date, (a) such applicable Reset Date shall be deemed to mean the Exercise Date, (b) such applicable Reset Period shall be deemed to have
commenced on the applicable date set forth in clause (i), (ii) or (iii) hereof and ended on the twenty-first (21st) Trading Day thereafter
and (c) the applicable Reset Price and Reset Share Amount for such exercised Warrants shall be calculated pursuant to this Section 2(a).
For the avoidance of doubt, following the calculation of the Reset Price and Reset Share Amount pursuant to this Section 2(a)(i), the
Company&rsquo;s obligations with regard to such exercised Warrants shall be deemed satisfied and no additional Reset Price and Reset
Share Amount shall apply to such exercised Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Adjustment Upon Subdivision or Combination of Common Stock</U>. If the Company at any time on or after the Subscription Date subdivides
(by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding Common Stock into a greater
number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of
Warrant Shares will be proportionately increased. If the Company at any time on or after the Subscription Date combines (by combination,
reverse stock split or otherwise) one or more classes of its outstanding Common Stock into a smaller number of shares, the Exercise Price
in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately
decreased. Any adjustment under this Section 2(b) shall become effective at the close of business on the date the subdivision or combination
becomes effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Partial Reset</U>. If less than all of the Registrable Securities have been registered pursuant to the clause (i) of the definition
of Reset Date and a Holder has deemed the condition satisfied as to such Registrable Securities, then the Reset Date shall apply only
to such portion of the Registrable Securities, and the Company&rsquo;s obligations will continue to apply with regard to the Registrable
Securities for which the definition of Reset Date has not been not satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>RIGHTS UPON DISTRIBUTION OF ASSETS</U>. If the Company shall declare or make any dividend or other distribution of its assets (or
rights to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise (including, without limitation, any
distribution of cash, stock or other securities, property, options, evidence of indebtedness or any other assets by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without
limitation, the Maximum Percentage) immediately before the date of which a record is taken for such Distribution, or, if no such record
is taken, the date as of which the record holders of Common Stock is to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder and
the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution
to such extent (and shall not be entitled to beneficial ownership of such Common Stock as a result of such Distribution (and beneficial
ownership) to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time
or times as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, at which
time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial Distribution or on
any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Purchase Rights</U>. In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells
any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders
of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise
of this Warrant, including without limitation, the Maximum Percentage) immediately before the date on which a record is taken for the
grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock
is to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the
Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder and the other Attribution Parties exceeding
the Maximum Percentage, then the Holder shall not be entitled to participate in such Purchase Right to such extent (and shall not be
entitled to beneficial ownership of such Common Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and
such Purchase Right to such extent shall be held in abeyance for the benefit of the Holder until such time or times as its right thereto
would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times the Holder
shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase
Right held similarly in abeyance) to the same extent as if there had been no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Fundamental Transactions</U>. Except the Merger, the Company shall not enter into a Fundamental Transaction unless the Successor Entity
assumes in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the
provisions of this Section 4(b) pursuant to written agreements in form and substance satisfactory to the Required Holders, including
agreements , if so requested by the Holder, to deliver to each holder of the SPA Warrants in exchange for such SPA Warrants a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant, including, without
limitation, an adjusted exercise price equal to the value for the Common Stock reflected by the terms of such Fundamental Transaction,
and exercisable for a corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable
upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and satisfactory to the Required Holders, and with an exercise price which applies the exercise price hereunder to such shares of capital
stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value
of such shares of capital stock, such adjustments to the number of shares of capital stock and such exercise price being for the purpose
of protecting the economic value of this Warrant immediately prior to the occurrence or consummation of such Fundamental Transaction).
Any security issuable or potentially issuable to the Holder pursuant to the terms of this Warrant on the consummation of a Fundamental
Transaction that was within the Company&rsquo;s control to enter into or to avoid shall be registered and freely tradable by the Holder
without any restriction or limitation or the requirement to be subject to any holding period pursuant to any applicable securities laws.
<FONT STYLE="background-color: white">No later than (i) thirty (30) days prior to the occurrence or consummation of any Fundamental Transaction
or (ii) if later, the first Trading Day following the date the Company first becomes aware of the occurrence or potential occurrence
of a Fundamental Transaction, the Company shall deliver written notice thereof via facsimile or electronic mail and overnight courier
to the Holder. </FONT>Upon the occurrence or consummation of any Fundamental Transaction that was within the Company&rsquo;s control
to enter into or to avoid, it shall be a required condition to the occurrence or consummation of any such Fundamental Transaction that,
the Company and the Successor Entity or Successor Entities, jointly and severally, shall succeed to, and the Company shall cause any
Successor Entity or Successor Entities to jointly and severally succeed to, and be added to the term &ldquo;Company&rdquo; under this
Warrant (so that from and after the date of such Fundamental Transaction, each and every provision of this Warrant referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Company and
the Successor Entity or Successor Entities, jointly and severally, may exercise every right and power of the Company prior thereto and
shall assume all of the obligations of the Company prior thereto under this Warrant with the same effect as if the Company and such Successor
Entity or Successor Entities, jointly and severally, had been named as the Company in this Warrant, and, solely at the request of the
Holder, if the Successor Entity and/or Successor Entities is a publicly traded corporation whose common stock is quoted on or listed
for trading on an Eligible Market, shall deliver (in addition to and without limiting any right under this Warrant) to the Holder in
exchange for this Warrant a security of the Successor Entity and/or Successor Entities evidenced by a written instrument substantially
similar in form and substance to this Warrant and exercisable for a corresponding number of shares of capital stock of the Successor
Entity and/or Successor Entities (the &ldquo;<B>Successor Capital Stock</B>&rdquo;) equivalent to the shares of Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction (such corresponding number of shares of Successor Capital Stock to be delivered to the Holder shall be equal to the greater
of (A) the quotient of (i) the aggregate dollar value of all consideration (including cash consideration and any consideration other
than cash (&ldquo;<B>Non-Cash Consideration</B>&rdquo;), in such Fundamental Transaction, as such values are set forth in any definitive
agreement for the Fundamental Transaction that has been executed at the time of the first public announcement of the Fundamental Transaction
or, if no such value is determinable from such definitive agreement, as determined in accordance with Section 12 with the term &ldquo;Non-Cash
Consideration&rdquo; being substituted for the term &ldquo;Exercise Price&rdquo;) that the Holder would have been entitled to receive
upon the happening of such Fundamental Transaction or the record, eligibility or other determination date for the event resulting in
such Fundamental Transaction, had this Warrant been exercised immediately prior to such Fundamental Transaction or the record, eligibility
or other determination date for the event resulting in such Fundamental Transaction (without regard to any limitations on the exercise
of this Warrant) (the &ldquo;<B>Aggregate Consideration</B>&rdquo;) divided by (ii) the per share Closing Sale Price of such Successor
Capital Stock on the Trading Day immediately prior to the consummation or occurrence of the Fundamental Transaction and (B) the product
of (i) the quotient obtained by dividing (x) the Aggregate Consideration, by (y) the Closing Sale Price of the Common Stock on the Trading
Day immediately prior to the consummation or occurrence of the Fundamental Transaction and (ii) the highest exchange ratio pursuant to
which any shareholder of the Company may exchange Common Stock for Successor Capital Stock) (<U>provided</U>, <U>however</U>, to the
extent that the Holder&rsquo;s right to receive any such shares of publicly traded common stock (or their equivalent) of the Successor
Entity would result in the Holder and its other Attribution Parties exceeding the Maximum Percentage, if applicable, then the Holder
shall not be entitled to receive such shares to such extent (and shall not be entitled to beneficial ownership of such shares of publicly
traded common stock (or their equivalent) of the Successor Entity as a result of such consideration to such extent) and the portion of
such shares shall be held in abeyance for the Holder until such time or times, as its right thereto would not result in the Holder and
its other Attribution Parties exceeding the Maximum Percentage, at which time or times the Holder shall be delivered such shares to the
extent as if there had been no such limitation), and such security shall be satisfactory to the Holder, and with an identical exercise
price to the Exercise Price hereunder (such adjustments to the number of shares of capital stock and such exercise price being for the
purpose of protecting after the consummation or occurrence of such Fundamental Transaction the economic value of this Warrant that was
in effect immediately prior to the consummation or occurrence of such Fundamental Transaction, as elected by the Holder solely at its
option). Upon occurrence or consummation of the Fundamental Transaction <FONT STYLE="background-color: white">that was within the Company&rsquo;s
control to enter into or to avoid</FONT>, and it shall be a required condition to the occurrence or consummation of such Fundamental
Transaction that, the Company and the Successor Entity or Successor Entities shall deliver to the Holder confirmation that there shall
be issued upon exercise of this Warrant at any time after the occurrence or consummation of the Fundamental Transaction, as elected by
the Holder solely at its option, Common Stock, Successor Capital Stock or, in lieu of the Common Stock or Successor Capital Stock (or
other securities, cash, assets or other property purchasable upon the exercise of this Warrant prior to such Fundamental Transaction),
such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription
rights), which for purposes of clarification may continue to be Common Stock, if any, that the Holder would have been entitled to receive
upon the happening of such Fundamental Transaction or the record, eligibility or other determination date for the event resulting in
such Fundamental Transaction, had this Warrant been exercised immediately prior to such Fundamental Transaction or the record, eligibility
or other determination date for the event resulting in such Fundamental Transaction (without regard to any limitations on the exercise
of this Warrant), as adjusted in accordance with the provisions of this Warrant. In addition to and not in substitution for any other
rights hereunder, prior to the occurrence or consummation of any Fundamental Transaction <FONT STYLE="background-color: white">that was
within the Company&rsquo;s control to enter into or to avoid</FONT>, pursuant to which holders of Common Stock are entitled to receive
securities, cash, assets or other property with respect to or in exchange for Common Stock (a &ldquo;<B>Corporate Event</B>&rdquo;),
the Company shall make appropriate provision to ensure that, and any applicable Successor Entity or Successor Entities shall ensure that,
and it shall be a required condition to the occurrence or consummation of such Corporate Event that, the Holder will thereafter have
the right to receive upon exercise of this Warrant at any time after the occurrence or consummation of the Corporate Event, Common Stock
or Successor Capital Stock or, if so elected by the Holder, in lieu of the Common Stock (or other securities, cash, assets or other property)
purchasable upon the exercise of this Warrant prior to such Corporate Event (but not in lieu of such items still issuable under Sections
3 and 4(a), which shall continue to be receivable on the Common Stock or on the such shares of stock, securities, cash, assets or any
other property otherwise receivable with respect to or in exchange for Common Stock), such shares of stock, securities, cash, assets
or any other property whatsoever (including warrants or other purchase or subscription rights and any Common Stock) which the Holder
would have been entitled to receive upon the occurrence or consummation of such Corporate Event or the record, eligibility or other determination
date for the event resulting in such Corporate Event, had this Warrant been exercised immediately prior to such Corporate Event or the
record, eligibility or other determination date for the event resulting in such Corporate Event (without regard to any limitations on
exercise of this Warrant). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably satisfactory
to the Holder. The provisions of this Section 4(b) shall apply similarly and equally to successive Fundamental Transactions and Corporate
Events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>NON-CIRCUMVENTION</U>. The Company hereby covenants and agrees that the Company will not, by amendment of its articles of incorporation
or bylaws, or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale
of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
and will at all times in good faith carry out all of the provisions of this Warrant and take all action as may be required to protect
the rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any Common
Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be
necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock
upon the exercise of this Warrant, and (iii) shall, so long as any of the SPA Warrants are outstanding, take all action necessary to
reserve and keep available out of its authorized and unissued Common Stock, solely for the purpose of effecting the exercise of the SPA
Warrants, 100% of the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of the SPA Warrants
then outstanding (without regard to any limitations on exercise and assuming that the Maximum Eligibility Number is being determined
based on a Reset Price equal to $0.502 (as adjusted for stock splits, stock dividends, recapitalizations, reorganizations, reclassification,
combinations, reverse stock splits or other similar events occurring after the Subscription Date)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>WARRANT HOLDER NOT DEEMED A SHAREHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in such Person&rsquo;s
capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of
the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person&rsquo;s
capacity as the Holder of this Warrant, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent
to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or
otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of
the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained
in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant
or otherwise) or as a shareholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.
Notwithstanding this Section 6, the Company shall provide the Holder with copies of the same notices and other information given to the
shareholders of the Company generally, contemporaneously with the giving thereof to the shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>REISSUANCE OF WARRANTS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transfer of Warrant</U>. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the
Company will forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as
the Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less
than the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section
7(d)) to the Holder representing the right to purchase the number of Warrant Shares not being transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Lost, Stolen or Mutilated Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss,
theft, destruction or mutilation of this Warrant, and, in the case of loss, theft or destruction, of any indemnification undertaking
by the Holder to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company
shall execute and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant
Shares then underlying this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Exchangeable for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office
of the Company, for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the
number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of
such Warrant Shares as is designated by the Holder at the time of such surrender; <U>provided</U>, <U>however</U>, that no SPA Warrants
for fractional Warrant Shares shall be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Issuance of New Warrants</U>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such
new Warrant (i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right
to purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or
Section 7(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other
new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii)
shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have
the same rights and conditions as this Warrant.</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>NOTICES</U>. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given
in accordance with Section 5.4 of the Securities Purchase Agreement. The Company shall provide the Holder with prompt written notice
of all actions taken pursuant to this Warrant, including in reasonable detail a description of such action and the reason therefor. Without
limiting the generality of the foregoing, the Company will give written notice to the Holder (i) immediately upon any adjustment of the
Exercise Price, setting forth in reasonable detail, and certifying, the calculation of such adjustment and (ii) at least fifteen (15)
days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon
the Common Stock, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities or rights to purchase stock,
warrants, securities or other property to holders of Common Stock or (C) for determining rights to vote with respect to any Fundamental
Transaction, dissolution or liquidation; <U>provided</U> in each case that such information shall be made known to the public prior to
or in conjunction with such notice being provided to the Holder. It is expressly understood and agreed that the time of exercise specified
by the Holder in each Exercise Notice shall be definitive and may not be disputed or challenged by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>AMENDMENT AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant may be amended or waived and the Company
may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained
the written consent of the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>GOVERNING LAW; JURISDICTION; JURY TRIAL</U>. This Warrant shall be governed by and construed and enforced in accordance with, and
all questions concerning the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal
laws of the State of Nevada, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of
New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Nevada.
The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York,
Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum
or that the venue of such suit, action or proceeding is improper. The Company hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by mailing a copy thereof to the Company at the address set forth
on the signature page to the Securities Purchase Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law. Nothing contained herein shall be deemed or operate to preclude the Holder from bringing suit or taking other legal
action against the Company in any other jurisdiction to collect on the Company&rsquo;s obligations to the Holder, to realize on any collateral
or any other security for such obligations, or to enforce a judgment or other court ruling in favor of the Holder. <B>THE COMPANY HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN
CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>CONSTRUCTION; HEADINGS</U>. This Warrant shall be deemed to be jointly drafted by the Company and all the Buyers and shall not be
construed against any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form
part of, or affect the interpretation of, this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>DISPUTE RESOLUTION</U>. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the
Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile or electronic mail within
two (2) Business Days of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder. If the Holder
and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three (3)
Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within
two (2) Business Days submit via facsimile or electronic mail (a) the disputed determination of the Exercise Price to an independent,
reputable investment bank selected by the Company and approved by the Holder or (b) the disputed arithmetic calculation of the Warrant
Shares to the Company&rsquo;s independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant,
as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later than
ten (10) Business Days from the time it receives the disputed determinations or calculations. Such investment bank&rsquo;s or accountant&rsquo;s
determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and in
addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree
of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages
for any failure by the Company to comply with the terms of this Warrant. The Company acknowledges that a breach by it of its obligations
hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore
agrees that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other
available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other
security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>TRANSFER</U>. This Warrant and the Warrant Shares may be offered for sale, sold, transferred, pledged or assigned without the consent
of the Company, except as may otherwise be required by Section 4.1 of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>SEVERABILITY</U>. If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by
a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or
the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as
close as possible to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<U>DISCLOSURE</U>. Upon receipt or delivery by the Company of any notice in accordance with the terms of this Warrant, unless the Company
has in good faith determined that the matters relating to such notice do not constitute material, nonpublic information relating to the
Company or its Subsidiaries (as defined in the Securities Purchase Agreement), the Company shall contemporaneously with any such receipt
or delivery publicly disclose such material, nonpublic information on a Current Report on Form 8-K or otherwise. In the event that the
Company believes that a notice contains material, nonpublic information relating to the Company or its Subsidiaries, the Company so shall
indicate to the Holder contemporaneously with delivery of such notice, and in the absence of any such indication, the Holder shall be
allowed to presume that all matters relating to such notice do not constitute material, nonpublic information relating to the Company
or its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<U>CERTAIN DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>1933 Act</B>&rdquo; means the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<B>Affiliate</B>&rdquo; shall have the meaning ascribed to such term in Rule 405 of the 1933 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<B>Common Stock</B>&rdquo; means (i) the Company&rsquo;s common stock, par value $0.00001, and (ii) any share capital into which
such Common Stock shall have been changed or any share capital resulting from a reclassification, reorganization or reclassification
of such Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<B>Attribution Parties</B>&rdquo; means, collectively, the following Persons: (i) any investment vehicle, including, any funds,
feeder funds or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly managed or advised
by the Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder
or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the
foregoing and (iv) any other Persons whose beneficial ownership of the Common Stock would or could be aggregated with the Holder&rsquo;s
and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of the foregoing is to subject
collectively the Holder and all other Attribution Parties to the Maximum Percentage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<B>Black Scholes Value</B>&rdquo; means the value of this Warrant calculated using the Black-Scholes Option Pricing Model obtained
from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day immediately following the public announcement of the applicable
Fundamental Transaction, or, if the Fundamental Transaction is not publicly announced, the date the Fundamental Transaction is consummated,
for pricing purposes and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining
term of this Warrant as of such date of request, (ii) an expected volatility equal to the greater of 100% and the 100 day volatility
obtained from the HVT function on Bloomberg as of the Trading Day immediately following the public announcement of the applicable Fundamental
Transaction, or, if the Fundamental Transaction is not publicly announced, the date the Fundamental Transaction is consummated, (iii)
the underlying price per share used in such calculation shall be the greater of (x) the highest Weighted Average Price of the Common
Stock during the period beginning on the Trading Day prior to the execution of definitive documentation relating to the applicable Fundamental
Transaction and ending on (A) the Trading Day immediately following the public announcement of such Fundamental Transaction, if the applicable
Fundamental Transaction is publicly announced or (B) the Trading Day immediately following the consummation of the applicable Fundamental
Transaction if the applicable Fundamental Transaction is not publicly announced and (y) the sum of the price per share being offered
in cash, if any, plus the value of any non-cash consideration, if any, being offered in the Fundamental Transaction, (iv) a zero cost
of borrow and (v) a 360 day annualization factor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<B>Bloomberg</B>&rdquo; means Bloomberg Financial Markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New
York are authorized or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<B>Closing Bid Price</B>&rdquo; and &ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the last closing
bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the
Principal Market begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price,
as the case may be, then the last bid price or the last trade price, respectively, of such security prior to 4:00:00 p.m., New York time,
as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the
last closing bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where
such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade
price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as reported by
Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of
the bid prices, or the ask prices, respectively, of any market makers for such security as reported on the Pink Open Market. If the Closing
Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing
Bid Price or the Closing Sale Price, as the case may be, of such security on such date shall be the fair market value as mutually determined
by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such
dispute shall be resolved pursuant to Section 12. All such determinations to be appropriately adjusted for any stock dividend, stock
split, stock combination, reclassification or other similar transaction during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<B>Closing Date</B>&rdquo; shall have the meaning ascribed to such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<B>Convertible Securities</B>&rdquo; means any stock or securities (other than Options) directly or indirectly convertible into
or exercisable or exchangeable for Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<B>Intentionally omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&ldquo;<B>Eligible Market</B>&rdquo; means the Principal Market, the NYSE American, The Nasdaq Global Select Market, The Nasdaq Global
Market, The New York Stock Exchange, Inc., the OTC QB or the OTC QX.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<B>Intentionally omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<B>Intentionally omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<B>Intentionally omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<B>&ldquo;Floor Price&rdquo; </B><FONT STYLE="background-color: white">means a price equal to twenty percent (20%) of the Nasdaq Minimum
Price on the Subscription Date, as defined in Nasdaq Listing Rule 5635(d)(1)(A) (which price shall be appropriately adjusted for any
stock dividend, stock split, stock combination, reclassification or similar transaction)</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
&ldquo;<B>Fundamental Transaction</B>&rdquo; means (A) that the Company shall, directly or indirectly, including through Subsidiaries,
Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the
surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all
of the properties or assets of the Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule 1-02 of Regulation
S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject
to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that
is accepted by the holders of more than either (x) 50% of the outstanding Common Stock, (y) 50% of the outstanding Common Stock calculated
as if any Common Stock held by all Subject Entities making or party to, or Affiliated with any Subject Entities making or party to, such
purchase, tender or exchange offer were not outstanding; or (z) such number of shares of Common Stock such that all Subject Entities
making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange offer, become collectively
the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of the outstanding Common Stock, or (iv) consummate
a stock purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire,
either (x) more than 50% of the outstanding Common Stock, (y) more than 50% of the outstanding Common Stock calculated as if any Common
Stock held by all the Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such stock purchase
agreement or other business combination were not outstanding; or (z) such number of shares of Common Stock such that the Subject Entities
become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of the outstanding Common Stock,
or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the Company shall, directly or indirectly, including through
Subsidiaries, Affiliates or otherwise, in one or more related transactions, allow any Subject Entity individually or the Subject Entities
in the aggregate to be or become the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly,
whether through acquisition, purchase, assignment, conveyance, tender, tender offer, exchange, reduction in outstanding Common Stock,
merger, consolidation, business combination, reorganization, recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization
or reclassification or otherwise in any manner whatsoever, of either (x) more than 50% of the aggregate ordinary voting power represented
by issued and outstanding Common Stock, (y) more than 50% of the aggregate ordinary voting power represented by issued and outstanding
Common Stock not held by all such Subject Entities as of the Subscription Date calculated as if any Common Stock held by all such Subject
Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power represented by issued and outstanding Common
Stock or other equity securities of the Company sufficient to allow such Subject Entities to effect a statutory short form merger or
other transaction requiring other shareholders of the Company to surrender their Common Stock without approval of the shareholders of
the Company or (C) directly or indirectly, including through Subsidiaries, Affiliates or otherwise, in one or more related transactions,
the issuance of or the entering into any other instrument or transaction structured in a manner to circumvent, or that circumvents, the
intent of this definition in which case this definition shall be construed and implemented in a manner otherwise than in strict conformity
with the terms of this definition to the extent necessary to correct this definition or any portion of this definition which may be defective
or inconsistent with the intended treatment of such instrument or transaction; provided, however, that the Merger shall not constitute
a Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
&ldquo;<B>Group</B>&rdquo; means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
&ldquo;<B>Maximum Eligibility Number</B>&rdquo; means initially zero (0) and such number shall be increased (but not decreased) on the
Reset Date in accordance with Section 2(a), subject to any exercise pursuant to Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<B>&ldquo;Merger&rdquo; </B>means that certain merger, despac transaction and the following distribution of CLOE&rsquo;s (as defined
below) common stock as set out in the Merger Agreement, dated as of June 1, 2023, by and between the Company, Kustom Entertainment, Inc.,
a Delaware corporation, Clover Leaf Capital Corp., a Delaware corporation (&ldquo;CLOE&rdquo;), CL Merger Sub, Inc., a Nevada corporation,
and Yntegra Capital Investments LLC, a Delaware limited liability company, as may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
&ldquo;<B>Options</B>&rdquo; means any rights, warrants or options to subscribe for or purchase (i) Common Stock or (ii) Convertible
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<B>Intentionally omitted</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
&ldquo;<B>Parent Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person, including
such entity whose common capital or equivalent equity security is quoted or listed on an Eligible Market (or, if so elected by the Required
Holders, any other market, exchange or quotation system), or, if there is more than one such Person or such entity, the Person or such
entity designated by the Required Holders or in the absence of such designation, such Person or entity with the largest public market
capitalization as of the date of consummation of the Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
&ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization, any other entity and a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
&ldquo;<B>Pre-funded Warrants</B>&rdquo; shall have the meaning ascribed to such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
&ldquo;<B>Principal Market</B>&rdquo; means The Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
&ldquo;<B>Public Information Failure</B>&rdquo; shall have the meaning ascribed to such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
&ldquo;<B>Purchase Price</B>&rdquo; shall have the meaning ascribed to such term in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
&ldquo;<B>Purchased Shares</B>&rdquo; shall mean the number of Shares purchased by Holder as specified below such Holder&rsquo;s name
on the signature page to the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
&ldquo;<B>Registrable Securities</B>&rdquo; shall have the meaning ascribed to such term in the Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
&ldquo;<B>Registration Rights Agreement</B>&rdquo; means that certain Registration Rights Agreement dated as of the Subscription Date
by and among the Company and the Buyers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
&ldquo;<B>Registration Statement</B>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights
Agreement and covering the resale by the Buyers of the Registrable Securities (as defined in the Registration Rights Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
&ldquo;<B>Required Holders</B>&rdquo; means the holders of the SPA Warrants representing at least a majority of the Common Stock underlying
the SPA Warrants then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
&ldquo;<B>Reset Date</B>&rdquo; means the date following Stockholder Approval that is the earliest of the following dates, (i) the date
on which for twenty (20) consecutive Trading Days all Registrable Securities have become and remained registered pursuant to an effective
Registration Statement that is available for the resale of all Registrable Securities, <U>provided</U>, <U>however</U>, if less than
all Registrable Securities have become registered for resale on the date that a Registration Statement is declared effective, the Holder
with respect to itself only, shall have the right in its sole and absolute discretion to deem such condition satisfied, including with
regard only to the Registrable Securities that have been so registered, (ii) the date on which the Holder, for twenty (20) consecutive
Trading Days can sell all Registrable Securities pursuant to Rule 144 without restriction or limitation and the Company has not had a
Public Information Failure or (iii) twelve (12) months and twenty (20) Trading Days immediately following the Issuance Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
&ldquo;<B>Reset Period</B>&rdquo; means the period commencing on the twentieth- (20<SUP>th</SUP>) Trading Day immediately preceding the
Reset Date and ending on the Reset Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
&ldquo;<B>Reset Price</B>&rdquo; means the greater of (i) the lowest single day Weighted Average Price of the Common Stock during the
Reset Period and (ii) the Floor Price (as adjusted for stock splits, stock dividends, recapitalizations, reorganizations, reclassification,
combinations, reverse stock splits or other similar events occurring after the Subscription Date).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<FONT STYLE="background-color: white">&ldquo;<B>Reset Share Amount</B>&rdquo; means the number of shares of Common Stock equal to the
number (if positive) obtained by subtracting (I) the sum of (x) the number of Purchased Shares purchased by the Holder on the Closing
Date pursuant to the Securities Purchase Agreement (as adjusted for stock splits, stock dividends, recapitalizations, reorganizations,
reclassification, combinations, reverse stock splits or other similar events occurring after the Subscription Date) and (y) the number
of shares of Common Stock issuable upon exercise in full of any Pre-funded Warrants (without regard to any limitation on exercise contained
therein) purchased by the Holder on the Closing Date pursuant to the Securities Purchase Agreement (as adjusted for stock splits, stock
dividends, recapitalizations, reorganizations, reclassification, combinations, reverse stock splits or other similar events occurring
after the Subscription Date), from (II) the quotient determined by dividing (x) the sum of (i) the aggregate Purchase Price paid by the
Holder on the Closing Date and (ii) the aggregate of all exercise prices paid or payable by the Holder upon exercise in full of the Pre-Funded
Warrants, by (y) the applicable Reset Price determined as of the Reset Date</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
&ldquo;<B>Series A Warrant</B>&rdquo; shall have the meaning ascribed to such term in the Securities Purchase Agreement<FONT STYLE="background-color: white">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholder
Approval</B>&rdquo; shall have the meaning ascribed to such term in the Series A Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Stockholder
Approval Date</B>&rdquo; means the date on which Stockholder Approval is received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Standard
Settlement Period</B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Eligible Market with respect to the Common Stock as in effect on the date of delivery of the applicable Exercise Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
&ldquo;<B>Subject Entity</B>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
&ldquo;<B>Successor Entity</B>&rdquo; means one or more Person or Persons (or, if so elected by the Holder, the Company or Parent Entity)
formed by, resulting from or surviving any Fundamental Transaction or one or more Person or Persons (or, if so elected by the Holder,
the Company or the Parent Entity) with which such Fundamental Transaction shall have been entered into.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<B>Intentionally omitted</B><FONT STYLE="background-color: white">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
&ldquo;<B>Trading Day</B>&rdquo; means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market
is not the principal trading market for the Common Stock on such day, then on the principal securities exchange or securities market
on which the Common Stock is then traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
&ldquo;<B>Weighted Average Price</B>&rdquo; means, for any security as of any date, the dollar volume-weighted average price for such
security on the Principal Market during the period beginning at 9:30:01 a.m., New York time (or such other time as the Principal Market
publicly announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as the Principal Market
publicly announces is the official close of trading), as reported by Bloomberg through its &ldquo;Volume at Price&rdquo; function or,
if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic
bulletin board for such security during the period beginning at 9:30:01 a.m., New York time (or such other time as such market publicly
announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as such market publicly announces
is the official close of trading), as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security
by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers
for such security as reported on the Pink Open Market. If the Weighted Average Price cannot be calculated for a security on a particular
date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually
determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security,
then such dispute shall be resolved pursuant to Section 12 with the term &ldquo;Weighted Average Price&rdquo; being substituted for the
term &ldquo;Exercise Price.&rdquo; All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock
combination, reclassification or other similar transaction during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Signature
Page Follows]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out
above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
    ALLY, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    E. Ross</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXERCISE
NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
TO PURCHASE COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
ALLY, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder hereby exercises the right to purchase _________________ shares of Common Stock (&ldquo;<B>Warrant Shares</B>&rdquo;)
of Digital Ally, Inc., a Nevada company (the &ldquo;<B>Company</B>&rdquo;), evidenced by the attached Warrant to Purchase Common Stock
(the &ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth
in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Form of Exercise Price. The Holder intends that payment of the Exercise Price shall be made as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    &ldquo;<U>Cash Exercise</U>&rdquo; with respect to _________________ Warrant Shares; and/or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to _______________ Warrant Shares, resulting in a delivery obligation of the
    Company to the Holder of __________ Common Stock representing the applicable Net Number.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Payment of Exercise Price. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares
to be issued pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in
accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Delivery of Warrant Shares. The Company shall deliver to the holder __________ Warrant Shares in accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
_______________ __, ______</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Registered Holder</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACKNOWLEDGMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby acknowledges this Exercise Notice and hereby directs Securities Transfer Corporation to issue the above indicated number
of shares of Common Stock in accordance with the Transfer Agent Instructions dated ________ __, 2024 from the Company and acknowledged
and agreed to by Securities Transfer Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
    ALLY, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    E. Ross</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>5
<FILENAME>ex4-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRE-FUNDED
WARRANT TO PURCHASE COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
ALLY, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: June 25, 2024</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: June 25, 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK</B> (the &ldquo;<B><U>Warrant</U></B>&rdquo;) certifies that, for value received, [&#9679;]
or its assigns (the &ldquo;<B><U>Holder</U></B>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time until this Warrant is exercised in full (the &ldquo;<B><U>Termination Date</U></B>&rdquo;)
but not thereafter, to subscribe for and purchase from Digital Ally, Inc., a Nevada corporation (the &ldquo;<B><U>Company</U></B>&rdquo;),
up to [&#9679;] shares (as subject to adjustment hereunder, the &ldquo;<B><U>Warrant Shares</U></B>&rdquo;) of Common Stock. The purchase
price of one (1) share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section &lrm;2.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Definitions</U></B>.
                                            In addition to the terms defined elsewhere in this Warrant or in the Securities Purchase
                                            Agreement dated June 24, 2024, the following terms have the meanings indicated in this Section
                                            &lrm;1:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1. &ldquo;<B><U>Affiliate</U></B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2. &ldquo;<B><U>Bid
Price</U></B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day
from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3. &ldquo;<B><U>Board
of Directors</U></B>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4. &ldquo;<B><U>Business
Day</U></B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5. &ldquo;<B><U>Commission</U></B>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6. &ldquo;<B><U>Common
Stock</U></B>&rdquo; means the common stock of the Company, $0.001 par value per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7. &ldquo;<B><U>Common
Stock Equivalents</U></B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8. &ldquo;<B><U>Exchange
Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9. &ldquo;<B><U>Merger</U></B>&rdquo;
means that certain merger, despac transaction and the following distribution of CLOE&rsquo;s (as defined below) common stock as set out
in the Merger Agreement, dated as of June 1, 2023, by and between the Company, Kustom Entertainment, Inc., a Delaware corporation, Clover
Leaf Capital Corp., a Delaware corporation (&ldquo;CLOE&rdquo;), CL. Merger Sub, Inc., a Nevada corporation, and Yntegra Capital Investments
LLC, a Delaware limited liability company, as may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10. &ldquo;<B><U>Person</U></B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11. &ldquo;<B><U>Securities
Act</U></B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12. &ldquo;<B><U>Subsidiary</U></B>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13. &ldquo;<B><U>Trading
Day</U></B>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14. &ldquo;<B><U>Trading
Market</U></B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the
date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York
Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15. &ldquo;<B><U>Transaction
Documents</U></B>&rdquo; means the Securities Purchase Agreement dated June 24, 2024, these Warrants, such other Warrants as contemplated
in the Securities Purchase Agreement, the Registration Rights Agreement, the Placement Agent Agreement, the Lock-Up Agreement and all
exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16. &ldquo;<B><U>Transfer
Agent</U></B>&rdquo; means Securities Transfer Corporation, the current transfer agent of the Company, with a mailing address of 901
N. Dallas Parkway, Suite 380, Plano, Texas 75093, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17. &ldquo;<B><U>VWAP</U></B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock
so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18. &ldquo;<B><U>Warrants</U></B>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exercise</U></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1. <B><U>Exercise
of Warrant</U></B>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise substantially in the form attached hereto as Exhibit <U>&lrm;2.1</U> (the
&ldquo;<B><U>Notice of Exercise</U></B>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section &lrm;2.4.1 herein) following the date of exercise as aforesaid, the Holder shall
deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank unless the cashless exercise procedure specified in Section &lrm;2.3 below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and
the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within
three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant
resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the
Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2. <B><U>Exercise
Price</U></B>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant.
The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any
circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination
Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder
(the &ldquo;Exercise Price&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3. <B><U>Cashless
Exercise</U></B>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable
                                            Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant
                                            to Section &lrm;2.1 hereof on a day that is not a Trading Day or (2) both executed and delivered
                                            pursuant to Section &lrm;2.1 hereof on a Trading Day prior to the opening of &ldquo;regular
                                            trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal
                                            securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP
                                            on the Trading Day immediately preceding the date of the applicable Notice of Exercise or
                                            (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg
                                            L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise
                                            if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading
                                            Day and is delivered within two (2) hours thereafter (including until two (2) hours after
                                            the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section &lrm;2.1
                                            hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of
                                            such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and
                                            delivered pursuant to Section &lrm;2.1 hereof after the close of &ldquo;regular trading hours&rdquo;
                                            on such Trading Day;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance
                                            with the terms of this Warrant if such exercise were by means of a cash exercise rather than
                                            a cashless exercise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the holding period
of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. Without limiting any other provision in the
Transaction Documents, assuming (i) the Holder is not an Affiliate of the Company, and (ii) all of the applicable conditions of Rule
144 promulgated under the Securities Act with respect to Holder and the Warrant Shares are met in the case of such a cashless exercise,
the Company agrees that the Company will cause the removal of the legend from such Warrant Shares (including by delivering an opinion
of the Company&rsquo;s counsel to the Company&rsquo;s transfer agent at its own expense to ensure the foregoing), and the Company agrees
that the Holder is under no obligation to sell the Warrant Shares issuable upon the exercise of the Warrant prior to removing the legend.
The Company agrees not to take any position contrary to this Section &lrm;2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4. <B><U>Mechanics
of Exercise</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.1. <B><U>Delivery
of Warrant Shares upon Exercise</U></B>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<B><U>DWAC</U></B>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1)
Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<B><U>Warrant Share Delivery Date</U></B>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. Notwithstanding anything herein to the contrary, upon delivery of the Notice of Exercise, the Holder shall be deemed for
purposes of Regulation SHO under the Exchange Act to have become the holder of the Warrant Shares irrespective of the date of delivery
of the Warrant Shares. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the third (3rd) Trading Day after the Warrant Share Delivery Date) for each
Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company
agrees to maintain a Transfer Agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.
As used herein, &ldquo;<B><U>Standard Settlement Period</U></B>&rdquo; means the standard settlement period, expressed in a number of
Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of
the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m.
(New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Transaction
Documents, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial
Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of
the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.2. <B><U>Delivery
of New Warrants Upon Exercise</U></B>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.3. <B><U>Rescission
Rights</U></B>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section &lrm;2.4.1
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.4. <B><U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares upon Exercise</U></B>. In addition to any other rights available to the Holder,
if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
&lrm;2.4.1 above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<B><U>Buy-In</U></B>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which
(x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored and return any amount received by the Company in respect of the Exercise Price for those Warrant Shares (in which case
such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had
the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise
of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.5. <B><U>No
Fractional Shares or Scrip</U></B>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of
this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.6. <B><U>Charges,
Taxes and Expenses</U></B>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto as <U>Exhibit &lrm;2.4.6</U> duly executed by the
Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the
Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic
delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.7. <B><U>Closing
of Books</U></B>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this
Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5. <B><U>Holder&rsquo;s
Exercise Limitations</U></B>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section &lrm;2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B><U>Attribution Parties</U></B>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
unconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section &lrm;2.5, beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section &lrm;2.5 applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to
any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section &lrm;2.5, in determining the number of outstanding shares of Common Stock, a Holder
may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since
the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<B><U>Beneficial Ownership Limitation</U></B>&rdquo;
shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section &lrm;2.5, provided that the Beneficial
Ownership Limitation in no event exceeds 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to
the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section &lrm;2.5 shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such
notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section &lrm;2.5 to correct this paragraph (or any portion hereof) which may be defective or
inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Certain
                                            Adjustments</U></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1. <B><U>Stock
Dividends and Splits</U></B>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable in shares of Common
Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common Stock
any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator
shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which
the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of Shares issuable
upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.
Any adjustment made pursuant to this Section &lrm;3.1 shall become effective immediately after the record date for the determination
of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in
the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2. <B><U>Subsequent
Rights Offerings</U></B>. In addition to any adjustments pursuant to Section &lrm;3.1 above, if at any time the Company grants, issues
or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all (or substantially
all) of the record holders of any class of shares of Common Stock (the &ldquo;<B><U>Purchase Rights</U></B>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could
have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall
be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3. <B><U>Pro
Rata Distributions</U></B>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to all (or substantially all) holders of shares of Common Stock, by way
of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<B><U>Distribution</U></B>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4. <B><U>Fundamental
Transaction</U></B>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock
or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant
to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power
of the common equity of the Company (each a &ldquo;<B><U>Fundamental Transaction</U></B>&rdquo;); provided, however, that the Merger
shall not constitute a Fundamental Transaction, then, upon any subsequent exercise of this Warrant, the Holder shall have the right to
receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section &lrm;2.5 on the exercise of this Warrant), the
number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and
any additional consideration (the &ldquo;<B><U>Alternate Consideration</U></B>&rdquo;) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in Section &lrm;2.5 on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor
Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the
consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of
the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however,
that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of
Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration
(and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to
the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form
of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative
forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company
are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received
common stock/shares of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental
Transaction. &ldquo;<B><U>Black Scholes Value</U></B>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing
Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<B><U>Bloomberg</U></B>&rdquo;) determined as of the day
of consummation of the applicable contemplated Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate
corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) 100% and (2) the
100 day volatility as obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading
Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per
share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value
of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning
on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section
&lrm;3.7 and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated
Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by
wire transfer of immediately available funds (or such other consideration) within the later of (i) five (5) Business Days after the Holder&rsquo;s
election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<B><U>Successor Entity</U></B>&rdquo;) to assume in writing all of the
obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section &lrm;3.7
pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant that
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of
this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares
of capital stock (but taking into account the relative value of the shares of Common Stock prior to such Fundamental Transaction and
the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to
the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor
Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity
or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents
with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the
Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section &lrm;3.7 regardless
of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a
Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5. <B><U>Calculations</U></B>.
All calculations under this Section &lrm;3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of this Section &lrm;3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be
the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6. <B><U>Notice
to Holder</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.1. <B><U>Adjustment
to Exercise Price</U></B>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section &lrm;3, the Company shall
promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.2. <B><U>Notice
to Allow Exercise by Holder</U></B>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company
shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital
stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of Common Stock for securities, cash or other property
deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver
such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified
in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding
the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Transfer
                                            of Warrant</U></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1. <B><U>Transferability</U></B>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any
registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or
its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto as Exhibit <U>&lrm;2.4.6
</U>duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such
transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the
name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment,
and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly
be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant
to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company
within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.
The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2. <B><U>New
Warrants</U></B>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the
Holder or its agent or attorney. Subject to compliance with Section &lrm;4.1, as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3. <B><U>Warrant
Register</U></B>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<B><U>Warrant
Register</U></B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4. <B><U>Transfer
Restrictions</U></B>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that (x) the transferor
provide to the Company an opinion of counsel to the effect that such transfer does not require registration of such transferred Warrant
under the Securities Act and (y) that the transferee agree in writing to be bound by the terms of the Securities Purchase Agreement and
Registration Rights Agreement, with all the rights and obligations of a Purchaser under such agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5. <B><U>Representation
by the Holder</U></B>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing
or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except
pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Miscellaneous</U></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1. <B><U>No
Rights as Stockholder until Exercise; No Settlement in Cash</U></B>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section &lrm;2.4.1, except as expressly
set forth in Section &lrm;3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section <B>&lrm;</B>2.3 or to receive cash payments pursuant to Section <B>&lrm;</B>2.4.1 and Section <B>&lrm;</B>2.4.4 herein, in
no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2. <B><U>Loss,
Theft, Destruction or Mutilation of Warrant</U></B>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3. <B><U>Saturdays,
Sundays, Holidays, etc</U></B>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4. <B><U>Authorized
Shares</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.1. <B><U>Reservation
of Authorized and Unissued Shares</U></B>. The Company covenants that, during the period the Warrant is outstanding, it will reserve
from its authorized and unissued Common Stock a sufficient number of shares of Common Stock to provide for the issuance of the Warrant
Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall
constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of
the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant
Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading
Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise
of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment
for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable (which means that no
further sums are required to be paid by the holders thereof in connection with the issue thereof) and free from all taxes, liens and
charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.2. <B><U>Noncircumvention</U></B>.
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.3. <B><U>Authorizations,
Exemptions and Consents</U></B>. Before taking any action that would result in an adjustment in the number of Warrant Shares for which
this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents
thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5. <B><U>Governing
Law</U></B>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by
and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding
the foregoing, nothing in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim under
the federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6. <B><U>Restrictions</U></B>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7. <B><U>Nonwaiver
and Expenses</U></B>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that the right
to exercise this Warrant terminates on the Termination Date. No provision of this Warrant shall be construed as a waiver by the Holder
of any rights which the Holder may have under the federal securities laws and the rules and regulations of the Commission thereunder.
Without limiting any other provision of this Warrant or the Securities Purchase Agreement, if the Company willfully and knowingly fails
to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder
such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees,
including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing
any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8. <B><U>Notices</U></B>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service,
addressed to the Company, at 14001 Marshall Drive, Lenexa, KS 66215, Attention: Stanton Ross, Chief Executive Officer, email address:
stan.ross@digitalally.com, or such other email address or address as the Company may specify for such purposes by notice to the Holders.
Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally,
by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of
such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and
effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address
set forth in this Section &lrm;5.8 prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission,
if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section &lrm;5.8 on a day that is not
a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing,
if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required
to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the
Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form
8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9. <B><U>Limitation
of Liability</U></B>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for
the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10. <B><U>Remedies</U></B>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11. <B><U>Successors
and Assigns</U></B>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure
to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of
Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be
enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12. <B><U>Amendment</U></B>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13. <B><U>Severability</U></B>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14. <B><U>Headings</U></B>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[DGLY
Investor Pre-Funded PIPE Warrant Signature Page Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[DGLY
Investor Pre-Funded PIPE Warrant Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Pre-Funded PIPE Warrant to be executed by its officer thereunto duly authorized as of the
date first above indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIGITAL ALLY, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    Ross</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
&lrm;2.1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIGITAL ALLY, INC.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp; ]</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in lawful money of the United States.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp; ]</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if permitted the cancellation of such number of Warrant Shares
as is necessary, in accordance with the formula set forth in subsection &lrm;2.3, to exercise this Warrant with respect to the maximum
number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection &lrm;2.3.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4) The
undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investing Entity: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity</I>:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
&lrm;2.4.6</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares of Common Stock.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>6
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<B><U>Agreement</U></B>&rdquo;) is dated as of [&#9679;], 2024, between Digital Ally, Inc.,
a Nevada corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), and each purchaser identified on the signature pages hereto (including
their respective successors and assigns, each a &ldquo;<B><U>Purchaser</U></B>&rdquo; and collectively, the &ldquo;<B><U>Purchasers</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
(the &ldquo;<B><U>Securities Act</U></B>&rdquo;), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each
Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully
described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE, IN CONSIDERATION</B> of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Definitions</U></B>.
    In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
    set forth in this Section 1:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.
&ldquo;<B><U>Acquiring Person</U></B>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.
&ldquo;<B><U>Action</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.
&ldquo;<B><U>Affiliate</U></B>&rdquo; means any Person that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4.
&ldquo;<B><U>Agreement</U></B>&rdquo; shall have the meaning ascribed to such term in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5.
&ldquo;<B><U>BHCA</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.42.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6.
&ldquo;<B><U>Board of Directors</U></B>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7.
&ldquo;<B><U>Business Day</U></B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City
of New York are authorized or required by law to remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8.
&ldquo;<B><U>Buy-In Price</U></B>&rdquo; shall have the meaning ascribed to such term in Section 4.1.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9.
&ldquo;<B><U>Closing</U></B>&rdquo; means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10.
&ldquo;<B><U>Closing Date</U></B>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered
by the applicable parties thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount
and (ii) the Company&rsquo;s obligations to deliver the Securities, in each case, have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11.
&ldquo;<B><U>Code</U></B>&rdquo; means the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12.
&ldquo;<B><U>Commission</U></B>&rdquo; means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.
&ldquo;<B><U>Common Warrants</U></B>&rdquo; means the Series A Warrants and the Series B Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14.
&ldquo;<B><U>Common Stock</U></B>&rdquo; means the shares of the Company&rsquo;s common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15.
&ldquo;<B><U>Common Stock Equivalents</U></B>&rdquo; means any securities of the Company which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.
&ldquo;<B><U>Company</U></B>&rdquo; shall have the meaning ascribed to such term in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17.
&ldquo;<B><U>Company Counsel</U></B>&rdquo; means with respect to U.S. federal securities law and New York law, Sullivan &amp; Worcester
LLP, 1633 Broadway, New York, NY 10019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18.
&ldquo;<B><U>Disclosure Schedules</U></B>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19.
&ldquo;<B><U>Disclosure Time</U></B>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m.
(New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately
following the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed
between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time)
on the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20.
&ldquo;<B><U>Disqualification Event</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.44.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.
&ldquo;<B>Escrow Agent</B>&rdquo; means Continental Stock Transfer &amp; Trust Company, with offices at 1 State Street, 30th Floor, New
York, NY 10004.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.22.
&ldquo;<B><U>Escrow Agreement</U></B>&rdquo; means the escrow agreement entered into prior to the date hereof, by and among the Company,
the Escrow Agent and the Placement Agent pursuant to which the Purchasers shall deposit Subscription Amounts with the Escrow Agent to
be applied to the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.23.
&ldquo;<B><U>Evaluation Date</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.19.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.24.
&ldquo;<B><U>Exchange Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.25.
&ldquo;<B><U>Exempt Issuance</U></B>&rdquo; means (i) any conventional bank loans that are not convertible into shares of Common Stock
or Common Stock Equivalents and do not involve any issuance of any shares of Common Stock or Common Stock Equivalents or other security
of the Company in connection therewith; (ii) shares of Common Stock or options issued to employees, officers or directors of the Company
pursuant to the Company&rsquo;s equity incentive plans or pursuant to the compensation agreements previously authorized by the Board
of Directors; (iii) securities issued upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other
securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement,
provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to
decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations)
or to extend the term of such securities; and (iv) securities issued pursuant to acquisitions or strategic transactions (whether by merger,
consolidation, purchase of equity, purchase of assets, reorganization or otherwise) approved by a majority of the disinterested directors
of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no
registration rights that require or permit the filing of any registration statement in connection therewith during the period set forth
in Section 4.10 hereof, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is,
itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company
and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.26.
&ldquo;<B><U>FCPA</U></B>&rdquo; means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.27.
&ldquo;<B><U>Federal Reserve</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.42.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.28.
&ldquo;<B><U>GAAP</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.29.
&ldquo;<B><U>Indebtedness</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.28.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.30.
&ldquo;<B><U>Intellectual Property Rights</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.16.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.31.
&ldquo;<B><U>Issuer Covered Person</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.44.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.32.
&ldquo;<B><U>IT Systems and Data</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.47.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.33.
&ldquo;<B><U>Legend Removal Date</U></B>&rdquo; shall have the meaning ascribed to such term in Section 4.1.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.34.
&ldquo;<B><U>Liens</U></B>&rdquo; means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right
or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.35.
&ldquo;<B><U>Lock-Up Agreement</U></B>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and
the directors, executive officers and stockholders holding at least five percent (5%) of the outstanding shares of Common Stock on a
fully converted basis as set forth on <B><U>Schedule 1.32</U></B>, in the form of <B><U>Exhibit 1.35</U></B> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.36.
&ldquo;<B><U>Material Adverse Effect</U></B>&rdquo; shall have the meaning assigned to such term in Section 3.1.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.37.
&ldquo;<B><U>Material Permits</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.14.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.38.
&ldquo;<B><U>Merger</U></B>&rdquo; means that certain merger, despac transaction and the following distribution of CLOE&rsquo;s (as defined
below) common stock as set out in the Merger Agreement, dated as of June 1, 2023, by and between the Company, Kustom Entertainment, Inc.,
a Delaware corporation, Clover Leaf Capital Corp., a Delaware corporation (&ldquo;CLOE&rdquo;), CL. Merger Sub, Inc., a Nevada corporation,
and Yntegra Capital Investments LLC, a Delaware limited liability company, as may be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.39.
&ldquo;<B><U>Money Laundering Laws</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.43.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.40.
&ldquo;<B><U>OFAC</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.40.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.41.
&ldquo;<B><U>Per Unit Purchase Price</U></B>&rdquo; equals $[&#9679;] (less $0.0001 for each Pre-Funded Warrant), subject to adjustment
for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur
after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.42.
&ldquo;<B><U>Person</U></B>&rdquo; means an individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any
kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.43.
&ldquo;<B><U>PFIC</U></B>&rdquo; shall have the meaning ascribed to such term in Section 4.18.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.44.
&ldquo;<B><U>Placement Agent</U></B>&rdquo; means Aegis Capital Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.45.
&ldquo;<B><U>Placement Agent Agreement</U></B>&rdquo; means the placement agent agreement, dated on or about the date hereof, between
the Company and the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.46.
&ldquo;<B><U>Pre-Funded Warrants</U></B>&rdquo; means the pre-funded Common Stock purchase warrants, in the form of <B><U>Exhibit 1.46.1
</U></B>attached hereto delivered to the Purchasers at the Closing in accordance with Section 2.2.1 hereof, which Pre-Funded Warrants
shall be exercisable immediately and shall expire when exercised in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.47.
&ldquo;<B><U>Proceeding</U></B>&rdquo; means an action, claim, suit, investigation or proceeding (including, without limitation, an informal
investigation or partial proceeding, such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.48.
&ldquo;<B><U>Public Information Failure</U></B>&rdquo; shall have the meaning ascribed to such term in Section 4.2.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.49.
&ldquo;<B><U>Purchaser</U></B>&rdquo; shall have the meaning ascribed to such term in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.50.
&ldquo;<B><U>Purchaser Party</U></B>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.51.
&ldquo;<B><U>Registration Rights Agreement</U></B>&rdquo; means the Registration Rights Agreement, dated as of the date hereof, by and
among the Company and the Purchaser Parties, in the form of <B><U>Exhibit 1.51</U></B> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.52.
&ldquo;<B><U>Release Date</U></B>&rdquo; means the later of (x) the earlier of (i) the Resale Effective Date registering all of the Securities
or (ii) the date that the Securities can be sold, assigned or transferred without restriction or limitation pursuant to Rule 144 or Rule
144A promulgated under the 1933 Act, as amended, (or a successor rule thereto) and (y) the date that the Company obtains the Stockholder
Approval or a board approval in lieu of Stockholder Approval to effect the purposes of the Stockholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.53.
&ldquo;<B><U>Required Approvals</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.54.
&ldquo;<B><U>Resale Effective Date</U></B>&rdquo; means the earliest of the date that (a) the initial Resale Registration Statement registering
for resale all Shares and Warrant Shares has been declared effective by the Commission, (b) all of the Shares and Warrant Shares have
been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the
current public information required under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary
of the Closing Date provided that a holder of Shares and Warrant Shares is not an Affiliate of the Company, or (d) all of the Shares
and Warrant Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume
or manner-of-sale restrictions and Company Counsel has delivered to such holders a standing written unqualified opinion that resales
may then be made by such holders of the Shares and Warrant Shares pursuant to such exemption which opinion shall be in form and substance
reasonably acceptable to such holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.55.
&ldquo;<B><U>Resale Registration Statement</U></B>&rdquo; means a registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Purchasers of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.56.
&ldquo;<B><U>Rule 144</U></B>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be
amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially
the same purpose and effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.57.
&ldquo;<B><U>Rule 424</U></B>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be
amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially
the same purpose and effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.58.
&ldquo;<B><U>SEC Reports</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.59.
&ldquo;<B><U>Securities</U></B>&rdquo; means the Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.60.
&ldquo;<B><U>Securities Act</U></B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.61.
&ldquo;<B><U>Series A Warrants</U></B>&rdquo; means the warrants to purchase shares of Common Stock delivered to the Purchasers at the
Closing in accordance with Section 2.2.1 hereof, which Series A Warrants shall be in the form of Exhibit 1.60 attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.62.
&ldquo;<B><U>Series B Warrants</U></B>&rdquo; means the warrants to purchase shares of Common Stock delivered to the Purchasers at the
Closing in accordance with Section 2.2.1 hereof, which Series B Warrants shall be in the form of Exhibit 1.61 attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.63.
&ldquo;<B><U>Shares</U></B>&rdquo; means shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.64.
&ldquo;<B><U>Short Sales</U></B>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange
Act (but shall not be deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.65.
&ldquo;<B><U>Stockholder Approval</U></B>&rdquo; means such approval as may be required by the applicable rules and regulations of the
Nasdaq Stock Market (or any successor entity) from the stockholders of the Company, or board of directors in lieu thereof, with respect
to issuance of all of the Warrants and the Warrant Shares upon the exercise thereof and/or to give full effect to the terms of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.66.
&ldquo;<B><U>Subscription Amount</U></B>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants
purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription
Amount,&rdquo; in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.67.
&ldquo;<B><U>Subsidiary</U></B>&rdquo; means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable,
also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.68.
&ldquo;<B><U>Trading Day</U></B>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.69.
&ldquo;<B><U>Trading Market</U></B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted
for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select
Market, the New York Stock Exchange, the OTCQB, OTCQX, Pink Open Market (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.70.
&ldquo;<B><U>Transaction Documents</U></B>&rdquo; means this Agreement, the Securities, the Registration Rights Agreement, the Placement
Agent Agreement, the Lock-Up Agreement, the Escrow Agreement, and all exhibits and schedules thereto and hereto and any other documents
or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.71.
&ldquo;<B><U>Transfer Agent</U></B>&rdquo; means Securities Transfer Corporation, the current transfer agent of the Company, with a mailing
address of 901 N. Dallas Parkway, Suite 380, Plano, Texas 75093 and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.72.
&ldquo;<B><U>Variable Rate Transaction</U></B>&rdquo; means a transaction in which the Company (i) issues or sells any shares of Common
Stock or Common Stock Equivalents either (A) at a conversion price, exercise price or exchange rate or other price that is based upon,
and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such
debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after
the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock, other than in connection with customary anti-dilution adjustments
resulting from future stock splits, stock dividends or similar transactions, or (ii) issues or sells any amortizing convertible security
that amortizes prior to its maturity date, whereby it is required to or has the option to (or the investor in such security has the option
to require the Company to) make such amortization payments in Common Stock (whether or not such payments in stock are subject to certain
equity conditions) or (iii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line
of credit or &ldquo;at-the-market&rdquo; offering, whereby it may sell securities at a future determined price, regardless of whether
Shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled, provided
that any issuance of shares upon the exercise of the Common Warrants issuable hereunder will not be deemed a Variable Rate Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.73.
&ldquo;<B><U>VWAP</U></B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if
the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date
(or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P.
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the OTC Pink (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per
share of Common Stock so reported, or (d) in all other cases, the fair market value of the Common Stock as determined by an independent
appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.74.
&ldquo;<B><U>Warrants</U></B>&rdquo; means the Series A Warrants, the Series B Warrants and/or Pre-Funded Warrants, as the context deems
appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.75.
&ldquo;<B><U>Warrant Shares</U></B>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Purchase
    and Sale</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
<B><U>Closing</U></B>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with
the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not
jointly, agree to purchase, up to an aggregate of approximately $3.0 million of Common Stock and Warrants; provided, however, that a
Purchaser in its sole discretion, may elect to purchase Pre-Funded Warrants in lieu of Shares in such manner to result in the same aggregate
purchase price being paid by such Purchaser less $0.0001 per Pre-Funded Warrant. Each Purchaser shall deliver to the Escrow Agent, via
wire transfer, immediately available funds equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto
executed by such Purchaser, and the Company shall deliver to each Purchaser its respective Shares and Warrants, as determined pursuant
to Section 2.2.1, and the Company and each Purchaser shall deliver the other items set forth in Section 2.2.2 deliverable at the Closing.
Upon satisfaction of the covenants and conditions set forth in Sections 2.3.1 and 2.3.2, the Closing shall take place remotely by electronic
means. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via &ldquo;Delivery Versus Payment&rdquo;
(&ldquo;DVP&rdquo;) (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo; names and addresses
and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such
Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall
be made by the Placement Agent (or its clearing firm) by wire transfer to the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
<B><U>Deliveries</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.
The Company shall deliver or cause to be delivered to each Purchaser the following at the times stated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.1
on the date hereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.1.1.
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.1.2.
a certificate executed by the Chief Financial Officer of the Company in customary form reasonably satisfactory to the Placement Agent
and its counsel;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.1.3.
the Lock-Up Agreements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.1.4.
the Registration Rights Agreement duly executed by the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.1.5.
the Escrow Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.2
on or prior to the Closing Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.2.1.
a legal opinion of Company Counsel, addressed to the Placement Agent and the Purchasers, in form and substance reasonably acceptable
to the Placement Agent and Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.2.2.
a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
(or at the request of the Purchaser, book entry statement) evidencing a number of Shares equal to such Purchaser&rsquo;s Subscription
Amount divided by the Per Unit Purchase Price, registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.2.3.
for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded
Warrants divided by the Per Unit Purchase Price, with an exercise price equal to $0.0001, subject to adjustment as provided therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.2.4.
the Company shall have provided the flow of funds, on Company letterhead and executed by the Chief Executive Officer or Chief Financial
Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.2.5.
a duly executed and delivered Officers&rsquo; Certificate, in customary form reasonably satisfactory to the Placement Agent and its counsel;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.2.6.
the Series A Warrants registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100.0% of
the sum of the number of Shares and Pre-Funded Warrants stated on such Purchaser&rsquo;s signature page hereto, each with an exercise
price equal to $[&#9679;], subject to adjustment as provided therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.2.7.
the Series B Warrants registered in the name of such Purchaser to purchase up to the Maximum Eligibility Number (as defined in the Series
B Warrants), each with an exercise price equal to $0.001, subject to adjustment as provided therein; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.2.8.
a duly executed joint written instructions to the Escrow Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.2.
Each Purchaser, and the Placement Agent, as appicable, shall deliver or cause to be delivered to the Company or the Escrow Agent, as
applicable, the following at the times stated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.2.1
on the date hereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.2.1.1.
this Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.2.1.2.
the Registration Rights Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.2.1.3.
a duly executed joint written instructions to the Escrow Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.2.1.4.
the Escrow Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.2.1.5.
Placement Agent Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.2.2
on or prior to the Closing Date, such Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified in writing by the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.
<B><U>Closing Conditions</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.1.
The obligations of the Company hereunder in connection with the Closing are subject to each of the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.1.1
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless
as of a specific date therein in which case they shall be accurate as of such date).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.1.2
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.1.3
the delivery by each Purchaser of the items set forth in Section 2.2.2 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.2.
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to each of the following conditions
being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.2.1
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate as of such date).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.2.2
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.2.3
the delivery by the Company of the items set forth in Section 2.2.1 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.2.4
there shall have been no Material Adverse Effect with respect to the Company since the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.2.5
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Representations
    and Warranties</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.
<B><U>Representations and Warranties of the Company</U></B>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules
shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained
in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each
Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.1.
<B><U>Subsidiaries</U></B>. All of the direct and indirect Subsidiaries of the Company are set forth on Schedule 3.1.1. The Company owns,
directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of
the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free
of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to
the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.2.
<B><U>Organization and Qualification</U></B>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<B><U>Material
Adverse Effect</U></B>&rdquo;; provided, however, that &ldquo;<B><U>Material Adverse Effect</U></B>&rdquo; shall not include any event,
occurrence, fact, condition or change, directly or indirectly, arising out of or attributable to: (i) general economic or political conditions,
(ii) conditions generally affecting the industry in which the Company or any Subsidiary operates, (iii) any changes in financial or securities
markets in general, (iv) acts of war (whether or not declared), armed hostilities or terrorism, or the escalation or worsening thereof,
(v) any pandemic, epidemics or human health crises (including COVID-19), (vi) any changes in applicable laws or accounting rules (including
GAAP), (vii) the announcement, pendency or completion of the transactions contemplated by the Transaction Documents, (viii) any action
required or permitted by the Transaction Documents or any action taken (or omitted to be taken) with the written consent of or at the
written request of Purchaser) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification, or (ix) any effect resulting from the public announcement of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.3.
<B><U>Authorization; Enforcement</U></B>. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and
the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part
of the Company and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection
herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms
hereof and thereof, will constitute the legal, valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.4.
<B><U>No Conflicts</U></B>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents
to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and
thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or
articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an
event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.5.
<B><U>Filings, Consents and Approvals</U></B>. The Company is not required to obtain any consent, waiver, authorization or order of,
give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority
or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)
the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Resale Registration Statement
pursuant to the Registration Rights Agreement, (iii) the notice and/or application(s) to each applicable Trading Market for the issuance
and sale of the Securities and the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby,
and (iv) the Stockholder Approval and such other filings as are required to be made under applicable state securities laws (the &ldquo;<B><U>Required
Approvals</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.6.
<B><U>Issuance of the Securities</U></B>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable (which means that no further sums are required to
be paid by the holders thereof in connection with the issue thereof), free and clear of all Liens imposed by the Company other than restrictions
on transfer provided for in the Transaction Documents and applicable law. The Warrant Shares, when issued in accordance with the terms
of the Transaction Documents, will be validly issued, fully paid and nonassessable (which means that no further sums are required to
be paid by the holders thereof in connection with the issue thereof), free and clear of all Liens imposed by the Company other than restrictions
on transfer provided for in the Transaction Documents and applicable law. The Company has reserved from its duly authorized capital stock
the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.7.
<B><U>Capitalization</U></B>. The capitalization of the Company as of the date hereof is as set forth on Schedule 3.1.7, which Schedule
3.1.7 shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the
date hereof. Other than as stated in Schedule 3.1.7, the Company has not issued any capital stock since its most recently filed periodic
report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans,
the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans. No Person has any
right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated
by the Transaction Documents. Except as set forth in Schedule 3.1.7, or pursuant to this Agreement, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common
Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The
issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities
to any Person (other than the Purchasers). Except as set forth in Schedule 3.1.7, there are no outstanding securities or instruments
of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or
instrument upon an issuance of securities by the Company or any Subsidiary. Except as set forth in Schedule 3.1.7, there are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the
Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued,
fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding
shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval
or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There
are no stockholders&rsquo; agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock
to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.8.
<B><U>SEC Reports; Financial Statements</U></B>. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof,
for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred
to herein as the &ldquo;<B><U>SEC Reports</U></B>&rdquo;) on a timely basis or has received a valid extension of such time of filing
and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied
in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports,
when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company is
not currently an issuer subject to Rule 144(i) under the Securities Act. The Company has filed Form 10 information at least one year
prior to the date hereof. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such
financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent
basis during the periods involved (&ldquo;<B><U>GAAP</U></B>&rdquo;), except as may be otherwise specified in such financial statements
or the notes thereto, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries
as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited
statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.9.
<B><U>Material Changes; Undisclosed Events, Liabilities or Developments</U></B>. Since the date of the latest audited financial statements
included within the SEC Reports, except as set forth on Schedule 3.1.9, (i) there has been no event, occurrence or development that has
had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence
or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or
their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least one (1) Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.10.
<B><U>Litigation</U></B>. Except as set forth in Schedule 3.1.10, there is no action, suit, inquiry, notice of violation, proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their
respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign) (collectively, an &ldquo;<B><U>Action</U></B>&rdquo;). None of the Actions set forth on Schedule 3.1.10, (i)
adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or (ii) would, if there
were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary,
nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal
or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not
pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the
Company except in the ordinary course of business that would not have a Material Adverse Effect. The Commission has not issued any stop
order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange
Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.11.
<B><U>Labor Relations</U></B>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.12.
<B><U>Compliance</U></B>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under),
nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.13.
<B><U>Environmental Laws</U></B>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws
relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface
or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants,
or toxic or hazardous substances or wastes (collectively, &ldquo;<B><U>Hazardous Materials</U></B>&rdquo;) into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters,
orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<B><U>Environmental Laws</U></B>&rdquo;);
(ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i),
(ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.14.
<B><U>Regulatory Permits</U></B>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the
appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in
the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect
(&ldquo;<B><U>Material Permits</U></B>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating
to the revocation or modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.15.
<B><U>Title to Assets</U></B>. The Company and the Subsidiaries have good and marketable title in fee simple to, or have valid and marketable
rights to lease or otherwise use, all real property and all personal property that is material to the business of the Company and the
Subsidiaries, in each case free and clear of all Liens, except for (i) Liens that do not materially affect the value of such property
and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii)
Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made in accordance with GAAP, and the
payment of which is neither delinquent nor subject to penalties. Neither the Company nor any of its Subsidiaries has received any written
notice of any claim of any sort that has been asserted by anyone adverse to the rights of the Company or its Subsidiaries under any of
the leases or subleases or licenses or with respect to the properties mentioned above, or affecting or questioning the rights of the
Company or any Subsidiary to the continued possession or use of the leased or subleased or licensed premises or the properties mentioned
above, other than such claims which would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.16.
<B><U>Intellectual Property</U></B>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications,
trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual
property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC
Reports and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<B><U>Intellectual Property Rights</U></B>&rdquo;).
None of, and neither the Company nor any Subsidiary has received written notice that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the
Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality
and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.17.
<B><U>Insurance</U></B>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged,
including, but not limited to, directors and officers insurance coverage in amount deemed prudent by the Company. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase
in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.18.
<B><U>Transactions with Affiliates and Employees</U></B>. Except as set forth on Schedule 3.1.18, during the past three fiscal years
and the subsequent interim period through the date of this Agreement, none of the officers or directors of the Company or any Subsidiary
and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction
with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement
or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from,
providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or
such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.19.
<B><U>Sarbanes-Oxley; Internal Accounting Controls</U></B>. The Company and the Subsidiaries are in material compliance with any and
all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules
and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. Except
as set forth on Schedule 3.1.19, the Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide
reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii)
transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have
evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period
covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<B><U>Evaluation Date</U></B>&rdquo;).
The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the
Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial
reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.20.
<B><U>Certain Fees</U></B>. Except for the fees and expenses of the Placement Agent, no brokerage or finder&rsquo;s fees or commissions
are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section 3.1.20 that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.21.
<B><U>Private Placement</U></B>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.22.
<B><U>Investment Company</U></B>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.23.
<B><U>Registration Rights</U></B>. Except as disclosed on Schedule 3.1.23 and other than to each of the Purchasers pursuant to the Registration
Rights Agreement, no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act
of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.24.
<B><U>Listing and Maintenance Requirements</U></B>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which
the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer
through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to
the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.25.
<B><U>Application of Takeover Protections</U></B>. The Company and the Board of Directors have taken all necessary action, if any, in
order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights
agreement) or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the
Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result
of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.26.
<B><U>Disclosure</U></B>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their
agents or counsel with any information that it believes constitutes or might constitute material, non-public information. The Company
understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the
Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, is true and correct and does not contain any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances
under which they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date
of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made
and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties
with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.27.
<B><U>No Integrated Offering</U></B>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section
3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any
offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the
Securities to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration
of any such securities under the Securities Act, or (ii) any applicable stockholder approval provisions of any Trading Market on which
any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.28.
<B><U>Solvency</U></B>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the
receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s
assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital
to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability
thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all
of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of
its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such
debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has
no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy
or reorganization laws of any jurisdiction within one year from the Closing Date. Schedule 3.1.28 sets forth as of the date hereof all
outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments.
For the purposes of this Agreement, &ldquo;<B><U>Indebtedness</U></B>&rdquo; means (x) any liabilities for borrowed money or amounts
owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements
and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due
under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to
any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.29.
<B><U>Tax Status</U></B>. Except as disclosed in Schedule 3.1.29, the Company and its Subsidiaries each (i) has made or filed all material
United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by
any jurisdiction to which it is subject, (ii) has paid all material taxes and other governmental assessments and charges that are material
in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably
adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.
There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
Company or of any Subsidiary know of no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.30.
<B><U>No General Solicitation</U></B>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of
the Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the
Purchasers and certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.31.
<B><U>Foreign Corrupt Practices Act</U></B>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary,
any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.32.
<B><U>Accountants</U></B>. The Company&rsquo;s accounting firm is RBSM LLP, 805 Third Avenue, Suite 1430, New York, NY 10022. To the
knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act
and (ii) shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the
now current fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.33.
<B><U>No Disagreements with Accountants and Lawyers</U></B>. There are no disagreements of any kind presently existing, or reasonably
anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company
and the Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability
to perform any of its obligations under any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.34.
<B><U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U></B>. The Company acknowledges and agrees that each of the
Purchasers is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions
contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company
(or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each
Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on
the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.35.
<B><U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U></B>. Notwithstanding anything in this Agreement or elsewhere herein
to the contrary (except for Sections 3.2.7 and 4.15 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers
has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities
of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities
(if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging
activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any
of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.36.
<B><U>Regulation M Compliance</U></B>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases
of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&rsquo;s placement agent
in connection with the placement of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.37.
<B><U>Officers&rsquo; Certificate</U></B>. Any certificate signed by any duly authorized officer of the Company and delivered to the
Purchasers shall be deemed a representation and warranty by the Company to the Purchasers as to the matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.38.
<B><U>D&amp;O Questionnaires</U></B>. To the Company&rsquo;s knowledge, all information contained in the questionnaires most recently
completed by each of the Company&rsquo;s directors and officers and beneficial owner of 5% or more of the shares of Common Stock or Common
Stock Equivalents is true and correct in all respects and the Company has not become aware of any information which would cause the information
disclosed in such questionnaires become inaccurate and incorrect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.39.
<B><U>Stock Option Plans</U></B>. Each stock option granted by the Company under the Company&rsquo;s stock option plan, if any, was granted
(i) in accordance with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair
market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option
granted under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has
been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options
with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results
or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.40.
<B><U>Office of Foreign Assets Control</U></B>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<B><U>OFAC</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.41.
<B><U>U.S. Real Property Holding Corporation</U></B>. The Company is not and has never been a U.S. real property holding corporation
within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.42.
<B><U>Bank Holding Company Act</U></B>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding
Company Act of 1956, as amended (the &ldquo;<B><U>BHCA</U></B>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve
System (the &ldquo;<B><U>Federal Reserve</U></B>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls,
directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent
(25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither
the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or
any entity that is subject to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.43.
<B><U>Money Laundering</U></B>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<B><U>Money Laundering
Laws</U></B>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any
Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.44.
<B><U>No Disqualification Events</U></B>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under
the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer
of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting
equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities
Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<B><U>Issuer Covered Person</U></B>&rdquo; and,
together, &ldquo;<B><U>Issuer Covered Persons</U></B>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described
in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;<B><U>Disqualification Event</U></B>&rdquo;), except for a Disqualification
Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is
subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e),
and has furnished to the Purchasers a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.45.
<B><U>Other Covered Persons</U></B>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered
Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale
of any Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.46.
<B><U>Notice of Disqualification Events</U></B>. The Company will notify the Purchasers and the Placement Agent in writing, prior to
the Closing Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage
of time, become a Disqualification Event relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.47.
<B><U>Cybersecurity</U></B>. (i) (a) There has been no security breach or other compromise of or relating to any of the Company&rsquo;s
or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its
respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology
(collectively, &ldquo;<B><U>IT Systems and Data</U></B>&rdquo;) and (b) the Company and the Subsidiaries have not been notified of, and
has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to
its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all
judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual
obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized
use, access, misappropriation or modification, except, in the case of clauses (i) and (ii) herein, as would not, individually or in the
aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable
safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security
of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent
with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.
<B><U>Representations and Warranties of the Purchasers</U></B>. Each Purchaser, for itself and for no other Purchaser, hereby represents
and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which
case they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.1.
<B><U>Organization; Authority</U></B>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing
and in good standing under the law of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the legal, valid and binding obligation of such Purchaser, enforceable against it in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.2.
<B><U>Own Account</U></B>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect
arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation
and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in
compliance with applicable federal and state securities laws). Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo;
as defined in Rule 144 and have not been registered under the Securities Act or any applicable state securities law and is acquiring
the Securities as principal for its own account and not with a view to or for distributing or reselling such Securities or any part thereof
in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities
in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings
with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable
state securities law (this representation and warranty shall not limit such Purchaser&rsquo;s right to sell the Securities pursuant to
a registration statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the
Securities hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.3.
<B><U>Purchaser Status</U></B>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on
each date on which it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1),
(a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo;
as defined in Rule 144A(a)(1) under the Securities Act. Such Purchaser hereby represents that neither such Purchaser nor any of its Rule
506(d) Related Parties (as defined below) is a &ldquo;bad actor&rdquo; within the meaning of Rule 506(d) promulgated under the Securities
Act. For purposes of this Agreement, &ldquo;Rule 506(d) Related Party&rdquo; shall mean a person or entity covered by the &ldquo;Bad
Actor disqualification&rdquo; provision of Rule 506(d) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.4.
<B><U>Experience of Such Purchaser</U></B>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.5.
<B><U>General Solicitation</U></B>. Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result
of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar
media or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation
or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.6.
<B><U>Access to Information</U></B>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents
(including all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as
it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering
of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial
condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment;
and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort
or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and
agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or
advice with respect to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate
has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may
have acquired non-public information with respect to the Company which such Purchaser agrees need not be and has not been provided to
it (other than with respect to the transactions contemplated by the Transaction Documents). In connection with the issuance of the Securities
to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.7.
<B><U>Equal Treatment of Purchasers</U></B>. No consideration (including any modification of any Transaction Document) shall be offered
or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.8.
<B><U>Certain Transactions and Confidentiality</U></B>. Other than consummating the transactions contemplated hereunder, such Purchaser
has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed
any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such
Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the
material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Other
    Agreements of the Parties</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.
<B><U>Transfer Restrictions</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.1.
The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section 4.1.2, the Company may require the transferor thereof to provide to the Company an opinion of
counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the
Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and
the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration
Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.2.
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in substantially
the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NEITHER]
THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY [AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of
any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act
to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.3.
Certificates evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1.2 hereof),
(i) while a registration statement (including the Resale Registration Statement) covering the resale of such security is effective under
the Securities Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 and the Company is then in compliance
with the current public information required under Rule 144 (assuming cashless exercise of the Warrants), (iii) if such Shares or Warrant
Shares are eligible for sale or may be sold under Rule 144 (assuming cashless exercise of the Warrants), without volume or manner-of-sale
restrictions, or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations
and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer
Agent or the Purchaser if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser,
respectively. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the
resale of the Warrant Shares, if the Shares or Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the
current public information required under Rule 144 (assuming cashless exercise of the Warrants), or if the Shares or Warrant Shares may
be sold under Rule 144 without the requirement for the Company to be in compliance with the current public information required under
Rule 144 as to such Shares or Warrant Shares or if such legend is not otherwise required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission), then such Shares or Warrant Shares
shall be issued free of all legends. The Company agrees that following the Resale Effective Date or at such time as such legend is no
longer required under this Section 4.1.3, it will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading
Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer
Agent of a certificate representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend (such date, the &ldquo;<B><U>Legend
Removal Date</U></B>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate representing such Shares that is free
from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent
that enlarge the restrictions on transfer set forth in this Section 4. Certificates for Securities subject to legend removal hereunder
shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with the Depository
Trust Company System as directed by such Purchaser. As used herein, &ldquo;Standard Settlement Period&rdquo; means the standard settlement
period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect
on the date of delivery of a certificate representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend.
In addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to the Purchaser, in cash, as partial liquidated
damages and not as a penalty, 2% of the total of the value of the Shares or Warrant Shares for which the removal of the legend is sought
(based on the VWAP of the Common Stock on the date such Shares or Warrant Shares are submitted to the Transfer Agent) for each full month
that said opinion is not delivered after the Legend Removal Date until such certificate is delivered without a legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.4.
In addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1.3, $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after the Legend Removal Date) for each Trading Day after the Legend Removal
Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered)
to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that
is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares
of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock
that such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of such
Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common
Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<B><U>Buy-In Price</U></B>&rdquo;)
over the product of (A) such number of Shares or Warrant Shares that the Company was required to deliver to such Purchaser by the Legend
Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the
date of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending on the
date of such delivery and payment under this clause (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.5.
Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or
an exemption therefrom, and that if Securities are sold pursuant to a Resale Registration Statement, they will be sold in compliance
with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing
Securities as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.
<B><U>Furnishing of Information; Public Information</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.1.
Until no Purchaser owns any Securities and the Warrants have terminated, the Company covenants to maintain the effectiveness of the registration
of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to use reasonable best efforts to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.2.
At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the
Securities (assuming cashless exercise for the Warrants) may be sold without the requirement for the Company to be in compliance with
Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to
satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or
becomes such an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<B><U>Public
Information Failure</U></B>&rdquo;) then, in addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a
Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to
sell the Securities, an amount in cash equal to two percent (2.0%) of the aggregate Subscription Amount of such Purchaser&rsquo;s Securities
on the day of a Public Information Failure and on every thirtieth (30th) day (prorated for periods totaling less than thirty days) thereafter
until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer
required for the Purchasers to transfer the Shares and Warrant Shares pursuant to Rule 144. The payments to which a Purchaser shall be
entitled pursuant to this Section 4.2.2 are referred to herein as &ldquo;<B><U>Public Information Failure Payments</U></B>.&rdquo; Public
Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information
Failure Payments are incurred and (ii) the third (3rd) Business Day after the event or failure giving rise to the Public Information
Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public
Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing
herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure, and such Purchaser shall
have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.
<B><U>Integration</U></B>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner
that would require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer
or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require stockholder approval
prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.
<B><U>Securities Laws Disclosure; Publicity</U></B>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the
material terms of the transactions contemplated hereby, and (b) file, within the time required by the Exchange Act a Current Report on
Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission. From and after the issuance of such press release,
the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any
of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents (including,
without limitation, the Placement Agent) in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries, or any of their respective officers, directors,
agents (including, without limitation, the Placement Agent), employees or Affiliates on the one hand, and any of the Purchasers or any
of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms that
each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each
Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, if
any, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without
the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser,
with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure
is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a) to the extent required by federal securities law in connection with (i) any Resale Registration Statement contemplated
by this Agreement or the Registration Rights Agreement and (ii) the filing of final Transaction Documents with the Commission and (b)
to the extent such disclosure is required by law or Trading Market regulations, in which such cases the Company shall (x) obtain prior
advice of competent counsel that such disclosure is required, (y) provide the Purchasers with prior notice of such disclosure permitted
under this Section 4.4 and (z) reasonably cooperate with such Purchasers regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5.
<B><U>Stockholder Rights Plan</U></B>. No claim will be made or enforced by the Company or, with the consent of the Company, any other
Person, that any Purchaser is an &ldquo;<B><U>Acquiring Person</U></B>&rdquo; under any control share acquisition, business combination,
poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter
adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of
receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6.
<B><U>Non-Public Information</U></B>. Except with respect to the material terms and conditions of the transactions contemplated by the
Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other
Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company
reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing
to the receipt of such information and agreed in writing with the Company to keep such information confidential. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To
the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates
delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and
agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective
officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers,
directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser
shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such
notice file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7.
<B><U>Use of Proceeds</U></B>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate
purposes (which for the avoidance of doubt may include acquisitions, in the Company&rsquo;s discretion), including working capital. The
Company shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment of trade
payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption of any shares of Common
Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8.
<B><U>Indemnification of Purchasers</U></B>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each
Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally
equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such
Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<B><U>Purchaser Party</U></B>&rdquo;) harmless from
any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid
in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer
or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the
Company in this Agreement or in the other Transaction Documents, (b) any action instituted against the Purchaser Parties in any capacity,
or any of them or their respecive Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with
respect to any of the transactions contemplated by the Transaction Documents. For the avoidance of doubt, the indemnification provided
herein is intended to, and shall also cover, direct claims brought by the Company against the Purchaser Parties; provided, however, that
such indemnification shall not cover any loss, claim, damage or liability to the extent it is finally judicially determined to be attributable
to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party
in any Transaction Document or any conduct by a Purchaser Party which is finally judicially determined to constitute fraud, gross negligence
or willful misconduct. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant
to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and, except with respect to direct claims brought
by the Company, the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable
to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the
defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that
(i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel to
the applicable Purchaser Party (which may be internal counsel), a material conflict on any material issue between the position of the
Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses
of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement for any settlement
by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed.
In addition, if any Purchaser Party takes actions to collect amounts due under any Transaction Documents or to enforce the provisions
of any Transaction Documents, then the Company shall pay the costs incurred by such Purchaser Party for such collection, enforcement
or action, including, but not limited to, attorneys&rsquo; fees and disbursements. The indemnification required by this Section 4.8 shall
be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser
Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9.
<B><U>Listing of Common Stock</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9.1.
The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which
it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares and Warrant Shares
on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such Trading Market. The Company further
agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application
all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares to
be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary
to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s
reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility
of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10.
<B><U>Subsequent Equity Sales</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10.1.
From the date hereof until sixty (60) days after the Release Date, neither the Company nor any Subsidiary shall (i) issue, enter into
any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii)
file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration
Rights Agreement or, solely with respect to securities issued pursuant to any share or option plan duly adopted for such purpose by the
Board of Directors or a committee of non-employee directors established for such purpose for services rendered to the Company, on Form
S-8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10.2.
From the date hereof until six (6) months from the Release Date, the Company and its Subsidiaries shall be prohibited from effecting
or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of shares of Common Stock or Common Stock
Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. Any Purchaser shall be entitled to obtain injunctive
relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10.3.
Notwithstanding the foregoing, this Section 4.10 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11.
<B><U>Certain Transactions and Confidentiality</U></B>. Each Purchaser, severally and not jointly with the other Purchasers, covenants
that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales,
including Short Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and
ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release
as described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction. Notwithstanding the
foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that
(i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities
of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any
securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by
this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser
shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries,
or any of their respective officers, directors, employees, agents or Affiliates after the issuance of the initial press release as described
in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth
above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12.
<B><U>Stockholder Approval</U></B>. In addition, the Company shall hold a special meeting of stockholders (which may also be at the annual
meeting of stockholders) at the earliest practicable date after the date hereof, but in no event later than sixty (60) days after the
Closing Date for the purpose of obtaining Stockholder Approval, with the recommendation of the Company&rsquo;s Board of Directors that
such proposal be approved, and the Company shall solicit proxies from its stockholders in connection therewith in the same manner as
all other management proposals in such proxy statement and all management-appointed proxyholders shall vote their proxies in favor of
such proposal. Within ten (10) Business Days following the Closing Date, the Company shall file with the Commission a preliminary proxy
statement to request for the purpose of obtaining Stockholder Approval, and the Company shall use its best efforts to obtain such Stockholder
Approval. In the event Stockholder Approval (or board approval in lieu thereof following six months after the Closing Date) does not
occur, the Company will be required to hold additional meetings at least one time every sixty (60) days until the earlier of the date
Stockholder Approval is obtained or the Warrants are no longer outstanding, with printed and mailed proxy statements sent to shareholders
for such meetings. Notwithstanding the foregoing, the Company may, in lieu of holding a special meeting of stockholders as aforesaid,
obtain the written consent of a majority of its stockholders covering the Stockholder Approval so long as prior to sixty (60) days after
the Closing Date, such written consents are obtained and in accordance with Exchange Act Rule 14c-2 at least twenty (20) days shall have
transpired from the date on which a written information statement containing the information specified in Schedule 14C detailing such
Stockholder Approval shall have been filed with the SEC and delivered to stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13.
<B><U>Form D; Blue Sky Filings</U></B>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14.
<B><U>Capital Changes</U></B>. Until the date that is sixty (60) days after the Release Date, the Company shall not undertake a reverse
or forward stock split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority
in interest of the Shares and Pre-Funded Warrants, based on the initial Subscription Amounts hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15.
<B><U>Acknowledgment of Dilution</U></B>. The Company acknowledges that the issuance of the Securities may result in dilution of the
outstanding shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges
that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares
pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or
reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the
dilutive effect that such issuance may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16.
<B><U>Lock-Up Agreements</U></B>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements
(and any lock-up agreements contemplated in the Lock-Up Agreements) except to extend the term of the lock-up period and shall enforce
the provisions of each Lock-Up Agreement (and any lock-up agreements contemplated in the Lock-Up Agreements) in accordance with its terms.
If any party to a Lock-Up Agreement (and any lock-up agreements contemplated in the Lock-Up Agreements) breaches any provision of a Lock-Up
Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms of such Lock-Up Agreement (and any
lock-up agreements contemplated in the Lock-Up Agreements).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17.
<B><U>Registration Rights Agreement</U></B>. On the date hereof, the Company shall enter into the Registration Rights Agreement and shall
not amend, modify, waive or terminate any provision of the Registration Rights Agreement, except pursuant to the terms of the Registration
Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18.
<B><U>QEF Election</U></B>. If a Purchaser so requests in writing for any taxable year of the Company, the Company, after consulting
with its outside accounting firm, shall within fifteen (15) Business Days notify such Purchaser in writing that either (A) neither the
Company nor any of its Subsidiaries was a &ldquo;passive foreign investment company&rdquo; as defined in Section 1297 of the Code (&ldquo;<B><U>PFIC</U></B>&rdquo;)
for such year, or (B) the Company and/or one or more of its Subsidiaries was a PFIC for such year, in which event the Company shall provide
to such Purchaser, upon the reasonable written request of such Purchaser, the information reasonably necessary to allow such Purchaser
to elect to treat each of the Company and any applicable Subsidiaries (if any), respectively, as a &ldquo;qualified electing fund&rdquo;
(within the meaning of Section 1295 of the Code for such year, including a &ldquo;PFIC Annual Information Statement&rdquo; as described
in Treasury Regulation Section 1.1295-1(g)(1) (or any successor Treasury Regulation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19.
<B><U>Reservation of Common Stock</U></B>. As of the date hereof, the Company has reserved and the Company shall continue to reserve
and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling
the Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20.
<B><U>Exercise Procedures</U></B>. The form of Exercise Notice (as defined in the Warrants) included in the Warrants set forth the totality
of the procedures required of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions
shall be required of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Exercise Notice
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Exercise Notice form be required
in order to exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with
the terms, conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Miscellaneous</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.
<B><U>Termination</U></B>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only
and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties,
if the Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>,
<U>however</U>, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.
<B><U>Fees and Expenses</U></B>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the
fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident
to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees
(including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any
exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities
to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.
<B><U>Entire Agreement</U></B>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.
<B><U>Notices</U></B>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication
is delivered via email at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City
time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email
at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address
for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided
pursuant to any Transaction Document constitutes, or contains material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.
<B><U>Amendments; Waivers</U></B>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written
instrument signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares
and Pre-Funded Warrants based on the initial Subscription Amounts hereunder (or, prior to Closing, the Company and each Purchaser) or,
in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment,
modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately
impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver
of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely
affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require
the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding
upon each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6.
<B><U>Headings</U></B>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7.
<B><U>Successors and Assigns</U></B>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8.
<B><U>No Third-Party Beneficiaries</U></B>. The Placement Agent shall be the third party beneficiary of the representations and warranties
of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for
the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision
hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9.
<B><U>Governing Law</U></B>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the law of the State of Nevada. Each party agrees that all legal Proceedings
concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction
Documents (whether brought against a party hereto or its respective affiliates, directors, officers, stockholders, partners, members,
employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby
irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City and County of New York for the
adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including
with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any
Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding
is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents
to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any
provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party
in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs
and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10.
<B><U>Survival</U></B>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11.
<B><U>Execution</U></B>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12.
<B><U>Severability</U></B>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13.
<B><U>Rescission and Withdrawal Right</U></B>. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such Shares and
the restoration of such Purchaser&rsquo;s right to acquire such Shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14.
<B><U>Replacement of Securities</U></B>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15.
<B><U>Remedies</U></B>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of
damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties
agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in
the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the
defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16.
<B><U>Payment Set Aside</U></B>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction
Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law
(including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent
of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force
and effect as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17.
<B><U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U></B>. The obligations of each Purchaser under any Transaction
Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for
the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein
or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute
the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers
are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents.
Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out
of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an
additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review
and negotiation of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel
have chosen to communicate with the Company through the legal counsel to the Placement Agent. The legal counsel of the Placement Agent
does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with
the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by
any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction
Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between
and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18.
<B><U>Liquidated Damages</U></B>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under
the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages
and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages
or other amounts are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19.
<B><U>Saturdays, Sundays, Holidays, etc</U></B>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20.
<B><U>Construction</U></B>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity
to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition,
each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21.
<B><U>WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[DGLY
Securities Purchase Agreement Signature Pages Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[DGLY
Securities Purchase Agreement &ndash; Company Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>DIGITAL
    ALLY, INC.</U></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U></U></B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Address
    for Notice:</U></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">stan.ross@digitalally.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    Ross</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[DGLY
Securities Purchase Agreement &ndash; Investor Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned has caused this Securities Purchase Agreement to be duly executed by its authorized signatory as of
the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Purchaser:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    of Authorized Signatory of Purchaser:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address of Authorized Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notice to Purchaser:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Delivery of Securities to Purchaser (if not same as address for notice):</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
    Amount: </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-funded
    Warrants:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
Ownership Blocker:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    A Warrants:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
Ownership Blocker:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    B Warrants:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    to [&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
Ownership Blocker:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employer
    Identification Number: </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
1.35</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Lock-Up Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
1.46</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Pre-Funded Warrant</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
1.51</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Registration Rights Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
1.60</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Series A Warrant</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
1.61</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
of Series B Warrant</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 48; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.
<SEQUENCE>7
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
RIGHTS AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Registration Rights Agreement (this &ldquo;<B><U>Agreement</U></B>&rdquo;) is made and entered into as of June 25, 2024, between Digital
Ally, Inc., a Nevada corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), and each of the several purchasers signatory hereto (each
such purchaser, a &ldquo;<B><U>Purchaser</U></B>&rdquo; and, collectively, the &ldquo;<B><U>Purchasers</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser
(the &ldquo;<B><U>Purchase Agreement</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and each Purchaser hereby agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Definitions</U>.
                                            </B>Capitalized terms used and not otherwise defined herein that are defined in the Purchase
                                            Agreement shall have the meanings given such terms in the Purchase Agreement. As used in
                                            this Agreement, the following terms shall have the following meanings:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0pt 0pt 0.5in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1. &ldquo;<B><U>Advice</U></B>&rdquo;
shall have the meaning set forth in Section &lrm;6.3&lrm;&lrm;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.
&ldquo;<B><U>Effectiveness Date</U></B>&rdquo; means, with respect to the Initial Registration Statement required to be filed
hereunder, thirty (30) calendar days following the Filing Date (or, in the event of a full review by the Commission, fifty (50)
calendar days following the Filing Date) and with respect to any additional Registration Statements which may be required pursuant
to Section 2.3 or Section 3.3, thirty (30) calendar days following the date on which an additional Registration Statement is required
to be filed hereunder (or, in the event of a full review by the Commission, fifty (50) calendar days following the date such
additional Registration Statement is required to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company
is notified by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to
further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth (5th) Trading Day following
the date on which the Company is so notified if such date precedes the dates otherwise required above, provided, further, if such
Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3. &ldquo;<B><U>Effectiveness
Period</U></B>&rdquo; shall have the meaning set forth in Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4. &ldquo;<B><U>Event</U></B>&rdquo;
shall have the meaning set forth in Section 2.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5. &ldquo;<B><U>Event
Date</U></B>&rdquo; shall have the meaning set forth in Section 2.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6.
&ldquo;<B><U>Filing Date</U></B>&rdquo; means, with respect to the Initial Registration Statement required hereunder twenty (20)
Trading Days after the Closing Date and, with respect to any additional Registration Statements which may be required pursuant to
Section 2.3 or Section 3.3, the earliest practical date on which the Company is permitted by SEC Guidance to file such additional
Registration Statement related to the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7. &ldquo;<B><U>Holder</U></B>&rdquo;
or &ldquo;<B><U>Holders</U></B>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8. &ldquo;<B><U>Indemnified
Party</U></B>&rdquo; shall have the meaning set forth in Section 5.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9. &ldquo;<B><U>Indemnifying
Party</U></B>&rdquo; shall have the meaning set forth in Section 5.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10. &ldquo;<B><U>Initial
Registration Statement</U></B>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11. &ldquo;<B><U>Losses</U></B>&rdquo;
shall have the meaning set forth in Section 5.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12. &ldquo;<B><U>Plan
of Distribution</U></B>&rdquo; shall have the meaning set forth in Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13. &ldquo;<B><U>Prospectus</U></B>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the
Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to
the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14. &ldquo;<B><U>Registrable
Securities</U></B>&rdquo; means, as of any date of determination, (a) all Common Stock, (b) all Warrant Shares then issued and issuable
upon exercise of the Warrants and Pre-Funded Warrants (assuming on such date the Warrants and Pre-Funded Warrants are exercised in full
without regard to any exercise limitations therein), and (c) any securities issued or then issuable upon any stock split, dividend or
other distribution, recapitalization or similar event with respect to the foregoing; <U>provided, however</U>, that any such Registrable
Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file
another, Registration Statement hereunder with respect thereto) for so long as (a) a Registration Statement with respect to the sale
of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable Securities have
been disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable Securities have been previously
sold in accordance with Rule 144, or (c) such securities become eligible for resale and without the requirement for the Company to be
in compliance with the current public information requirement under Rule 144 (if such requirement is applicable) as set forth in a written
opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders (assuming that such
securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities were
issued or are issuable, were at no time held by any Affiliate of the Company, as reasonably determined by the Company, upon the advice
of counsel to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15.
&ldquo;<B><U>Registration Statement</U></B>&rdquo; means any registration statement required to be filed hereunder pursuant to
Section 2.1 and any additional registration statements contemplated by Section 2.3 or Section 3.3, including (in each case) the
Prospectus, amendments and supplements to any such registration statement or Prospectus, including pre- and post-effective
amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in any such
registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16. &ldquo;<B><U>Rule
415</U></B>&rdquo; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17. &ldquo;<B><U>Rule
424</U></B>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18. &ldquo;<B><U>Selling
Stockholder Questionnaire</U></B>&rdquo; shall have the meaning set forth in Section 3.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19. &ldquo;<B><U>SEC
Guidance</U></B>&rdquo; means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (ii) the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Shelf
                                            Registration</U></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1. On
or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of
all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a
continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-1 (or Form S-3 to the extent the
Company is eligible to use such registration statement form, subject to the provisions of Section 2.5) and shall contain (unless otherwise
directed by at least 85% in interest of the Holders) substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as <U>Annex
2.1.1</U> and substantially the &ldquo;<U>Selling Stockholders</U>&rdquo; section attached hereto as <U>Annex 2.1.2</U>; <U>provided</U>,
<U>however</U>, that no Holder shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior
written consent. Subject to the terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed
under this Agreement (including, without limitation, under Section 3.3) to be declared effective under the Securities Act as promptly as
possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to
keep such Registration Statement continuously effective under the Securities Act until the date that all Registrable Securities covered
by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale
restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information
requirement under Rule 144 (to the extent applicable), as determined by the counsel to the Company pursuant to a written opinion letter
to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the &ldquo;<B><U>Effectiveness Period</U></B>&rdquo;).
The Company shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading
Day. The Company shall immediately notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on
the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for
effectiveness of such Registration Statement. The Company shall, by 9:30 a.m. (New York City time) on the Trading Day after the effective
date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424. Failure to so notify the Holder
within one (1) Trading Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an
Event under Section 2.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
Notwithstanding the registration obligations set forth in Section 2.1, if the Commission informs the Company that all of the
Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a
single registration statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable
efforts to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of
Registrable Securities permitted to be registered by the Commission, on Form S-1 or such other form available to register for resale
the Registrable Securities as a secondary offering, subject to the provisions of Section 2.5; with respect to filing on Form S-1 or
other appropriate form, and subject to the provisions of Section 2.4 with respect to the payment of liquidated damages; <U>provided</U>, <U>however</U>,
that prior to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the
registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and
Disclosure Interpretation 612.09.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3. Notwithstanding
any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2.4, if the Commission or any
SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration
Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the
registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable
Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.1. First,
the Company shall reduce or eliminate any securities to be included other than Registrable Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.2. Second,
the Company shall reduce Registrable Securities represented by the Warrant Shares (applied, in the case that some Warrant Shares may
be registered, to the Holders on a pro rata basis based on the total number of unregistered Warrant Shares held by such Holders); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.3. Third,
the Company shall reduce Registrable Securities represented by Common Stock (applied, in the case that some Common Stock may be registered,
to the Holders on a pro rata basis based on the total number of unregistered Common Stock held by such Holders).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a cutback hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the
calculations as to such Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with
the foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance
provided to the Company or to registrants of securities in general, one or more registration statements on Form S-1 or such other form
available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement,
as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.
If: (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial
Registration Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3.1
herein or the Company subsequently withdraws the filing of the Registration Statement, the Company shall be deemed to have not
satisfied this clause (i)) as of the Filing Date, or (ii) the Company fails to file with the Commission a request for acceleration
of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five
Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such
Registration Statement will not be &ldquo;reviewed&rdquo; or will not be subject to further review, or (iii) prior to the effective
date of a Registration Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments
made by the Commission in respect of such Registration Statement within ten (10) calendar days after the receipt of comments by or
notice from the Commission that such amendment is required in order for such Registration Statement to be declared effective, or
(iv) a Registration Statement registering for resale all of the Registrable Securities is not declared effective by the Commission
by the Effectiveness Date of the Initial Registration Statement (provided if the Registration Statement does not allow for the
resale of Registrable Securities at prevailing market prices (i.e., only allows for fixed price sales), the Company shall have been
deemed to have not satisfied this clause), or (v) after the effective date of a Registration Statement, such Registration Statement
ceases for any reason to remain continuously effective as to all Registrable Securities included in such Registration Statement, or
the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more than ten
(10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days)
during any 12-month period (any such failure or breach being referred to as an &ldquo;<B><U>Event</U></B>&rdquo;, and for purposes
of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading
Day period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded, and for
purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred
to as &ldquo;<B><U>Event Date</U></B>&rdquo;), then, in addition to any other rights the Holders may have hereunder or under
applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not
have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as
partial liquidated damages and not as a penalty, equal to the product of 2.0% multiplied by the aggregate Subscription Amount paid
by such Holder pursuant to the Purchase Agreement. If the Company fails to pay any partial liquidated damages pursuant to this
Section 2.4 in full within seven days after the date payable, the Company will pay interest thereon at a rate of 15% per annum (or
such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such partial
liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages
pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of an
Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5. If
Form S-1 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the
resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-1
as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect
until such time as a Registration Statement on Form S-1 covering the Registrable Securities has been declared effective by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6. Notwithstanding
anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as
any Underwriter without the prior written consent of such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Registration
                                            Procedures</U>. </B>In connection with the Company&rsquo;s registration obligations hereunder,
                                            the Company shall:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1. Not
less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the
filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed
to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is
notified of such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration
Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements
thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex 3.1
</U>(a &ldquo;<B><U>Selling Stockholder Questionnaire</U></B>&rdquo;) on a date that is not less than two (2) Trading Days prior to the
Filing Date or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials
in accordance with this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2. (i)
Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to
register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company), and (iv) comply in all material respects with the applicable
provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration
Statement during the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition
by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus as so supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3. If
during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to
the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such
Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4. Notify
the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by
an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and,
in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such
notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings
for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>,
<U>however</U>, that in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company and the Company agrees that the Holders shall not have any duty of confidentiality to the Company and shall not
have any duty to the Company not to trade on the basis of such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5. Use
its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable
Securities for sale in any jurisdiction, at the earliest practicable moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6. Furnish
to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7. Subject
to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by
each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any
amendment or supplement thereto, except after the giving of any notice pursuant to Section 3.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8. Prior
to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with
the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of such
Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States
as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the
Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9. If
requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted
by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10.
Upon the occurrence of any event contemplated by Section 3.4, as promptly as reasonably possible under the circumstances taking into
account the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature
disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a
supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any
other required document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading. If the Company notifies the Holders in
accordance with clauses (iii) through (vi) of Section 3.4 above to suspend the use of any Prospectus until the requisite changes to
such Prospectus have been made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts to
ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its
right under this Section 3.10 to suspend the availability of a Registration Statement and Prospectus, subject to the payment of
partial liquidated damages otherwise required pursuant to Section 2.4, for a period not to exceed 60 calendar days (which need not
be consecutive days) in any 12-month period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11. Otherwise
use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities Act and
the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement
or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at
any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12. The
Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration of
the resale of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13. The
Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially
owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the
Common Stock. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the
Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s request,
any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely
because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Registration
                                            Expenses</U></B>. All fees and expenses incident to the performance of, or compliance with,
                                            this Agreement by the Company shall be borne by the Company whether or not any Registrable
                                            Securities are sold pursuant to a Registration Statement. The fees and expenses referred
                                            to in the foregoing sentence shall include, without limitation, (i) all registration and
                                            filing fees (including, without limitation, fees and expenses of the Company&rsquo;s counsel
                                            and independent registered public accountants) (A) with respect to filings made with the
                                            Commission, (B) with respect to filings required to be made with any Trading Market on which
                                            the Common Stock is then listed for trading, and (C) in compliance with applicable state
                                            securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without
                                            limitation, fees and disbursements of counsel for the Company in connection with Blue Sky
                                            qualifications or exemptions of the Registrable Securities), (ii) printing expenses (including,
                                            without limitation, expenses of printing certificates for Registrable Securities), (iii)
                                            messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the
                                            Company, (v) Securities Act liability insurance, if the Company so desires such insurance
                                            to be purchased at the sole discretion of the Company, and (vi) fees and expenses of all
                                            other Persons retained by the Company in connection with the consummation of the transactions
                                            contemplated by this Agreement. In addition, the Company shall be responsible for all of
                                            its internal expenses incurred in connection with the consummation of the transactions contemplated
                                            by this Agreement (including, without limitation, all salaries and expenses of its officers
                                            and employees performing legal or accounting duties), the expense of any annual audit and
                                            the fees and expenses incurred in connection with the listing of the Registrable Securities
                                            on any securities exchange as required hereunder. In no event shall the Company be responsible
                                            for any broker or similar commissions of any Holder or, except to the extent provided for
                                            in the Transaction Documents, any legal fees or other costs of the Holders.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Indemnification</U></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1. <B><U>Indemnification
by the Company</U></B>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder,
the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal
as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other
Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title)
of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally
equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person,
to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including,
without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<B><U>Losses</U></B>&rdquo;), as incurred, arising
out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus
or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to
any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the
case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any violation
or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder,
in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such
untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder
expressly for use therein, or to the extent that such information relates to such Holder or such Holder&rsquo;s proposed method of distribution
of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement,
such Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved Annex 2.1.1 hereto for this
purpose) or (ii) in the case of an occurrence of an event of the type specified in Section 3.4(iii)-(vi), the use by such Holder of an
outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is
outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated
in Section 6.3. The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or
in connection with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any
Registrable Securities by any of the Holders in accordance with Section 6.7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2. <B><U>Indemnification
by Holders</U></B>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers,
agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of
the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by
applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement
thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact
required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in
light of the circumstances under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue
statement or omission is contained in any information so furnished in writing by such Holder to the Company expressly for inclusion
in such Registration Statement or such Prospectus or (ii) to the extent, but only to the extent, that such information relates to
such Holder&rsquo;s information provided in the Selling Stockholder Questionnaire or the proposed method of distribution of
Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration
Statement (it being understood that the Holder has approved Annex 2.1.1 hereto for this purpose), such Prospectus or in any
amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than the dollar amount of
the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any
damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such Holder upon
the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification
obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3. <B><U>Conduct
of Indemnification Proceedings</U></B>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an &ldquo;<B><U>Indemnified Party</U></B>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought
(the &ldquo;<B><U>Indemnifying Party</U></B>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party
has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such
Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to
any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to
the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent
such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing
that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to
assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying
Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which
consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified
Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section)
shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided
that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such
actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject
to appeal or further review) not to be entitled to indemnification hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4. <B><U>Contribution</U></B>.
If the indemnification under Section 5.1 or 5.2 is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party
harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in
such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with
the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The
relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a
material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and
the parties&rsquo; relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or
omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set
forth in this Agreement, any reasonable attorneys&rsquo; or other fees or expenses incurred by such party in connection with any
Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in
this Section was available to such party in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0pt 0pt 0.5in; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5.4 were determined by pro
rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the
immediately preceding paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in
amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this
Section 5  and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such
contribution obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have
to the Indemnified Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Miscellaneous</U></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1. <B><U>Remedies</U></B>.
In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the
Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including
recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder
agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the
provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach,
it shall not assert or shall waive the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2. <B><U>No
Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U></B>. Neither the Company nor any of its security
holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration
Statements other than the Registrable Securities. The Company shall not file any other registration statements until all Registrable
Securities are registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this
Section 6.2 shall not prohibit the Company from filing amendments to registration statements filed prior to the date of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3. <B><U>Discontinued
Disposition</U></B>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company
of the occurrence of any event of the kind described in Section 3.4(iii) through (vi), such Holder will forthwith discontinue disposition
of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<B><U>Advice</U></B>&rdquo;)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will
use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be
subject to the provisions of Section 2.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4. <B><U>Piggy-Back
Registrations</U></B>. If, at any time during the Effectiveness Period, there is not an effective Registration Statement covering all
of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement relating
to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form
S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely
in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock
option or other employee benefit plans, then the Company shall deliver to each Holder a written notice of such determination and, if
within fifteen days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include
in such registration statement all or any part of such Registrable Securities such Holder requests to be registered; <U>provided</U>,
<U>however</U>, that the Company shall not be required to register any Registrable Securities pursuant to this Section 6.4 that are eligible
for resale pursuant to Rule 144 (without volume restrictions and provided the Company is in compliance with the current public information
requirement under Rule 144) promulgated by the Commission pursuant to the Securities Act or that are the subject of a then effective
Registration Statement that is available for resales or other dispositions by such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5. <B><U>Amendments
and Waivers</U></B>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented,
and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by
the Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes
any Registrable Securities issuable upon exercise or conversion of any Security); provided that no such amendment, action or omission
that adversely affects, alters or changes the interests of any Holder in a manner disproportionate to the other Holders shall be effective
against such Holder without the prior written consent of such Holder. If a Registration Statement does not register all of the Registrable
Securities pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities
to be registered for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which
of its Registrable Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to
depart from the provisions hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that
does not directly or indirectly affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable
Securities to which such waiver or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be
amended, modified, or supplemented except in accordance with the provisions of the first sentence of this Section 6.5. No consideration
shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the
same consideration also is offered to all of the parties to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6. <B><U>Notices</U></B>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth
in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.7. <B><U>Successors
and Assigns</U></B>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of
the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder
without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their
respective rights hereunder in the manner and to the Persons as permitted under the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8.
<B><U>No Inconsistent Agreements</U></B>. The Company has not entered, as of the date hereof, nor shall the Company, on or after the
date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted
to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except as set forth on <U>Schedule 6.8</U>, the Company
has not previously entered into any agreement granting any registration rights with respect to any of its securities to any Person that
have not been satisfied in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.9. <B><U>Execution
and Counterparts</U></B>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.10. <B><U>Governing
Law</U></B>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11. <B><U>Cumulative
Remedies</U></B>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.12. <B><U>Severability</U></B>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.13. <B><U>Headings</U></B>.
The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or
affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.14. <B><U>Independent
Nature of Holders&rsquo; Obligations and Rights</U></B>. The obligations of each Holder hereunder are several and not joint with the
obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any
other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken
by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture
or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity
with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges
that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out
of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such
purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company,
not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested
to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company
and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[DGLY
Registration Rights Agreement Signature Pages Follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[DGLY
Registration Rights Agreement &ndash; Company Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
    ALLY, INC. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    Ross </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[DGLY
Registration Rights Agreement &ndash; Holder Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Holder:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Holder:</I></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
2.1.1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Plan
of Distribution</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Selling Stockholder (the &ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest
may, from time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange,
market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices.
A Selling Stockholder may use any one or more of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block
    as principal to facilitate the transaction;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
    of short sales;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated
    price per security;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933,
as amended (the &ldquo;<B><U>Securities Act</U></B>&rdquo;), if available, rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Annex 2.1.1 - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or
markdown in compliance with FINRA Rule 2121.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company
has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders
without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for
the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar
effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule
of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable
state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is
complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the Common Stock for the applicable restricted period, as defined in Regulation M,
prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the
Common Stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders
and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Annex 2.1.1 - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
2.1.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING
STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock being offered by the selling stockholders are those previously issued to the selling stockholders, and those issuable to
the selling stockholders, upon exercise of the warrants. For additional information regarding the issuances of those shares of Common
Stock and warrants, see &ldquo;Private Placement of shares of Common Stock and Warrants&rdquo; above. We are registering the shares of
Common Stock in order to permit the selling stockholders to offer the Common Stock for resale from time to time. Except for the ownership
of the shares of Common Stock and the warrants, the selling stockholders have not had any material relationship with us within the past
three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling stockholders and other information regarding the beneficial ownership of the shares of Common Stock by
each of the selling stockholders. The second column lists the number of shares of Common Stock beneficially owned by each selling stockholder,
based on its ownership of the shares of Common Stock and warrants, as of [&#9679;], 2024, assuming exercise of the warrants held by the
selling stockholders on that date, without regard to any limitations on exercises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of Common Stock being offered by this prospectus by the selling stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the selling stockholders, this prospectus generally covers the resale
of the sum of (i) the number of shares of Common Stock issued to the selling stockholders in the &ldquo;Private Placement of shares of
Common Stock and Warrants&rdquo; described above and (ii) the maximum number of shares of Common Stock issuable upon exercise of the
related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date
this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of
determination and all subject to adjustment as provided in the registration rights agreement, without regard to any limitations on the
exercise of the warrants. The fourth column assumes the sale of all of the Common Stock offered by the selling stockholders pursuant
to this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the warrants, a selling stockholder may not exercise the warrants to the extent such exercise would cause such selling stockholder,
together with its affiliates and attribution parties, to beneficially own a number of shares of Common Stock which would exceed 4.99%
or 9.99%, as applicable, of our then outstanding Common Stock following such exercise, excluding for purposes of such determination shares
of Common Stock issuable upon exercise of the warrants that have not been exercised. The number of Common Stock in the second column
does not reflect this limitation. The selling stockholders may sell all, some or none of their Common Stock in this offering. See &ldquo;Plan
of Distribution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Name of Selling Stockholder</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares of Common Stock Owned Prior to Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Maximum Number of shares of Common Stock to be Sold Pursuant to this Prospectus</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares of Common Stock Owned After Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 21%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 22%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 22%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 21%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Annex 2.1.2 - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
3.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
ALLY, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Selling
Stockholder Notice and Questionnaire</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner of shares of Common Stock (the &ldquo;<B><U>Registrable Securities</U></B>&rdquo;) of Digital Ally, Inc.,
a Nevada corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), understands that the Company has filed or intends to file with the Securities
and Exchange Commission (the &ldquo;<B><U>Commission</U></B>&rdquo;) a registration statement (the &ldquo;<B><U>Registration Statement</U></B>&rdquo;)
for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the &ldquo;<B><U>Securities Act</U></B>&rdquo;),
of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement (the &ldquo;<B><U>Registration Rights
Agreement</U></B>&rdquo;) to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company
upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto
in the Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly,
holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences
of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner (the &ldquo;<B><U>Selling Stockholder</U></B>&rdquo;) of Registrable Securities hereby elects to include
the Registrable Securities owned by it in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>QUESTIONNAIRE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Selling Stockholder</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex 3.1 - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote
    or dispose of the securities covered by this Questionnaire):</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Address for Notices to Selling Stockholder:</B></FONT></TD></TR>
</TABLE>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact Person:</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Broker-Dealer Status:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
    you a broker-dealer?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to
    the Company?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    &ldquo;no&rdquo; to Section 3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the
    Registration Statement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
    you an affiliate of a broker-dealer?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
     &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business,
    and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or
    indirectly, with any person to distribute the Registrable Securities?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    &ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the
    Registration Statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex 3.1 - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficial Ownership of Securities of the Company Owned
by the Selling Stockholder.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except
    as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other
    than the securities issuable pursuant to the Purchase Agreement.</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
    and Amount of other securities beneficially owned by the Selling Stockholder:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Relationships with the Company:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
    any exceptions here:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may
occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall
not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment
of the Registration Statement and the related prospectus and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either
in person or by its duly authorized agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">Date: </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
    Owner: ______________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 46%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
EMAIL A .PDF COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO STAN.ROSS@DIGITALALLY.COM, WITH A COPY TO DDANOVITCH@SULLIVANLAW.COM.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex 3.1 - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>8
<FILENAME>ex10-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-3_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
24, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PERSONAL
AND CONFIDENTIAL</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Stanton E. Ross, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Digital
Ally, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14001
Marshall Drive</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lenexa,
KS 66215</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
States</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>DGLY
    | PIPE Offering | Placement Agent Agreement</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Ross:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of this placement agent agreement (&ldquo;<B><U>Agreement</U></B>&rdquo;) is to outline our agreement pursuant to which Aegis
Capital Corp. (&ldquo;<B><U>Aegis</U></B>&rdquo;) will act as the placement agent on a &ldquo;best efforts&rdquo; basis in connection
with the proposed PIPE Offering (the &ldquo;<B><U>Placement</U></B>&rdquo;) by Digital Ally, Inc. (collectively, with its subsidiaries
and affiliates, the &ldquo;<B><U>Company</U></B>&rdquo;) of its shares of common stock, warrants and pre-funded warrants (collectively,
the &ldquo;<B><U>Securities</U></B>&rdquo;). This Agreement sets forth certain conditions and assumptions upon which the Placement is
premised. The Company expressly acknowledges and agrees that Aegis&rsquo;s obligations hereunder are on a reasonable &ldquo;best efforts&rdquo;
basis only and that the execution of this Agreement does not constitute a commitment by Aegis to purchase the Securities and does not
ensure the successful placement of the Securities or any portion thereof or the success of Aegis with respect to securing any other financing
on behalf of the Company. The Company confirms that entry into this Agreement and completion of the Placement with Aegis will not breach
or otherwise violate the Company&rsquo;s obligations to any other party or require any payments to such other party. For the sake of
clarity, such obligations may include but not be limited to obligations under an engagement letter, placement agency agreement, underwriting
agreement, advisory agreement, right of first refusal, tail fee obligation or other agreement. Capitalized terms that are used but not
otherwise defined herein shall have the meanings given to such terms in the Securities Purchase Agreement (as defined herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1345
Avenue of the Americas &#9679; New York, New York &#9679; 10105</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
813-1010 &#9679; Fax (212) 813-1047 &#9679; Member FINRA, SIPC</B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-3_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of our agreement in principle are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Engagement</U></B>.
                                            The Company hereby engages Aegis, for the period beginning on the date hereof and ending
                                            thirty (30) business days thereafter or upon the completion of the Placement, whichever is
                                            sooner (the &ldquo;<B><U>Engagement Period</U></B>&rdquo;), to act as the Company&rsquo;s
                                            exclusive investment bank in connection with the proposed Placement. During the Engagement
                                            Period or until the consummation of the Placement, and as long as Aegis is proceeding in
                                            good faith with preparations for the Placement, the Company agrees not to solicit, negotiate
                                            with or enter into any agreement with any other source of financing (whether equity, debt
                                            or otherwise), any underwriter, potential underwriter, placement agent, financial advisor,
                                            investment banking firm or any other person or entity in connection with an offering of the
                                            Company&rsquo;s debt or equity securities or any other financing by the Company. Aegis will
                                            use its reasonable &ldquo;best efforts&rdquo; to solicit offers to purchase the Securities
                                            from the Company on the terms, and subject to the conditions, set forth in the Prospectus
                                            (as in the Registration Rights Agreement). Aegis shall use commercially reasonable efforts
                                            to assist the Company in obtaining performance by each Purchaser (as defined below) whose
                                            offer to purchase Securities has been solicited by Aegis, but Aegis shall not, except as
                                            otherwise provided in this Agreement, be obligated to disclose the identity of any potential
                                            purchaser or have any liability to the Company in the event any such purchase is not consummated
                                            for any reason. The Company acknowledges that under no circumstances will Aegis be obligated
                                            to underwrite or purchase any Securities for its own account and, in soliciting purchases
                                            of the Securities, Aegis shall act solely as an agent of the Company. The services provided
                                            pursuant to this Agreement shall be on an &ldquo;agency&rdquo; basis and not on a &ldquo;principal&rdquo;
                                            basis.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>The
                                            Placement</U></B>. The Placement is expected to consist of the sale of up to approximately
                                            $3.0 million of the Company&rsquo;s Securities. The structure and pricing of the Placement
                                            will be mutually agreed upon by the Company, Aegis and the investors thereto. Aegis will
                                            act as placement agent for the Placement subject to, among other matters referred to herein
                                            and additional customary conditions, completion of Aegis&rsquo;s due diligence examination
                                            of the Company and its affiliates, listing approval by the Nasdaq Capital Market (&ldquo;<B><U>Exchange</U></B>&rdquo;)
                                            of the Securities to be issued, and the execution of a definitive Securities Purchase Agreement
                                            in connection with the Placement (the &ldquo;<B><U>Securities Purchase Agreement</U></B>&rdquo;).
                                            The actual size of the Placement, the precise number of Securities to be offered by the Company
                                            and the offering price will be the subject of continuing negotiations between the Company
                                            and the investors thereto. In connection with the entry into the Securities Purchase Agreement,
                                            the Company (i) will meet with Aegis and its representatives to discuss such due diligence
                                            matters and to provide such documents as Aegis may require; (ii) will not file with the Commission
                                            any document regarding the Placement without the prior approval of Aegis and its counsel;
                                            (iii) will deliver to Aegis and the investors in the Placement such legal and accounting
                                            opinions and letters (including, without limitation, accounting comfort letters, legal opinions,
                                            negative assurance letters, good standing certificates and officers&rsquo; and secretary
                                            certificates) as Aegis may require, all in form and substance acceptable to Aegis and (iv)
                                            will ensure that Aegis is a third party beneficiary of all representations, warranties, covenants,
                                            closing conditions and deliverables in connection with the Placement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Placement
                                            Compensation</U></B>. The placement commission will be 8.0% of the gross proceeds from the
                                            Placement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-3_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Registration
                                            Statement</U></B>. To the extent the Company decides to proceed with the Placement, the Company
                                            will, as soon as practicable and in no event later than the times set forth in the registration
                                            rights agreement (the &ldquo;<B><U>Registration Rights Agreement</U></B>&rdquo;) to be entered
                                            into with the investors in the Placement, prepare and file with the Securities and Exchange
                                            Commission (the &ldquo;<B><U>Commission</U></B>&rdquo;) a Registration Statement on Form
                                            S-1 (the &ldquo;<B><U>Registration Statement</U></B>&rdquo;) under the Securities Act of
                                            1933, as amended (the &ldquo;<B><U>Securities Act</U></B>&rdquo;) and a prospectus included
                                            therein (the &ldquo;<B><U>Prospectus</U></B>&rdquo;) covering the resale of the Securities
                                            to be offered and sold in the Placement. The Registration Statement (including the Prospectus
                                            therein), and all amendments and supplements thereto, will be in form reasonably satisfactory
                                            to the investors, Aegis and counsel to the investors and Aegis. Other than any information
                                            provided by the investors or Aegis in writing specifically for inclusion in the Registration
                                            Statement or the Prospectus, the Company will be solely responsible for the contents of its
                                            Registration Statement and Prospectus and any and all other written or oral communications
                                            provided by or on behalf of the Company to any actual or prospective investor of the Securities,
                                            and the Company represents and warrants that such materials and such other communications
                                            will not, as of the date of the offer or sale of the Securities, contain any untrue statement
                                            of a material fact or omit to state a material fact required to be stated therein or necessary
                                            in order to make the statements therein, in light of the circumstances under which they were
                                            made, not misleading. If at any time prior to the completion of the offer and sale of the
                                            Securities an event occurs that would cause the Registration Statement or Prospectus (as
                                            supplemented or amended) to contain an untrue statement of a material fact or to omit to
                                            state a material fact necessary in order to make the statements therein, in light of the
                                            circumstances under which they were made, not misleading, the Company will notify Aegis immediately
                                            of such event and Aegis will suspend solicitations of the prospective purchasers of the Securities
                                            until such time as the Company shall prepare a supplement or amendment to the Registration
                                            Statement or Prospectus that corrects such statement or omission.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Lock-Ups</U></B>.
                                            In connection with the Placement, the Company&rsquo;s directors, executive officers, employees
                                            and shareholders holding at least five percent (5%) of the outstanding common stock will
                                            enter into customary &ldquo;lock-up&rdquo; agreements in favor of the Placement Agent for
                                            period of sixty (60) days after the Release Date (the &ldquo;<B><U>Lock-Up Period</U></B>&rdquo;);
                                            provided, however, that any sales by parties to the lock-ups shall be subject to the lock-up
                                            agreements and provided further, that none of such common stock shall be saleable in the
                                            public market until the expiration of the Lock-Up Period.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-3_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Company
                                            Standstill</U></B>. In connection with the Placement, without the prior written consent of
                                            the investors, the Company will not, for a period of sixty (60) days after the later of the
                                            Release Date (the &ldquo;<B><U>Standstill Period</U></B>&rdquo;), (a) offer, sell, issue,
                                            or otherwise transfer or dispose of, directly or indirectly, any equity of the Company or
                                            any securities convertible into or exercisable or exchangeable for equity of the Company;
                                            (b) file or caused to be filed any registration statement with the Commission relating to
                                            the offering of any equity of the Company or any securities convertible into or exercisable
                                            or exchangeable for equity of the Company; or (c) enter into any agreement or announce the
                                            intention to effect any of the actions described in subsections (a) or (b) hereof (all of
                                            such matters, the &ldquo;<B><U>Standstill Restrictions</U></B>&rdquo;). So long as none of
                                            such equity securities shall be saleable in the public market until the expiration of the
                                            Standstill Period, the following matters shall not be prohibited by the Standstill Restrictions:
                                            (i) the adoption of an equity incentive plan and the grant of awards or equity pursuant to
                                            any equity incentive plan, and the filing of a registration statement on Form S-8; (ii) securities
                                            issued pursuant to agreements, options, restricted share units or convertible securities
                                            existing as of the date hereof provided the terms are not modified; and (iii) securities
                                            issued pursuant to acquisitions or strategic transactions (whether by merger, consolidation,
                                            purchase of equity, purchase of assets, reorganization or otherwise) approved by a majority
                                            of the disinterested directors of the Company, provided that such securities are issued as
                                            &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights
                                            that require or permit the filing of any registration statement in connection therewith during
                                            the Standstill Period, and provided that any such issuance shall only be to a person or entity
                                            (or to the equity holders of an entity) which is, itself or through its subsidiaries, an
                                            operating company or an owner of an asset in a business synergistic with the business of
                                            the Company and shall provide to the Company additional benefits in addition to the investment
                                            of funds, but shall not include a transaction in which the Company is issuing securities
                                            primarily for the purpose of raising capital or to an entity whose primary business is investing
                                            in securities. In no event should any equity transaction during the Standstill Period result
                                            in the sale of equity at an offering price to the public less than that of the Placement
                                            referred herein.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Expenses</U></B>.
                                            The Company will be responsible for and will pay all expenses relating to the Placement,
                                            including, without limitation, (a) all filing fees and expenses relating to the registration
                                            of the Securities with the Commission; (b) all Financial Industry Regulatory Authority, Inc.
                                            Public Offering filing fees; (c) all fees and expenses relating to the listing of the Company&rsquo;s
                                            equity or equity-linked securities on an Exchange; (d) all fees, expenses and disbursements
                                            relating to the registration or qualification of the Securities under the &ldquo;blue sky&rdquo;
                                            securities laws of such states and other jurisdictions as Aegis may reasonably designate
                                            (including, without limitation, all filing and registration fees, and the reasonable fees
                                            and disbursements of the Company&rsquo;s &ldquo;blue sky&rdquo; counsel, which will be Aegis&rsquo;s
                                            counsel) unless such filings are not required in connection with the Company&rsquo;s proposed
                                            Exchange listing; (e) all fees, expenses and disbursements relating to the registration,
                                            qualification or exemption of the Securities under the securities laws of such foreign jurisdictions
                                            as Aegis may reasonably designate; (f) the costs of all mailing and printing of the Placement
                                            documents; (g) transfer and/or stamp taxes, if any, payable upon the transfer of Securities
                                            from the Company to Aegis; (h) the fees and expenses of the Company&rsquo;s accountants;
                                            and (i) $50,000 for reasonable legal fees and disbursements for Aegis&rsquo;s counsel.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-3_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Closing;
                                            Closing Deliverables</U></B>. On the Closing Date, upon the terms and subject to the conditions
                                            set forth in the Securities Purchase Agreement, the Company agrees to sell, and the Purchasers,
                                            severally and not jointly, agree to purchase the Securities. Each Purchaser shall deliver
                                            to the Company, via wire transfer, immediately available funds equal to such Purchaser&rsquo;s
                                            Subscription Amount as set forth on the signature page in the Securities Purchase Agreement
                                            executed by such Purchaser, and the Company shall deliver to each Purchaser its respective
                                            Shares and Warrants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1. <B><U>Company
Deliveries</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1.
On the date hereof, upon the terms and subject to the conditions set forth in the Securities Purchase Agreement, the Company shall deliver
each of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1.1
This Agreement duly executed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1.2
The Securities Purchase Agreement duly executed by the Company</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1.3
A certificate executed by the Chief Financial Officer of the Company in customary form reasonably satisfactory to the Placement Agent
and its counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1.4
The Lock-Up Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1.5
The Registration Rights Agreement duly executed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1.6
The Escrow Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2.
On or prior to the Closing Date, upon the terms and subject to the conditions set forth in the Securities Purchase Agreement, the Company
shall deliver each the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2.1
A copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
(or at the request of the Purchaser, book entry statement) evidencing a number of unregistered Shares equal to such Purchaser&rsquo;s
Subscription Amount divided by the Per Unit Purchase Price, registered in the name of such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2.2
For each Purchaser of Pre-Funded Warrants, a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of
shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded Warrants divided by
the Per Unit Purchase Price, with an exercise price equal to $0.0001, subject to adjustment as provided therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-3_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2.3
The Company shall have provided the flow of funds, on Company letterhead and executed by the Chief Executive Officer or Chief Financial
Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2.4
A duly executed and delivered Officers&rsquo; Certificate, in customary form reasonably satisfactory to the Placement Agent and its counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2.5
The Series A Warrants and Series B Warrants registered in the name of such Purchaser equal to 100.0% warrant coverage for the sum of
the number of Shares and Pre-Funded Warrants stated on such Purchaser&rsquo;s signature page hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2.6
A duly executed joint written instructions to the Escrow Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Conditions
                                            of the Obligations of the Placement Agent</U></B>. The obligations of the Placement Agent
                                            hereunder shall be subject to the accuracy of the representations and warranties on the part
                                            of the Company set forth in the Securities Purchase Agreement, in each case as of the date
                                            hereof and as of the Closing Date as though then made, to the timely performance by each
                                            of the Company of its covenants and other obligations hereunder on and as of such dates,
                                            and to each of the following additional conditions:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.
<B><U>Closing Deliverables</U></B>. The Company shall have delivered all closing deliverables to the Placement Agent as set forth in
Section 9.1 as of the time required and in form reasonably satisfactory to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.1. <B><U>No
Material Changes</U></B>. Prior to and on the Closing Date: (i) there shall have been no Material Adverse Effect (as defined in the
Securities Purchase Agreement) or development involving a prospective Material Adverse Effect in the condition or prospects or the
business activities, financial or otherwise, of the Company since filing of the latest Form 10-Q of the Company; (ii) no action,
suit or proceeding, at law or in equity, shall have been pending or threatened against the Company or any affiliates of the Company
before or by any court or federal or state commission, board or other administrative agency wherein an unfavorable decision, ruling
or finding may materially adversely affect the business, operations, prospects or financial condition or income of the Company; and
(iii) no stop order shall have been issued under the Securities Act and no proceedings therefor shall have been initiated or
threatened by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.2. <B><U>Additional
Documents</U></B>. At the Closing Date, the Placement Agent&rsquo;s counsel shall have been furnished with such documents and
opinions as they may require in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of
any of the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the
Securities as herein contemplated shall be satisfactory in form and substance to the Placement Agent and Placement Agent&rsquo;s
counsel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-3_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Prior
                                            Agreement</U></B>. By entering into this Agreement, the parties agree that that certain letter
                                            of engagement, dated June 11, 2024, entered into between the same parties hereof, shall automatically
                                            terminate and cease to have any effect whatsoever and shall be superseded in its entirety
                                            by this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination</U></B>.
                                            Notwithstanding anything to the contrary contained herein, the Company agrees that the provisions
                                            relating to the payment of fees, reimbursement of expenses, tail fee, indemnification and
                                            contribution, confidentiality, conflicts, independent contractor and waiver of the right
                                            to trial by jury will survive any termination or expiration of this Agreement. Notwithstanding
                                            anything to the contrary contained herein, the Company has the right to terminate the Agreement
                                            for cause in compliance with FINRA Rule 5110(g)(5)(B)(i). The exercise of such right of termination
                                            for cause eliminates the Company&rsquo;s obligations with respect to the provisions relating
                                            to the tail fees. Notwithstanding anything to the contrary contained in this Agreement, in
                                            the event that no Placement is completed for any reason whatsoever during the Engagement
                                            Period, the Company shall be obligated to pay to Aegis its actual and accountable out-of-pocket
                                            expenses related to the Placement (including the fees and disbursements of Placement Agent&rsquo;s
                                            legal counsel) and if applicable, for electronic road show service used in connection with
                                            the Placement. During the engagement hereunder: (i) the Company will not, and will not permit
                                            its representatives to, other than in coordination with Aegis, contact or solicit institutions,
                                            corporations or other entities or individuals as potential purchasers of the Securities;
                                            and (ii) the Company will not pursue any financing transaction which would be in lieu of
                                            the Placement. Furthermore, the Company agrees that during Aegis&rsquo;s engagement hereunder,
                                            all inquiries from prospective investors will be referred to Aegis</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Publicity</U></B>.
                                            The Company agrees that it will not issue press releases or engage in any other publicity,
                                            without Aegis&rsquo;s prior written consent, commencing on the date hereof and continuing
                                            until the final Closing of the Placement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Information</U></B>.
                                            During the Engagement Period or until the Closing, the Company agrees to cooperate with Aegis
                                            and to furnish, or cause to be furnished, to Aegis, any and all information and data concerning
                                            the Company, and the Placement that Aegis deems appropriate (the &ldquo;<B><U>Information</U></B>&rdquo;).
                                            The Company will provide Aegis reasonable access during normal business hours from and after
                                            the date of execution of this Agreement until the Closing to all of the Company&rsquo;s assets,
                                            properties, books, contracts, commitments and records and to the Company&rsquo;s officers,
                                            directors, employees, appraisers, independent accountants, legal counsel and other consultants
                                            and advisors. Except as contemplated by the terms hereof or as required by applicable law,
                                            Aegis will keep strictly confidential all non-public Information concerning the Company provided
                                            to Aegis. No obligation of confidentiality will apply to Information that: (a) is in the
                                            public domain as of the date hereof or hereafter enters the public domain without a breach
                                            by Aegis, (b) was known or became known by Aegis prior to the Company&rsquo;s disclosure
                                            thereof to Aegis as demonstrated by the existence of its written records, (c) becomes known
                                            to Aegis from a source other than the Company which information is not provided by the breach
                                            of an obligation of confidentiality owed to the Company, (d) is disclosed by the Company
                                            to a third party without restrictions on its disclosure or (e) is independently developed
                                            by Aegis as demonstrated by its written records. For the avoidance of doubt, except as otherwise
                                            provided herein, all information which is not publicly available relating to the Company&rsquo;s
                                            proprietary technology is proprietary and confidential.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-3_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>No
                                            Third Party Beneficiaries; No Fiduciary Obligations</U></B>. This Agreement does not create,
                                            and shall not be construed as creating, rights enforceable by any person or entity not a
                                            party hereto, except those entitled hereto by virtue of the indemnification provisions hereof.
                                            The Company acknowledges and agrees that: (i) Aegis is not and shall not be construed as
                                            a fiduciary of the Company and shall have no duties or liabilities to the equity holders
                                            or the creditors of the Company or any other person or entity by virtue of this Agreement
                                            or the retention of Aegis hereunder, all of which are hereby expressly waived; and (ii) Aegis
                                            is a full service securities firm engaged in a wide range of businesses and from time to
                                            time, in the ordinary course of its business, Aegis or its affiliates may hold long or short
                                            positions and trade or otherwise effect transactions for its own account or the account of
                                            its customers in debt or equity securities or loans of the companies which may be the subject
                                            of the transactions contemplated by this Agreement. During the course of Aegis&rsquo;s engagement
                                            with the Company, Aegis may have in its possession material, non-public information regarding
                                            other companies that could potentially be relevant to the Company or the transactions contemplated
                                            herein but which cannot be shared due to an obligation of confidence to such other companies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Indemnification,
                                            Advancement &amp; Contribution</U></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1. <B><U>Indemnification</U></B>.
The Company agrees to indemnify and hold harmless Aegis, its affiliates and each person controlling Aegis (within the meaning of
Section 15 of the Securities Act), and the directors, officers, agents and employees of Aegis, its affiliates and each such
controlling person (Aegis, and each such entity or person hereafter is referred to as an &ldquo;<B><U>Indemnified
Person</U></B>&rdquo;) from and against any losses, claims, damages, judgments, assessments, costs and other liabilities
(collectively, the &ldquo;<B><U>Liabilities</U></B>&rdquo;), and shall reimburse each Indemnified Person for all fees and expenses
(including the reasonable fees and expenses of counsel for the Indemnified Persons) (collectively, the
&ldquo;<B><U>Expenses</U></B>&rdquo;) and agrees to advance payment of such Expenses as they are incurred by an Indemnified Person
in investigating, preparing, pursuing or defending any actions, whether or not any Indemnified Person is a party thereto, arising
out of or based upon (i) any untrue statement or alleged untrue statement of a material fact contained in (A) the Registration
Statement, Prospectus or any other offering documents (as from time to time each may be amended and supplemented), (B) any materials
or information provided to investors by, or with the approval of, the Company in connection with the marketing of the Placement,
including any &ldquo;road show&rdquo; or investor presentations made to investors by the Company (whether in person or
electronically), or (C) any application or other document or written communication (collectively called &ldquo;application&rdquo;)
executed by the Company or based upon written information furnished by the Company in any jurisdiction in order to qualify the
Securities under the securities laws thereof or to file for an exemption from such requirement or filed with the Commission, any
state securities commission or agency, any national securities exchange; or (ii) the omission or alleged omission therefrom of a
material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading, unless such statement or omission was made in reliance upon, and in conformity with,
information provided to the Company by Aegis in writing specifically for use in the Registration Statement, Prospectus or any other
offering documents with respect which or resulting from conduct by Aegis or another Indemnified Party, as to which Aegis shall
indemnify and hold harmless the Company, its officers, directors and controlling parties in the manner set forth in this Section 14.
The Company also agrees to reimburse and advance each Indemnified Person for all Expenses as they are incurred in connection with
such Indemnified Person&rsquo;s enforcement of his or its rights under this Section 14.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-3_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2. <B><U>Procedure</U></B>.
Upon receipt by an Indemnified Person of actual notice of an action against such Indemnified Person with respect to which indemnity
may reasonably be expected to be sought under this Section 14, such Indemnified Person shall promptly notify the Company in writing;
provided that failure by any Indemnified Person so to notify the Company shall not relieve the Company from any obligation or
liability which the Company may have on account of this Section 14 or otherwise to such Indemnified Person. The Company shall, if
requested by Aegis, assume the defense of any such action (including the employment of counsel designated by Aegis and reasonably
satisfactory to the Company). Any Indemnified Person shall have the right to employ separate counsel in any such action and
participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person
unless: (i) the Company has failed promptly to assume the defense and employ separate counsel reasonably acceptable to Aegis for the
benefit of Aegis and the other Indemnified Persons or (ii) such Indemnified Person shall have been advised that in the opinion of
counsel that there is an actual or potential conflict of interest that prevents (or makes it imprudent for) the counsel designated
by and engaged by the Company for the purpose of representing the Indemnified Person, to represent both such Indemnified Person and
any other person represented or proposed to be represented by such counsel, in which event the Company shall pay the reasonable fees
and expenses of one counsel, plus local counsel, for all Indemnified Parties, which counsel shall, if Aegis is a defendant, be
designated by Aegis. The Company shall not be liable for any settlement of any action effected without its written consent (which
shall not be unreasonably withheld). In addition, the Company shall not, without the prior written consent of Aegis, settle,
compromise or consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened action in respect of
which advancement, reimbursement, indemnification or contribution may be sought hereunder (whether or not such Indemnified Person is
a party thereto) unless such settlement, compromise, consent or termination (i) includes an unconditional release of each
Indemnified Person, acceptable to such Indemnified Party, from all Liabilities arising out of such action for which indemnification
or contribution may be sought hereunder and (ii) does not include a statement as to or an admission of fault, culpability or a
failure to act, by or on behalf of any Indemnified Person. The advancement, reimbursement, indemnification and contribution
obligations of the Company required hereby shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as every Liability and Expense is incurred and is due and payable, and in such amounts as fully satisfy
each and every Liability and Expense as it is incurred (and in no event later than 30 days following the date of any invoice
therefore).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-3_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3. <B><U>Contribution</U></B>.
In the event that a court of competent jurisdiction makes a finding, final beyond right of review, that indemnity is unavailable to
an Indemnified Person, the Company shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in
such proportion as is appropriate to reflect (i) the relative benefits to the Company, on the one hand, and to Aegis and any other
Indemnified Person, on the other hand, of the matters contemplated by this Section 14 or (ii) if the allocation provided by the
immediately preceding clause is not permitted by applicable law, not only such relative benefits but also the relative fault of the
Company, on the one hand, and Aegis and any other Indemnified Person, on the other hand, in connection with the matters as to which
such Liabilities or Expenses relate, as well as any other relevant equitable considerations; provided that in no event shall the
Company contribute less than the amount necessary to ensure that all Indemnified Persons, in the aggregate, are not liable for any
Liabilities and Expenses in excess of the amount of commissions and non-accountable expense allowance actually received by Aegis in
the Placement. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the
Company on the one hand or Aegis on the other and the parties&rsquo; relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. The Company and Aegis agree that it would not be just and equitable if
contributions pursuant to this subsection 14.3 were determined by pro rata allocation or by any other method of allocation which
does not take account of the equitable considerations referred to above in this subsection 14.3. For purposes of this paragraph, the
relative benefits to the Company, on the one hand, and to Aegis on the other hand, of the matters contemplated by this Section 14
shall be deemed to be in the same proportion as: (a) the total value received by the Company in the Placement, whether or not such
Placement is consummated, bears to (b) the commissions paid to Aegis under the this Agreement. Notwithstanding the above, no person
guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution
from a party who was not guilty of fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-3_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.4. <B><U>Limitation</U></B>.
The Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or
otherwise) to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant
to this Agreement, the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with
any such advice, services or transactions, except to the extent that a court of competent jurisdiction has made a finding that
Liabilities (and related Expenses) of the Company have resulted exclusively from such Indemnified Person&rsquo;s gross negligence or
willful misconduct in connection with any such advice, actions, inactions or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Equitable
                                            Remedies</U></B>. Each party to this Agreement acknowledges and agrees that (a) a breach
                                            or threatened breach by the Company of any of its obligations under the exclusivity provisions
                                            of Section 1 would give rise to irreparable harm to Aegis for which monetary damages would
                                            not be an adequate remedy and (b) if a breach or a threatened breach by the Company of any
                                            such obligations occurs, Aegis will, in addition to any and all other rights and remedies
                                            that may be available to such party at law, at equity, or otherwise in respect of such breach,
                                            be entitled to equitable relief, including a temporary restraining order, an injunction,
                                            specific performance of the terms of the exclusivity provisions of Section 1, as applicable,
                                            and any other relief that may be available from a court of competent jurisdiction, without
                                            any requirement to (i) post a bond or other security, or (ii) prove actual damages or that
                                            monetary damages will not afford an adequate remedy. Each party to this Agreement agrees
                                            that such party shall not oppose or otherwise challenge the existence of irreparable harm,
                                            the appropriateness of equitable relief or the entry by a court of competent jurisdiction
                                            of an order granting equitable relief, in either case, consistent with the terms of this
                                            Section 15.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Governing
                                            Law; Venue</U></B>. This Agreement will be deemed to have been made and delivered in the
                                            State of New York, USA, and this Agreement and the transactions contemplated hereby will
                                            be governed as to validity, interpretation, construction, effect and in all other respects
                                            by the internal laws of the State of New York, without regard to the conflict of laws principles
                                            thereof. Each of Aegis and the Company: (i) agrees that any legal suit, action or proceeding
                                            arising out of or relating to this Agreement and/or the transactions contemplated hereby
                                            will be instituted exclusively in the courts located in the Borough of Manhattan, City of
                                            New York, County of New York, State of New York (ii) waives any objection which it may have
                                            or hereafter to the venue of any such suit, action or proceeding, and (iii) irrevocably consents
                                            to the jurisdiction of the courts located in the City of New York, County of New York and
                                            State of New York, in any such suit, action or proceeding. Each of Aegis and the Company
                                            further agrees to accept and acknowledge service of any and all process which may be served
                                            in any such suit, action or proceeding in such courts and agrees that service of process
                                            upon the Company mailed by certified mail to the Company&rsquo;s address will be deemed in
                                            every respect effective service of process upon the Company, in any such suit, action or
                                            proceeding, and service of process upon Aegis mailed by certified mail to Aegis&rsquo;s address
                                            will be deemed in every respect effective service process upon Aegis, in any such suit, action
                                            or proceeding. Notwithstanding any provision of this Agreement to the contrary, the Company
                                            agrees that neither Aegis nor its affiliates, and the respective officers, directors, employees,
                                            agents and representatives of Aegis, its affiliates and each other person, if any, controlling
                                            Aegis or any of its affiliates, will have any liability (whether direct or indirect, in contract
                                            or tort or otherwise) to the Company for or in connection with the engagement and transaction
                                            described herein except for any such liability for losses, claims, damages or liabilities
                                            incurred by the Company that are finally judicially determined to have resulted from the
                                            bad faith or gross negligence of such individuals or entities. Aegis will act under this
                                            Agreement as an independent contractor with duties to the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-3_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Miscellaneous</U></B>.
                                            The Company represents and warrants that it has all required power and authority to enter
                                            into and carry out the terms and provisions of this Agreement and the execution, delivery
                                            and performance of this Agreement does not breach or conflict with any agreement, document
                                            or instrument to which it is a party or bound. This Agreement is legally binding upon and
                                            inures to the benefit of both the Company and Aegis and their respective assigns, successors,
                                            and legal representatives. If any provision of this Agreement is determined to be invalid
                                            or unenforceable in any respect, such determination will not affect such provision in any
                                            other respect, and the remainder of the Agreement shall remain in full force and effect.
                                            This Agreement may be executed in counterparts (including electronic counterparts), each
                                            of which shall be deemed an original but all of which together shall constitute one and the
                                            same instrument. The undersigned hereby consents to receipt of this Agreement in electronic
                                            form and understands and agrees that this Agreement may be signed electronically. Signatures
                                            to this Agreement transmitted in electronic form will have the same effect as physical delivery
                                            of a paper document bearing the original signature, and if any signature is delivered electronically
                                            evidencing an intent to sign this Agreement, such electronic mail or other electronic transmission
                                            shall create a valid and binding obligation of the undersigned with the same force and effect
                                            as if such signature were an original. Execution and delivery of this Agreement by electronic
                                            mail or other electronic transmission is legal, valid and binding for all purposes.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are in agreement with the foregoing, please sign and return to us one copy of this Agreement. This Agreement may be executed in counterparts
(including facsimile or .pdf counterparts), each of which shall be deemed an original but all of which together shall constitute one
and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page of DGLY PIPE Offering Placement Agent Agreement Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex10-3_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page of DGLY PIPE Offering Placement Agent Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aegis
    Capital Corp. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Rober Eide</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Eide</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGREED
AND ACCEPTED</B>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing accurately sets forth our understanding and agreement with respect to the matters set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Digital Ally, Inc.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stanton E. Ross</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    E. Ross</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>9
<FILENAME>ex10-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECOND
AMENDMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LOCK
UP AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Second Amendment (&ldquo;<B>Second Amendment</B>&rdquo;) to the Lock-Up Agreement (as defined below) is made and entered into as of June
24, 2024, by and among (i) Clover Leaf Capital Corp., a Delaware corporation (together with its successors, the &ldquo;<B>Purchaser</B>&rdquo;),
(ii) Yntegra Capital Investments LLC, a Delaware limited liability company, in the capacity as the representative from and after the
Effective Time (as defined below) for the stockholders of the Purchaser (other than the Company Stockholder (as defined below) as of
immediately prior to the Effective Time and its successors and assignees) in accordance with the terms and conditions of this Agreement
(the &ldquo;<B>Purchaser Representative</B>&rdquo;) and (iii) <B>Digital Ally, Inc.</B>, a Nevada corporation (the &ldquo;<B>Holder</B>&rdquo;).
Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Lock-Up Agreement (defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Purchaser, the Purchaser Representative and the Holder have entered into that certain Lock-Up Agreement, dated as of June 1, 2023
(the &ldquo;<B>Original Agreement</B>,&rdquo; and as amended, including by this Second Amendment, the &ldquo;<B>Lock-Up Agreement</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B><U>Section 2(h)</U> of the Lock-Up Agreement provides that the Lock-Up Agreement may be amended only with the written consent of
the Purchaser, the Purchaser Representative and Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Parties now desire to amend the Original Agreement to modify the number of Restricted Securities subject to restriction under the
Lock-Up Agreement, as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, and in accordance with the terms of the Lock-Up Agreement, the Parties hereto, intending to be legally bound,
do hereby acknowledge and agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Amendment to Lock-Up Agreement</U>. The third recital of the Original Agreement is hereby amended and restated in its entirety as
follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
pursuant to the Merger Agreement, and in view of the valuable consideration to be received by Holder thereunder, the parties desire to
enter into this Agreement, pursuant to which an amount of securities equal to between seventy percent (70%) and eighty percent (80%)
of all securities received by the Holder as Merger Consideration in the Merger at the Closing (which shall be set at the maximum amount
in such range that ensures the satisfaction of the closing condition set forth in Section 7.2(e) of the Merger Agreement, as determined
by the Holder in its reasonable discretion, subject to the approval of the Purchaser with such approval not to be unreasonably withheld),
together with any securities paid as dividends or distributions with respect to such securities or into which such securities are exchanged
or converted (the &ldquo;<B>Restricted Securities</B>&rdquo;), shall become subject to limitations on disposition as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Miscellaneous</U>. Except as expressly provided in this Second Amendment, all of the terms and provisions in the Original Agreement
and the Ancillary Documents are and shall remain unchanged and in full force and effect, on the terms and subject to the conditions set
forth therein. This Second Amendment does not constitute, directly or by implication, an amendment or waiver of any provision of the
Original Agreement or any Ancillary Document, or any other right, remedy, power or privilege of any party, except as expressly set forth
herein. Any reference to the Lock-Up Agreement in the Lock-Up Agreement or any other agreement, document, instrument or certificate entered
into or issued in connection therewith shall hereinafter mean the Original Agreement, as amended by this Second Amendment (or as the
Lock-Up Agreement may be further amended or modified after the date hereof in accordance with the terms thereof). The Original Agreement,
as amended by this Second Amendment, and the documents or instruments attached hereto or thereto or referenced herein or therein, constitutes
the entire agreement between the parties with respect to the subject matter of the Lock-Up Agreement, and supersedes all prior agreements
and understandings, both oral and written, between the parties with respect to its subject matter. If any provision of the Original Agreement
is materially different from or inconsistent with any provision of this Second Amendment, the provision of this Second Amendment shall
control, and the provision of the Original Agreement shall, to the extent of such difference or inconsistency, be disregarded. Section
2 of the Original Agreement is hereby incorporated herein by reference as if fully set forth herein, and such provisions apply to this
Second Amendment as if all references to the &ldquo;Agreement&rdquo; contained therein were instead references to this Second Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>[Remainder
of Page Intentionally Left Blank; Signature Pages Follow]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each Party hereto has caused this Second Amendment to be signed and delivered as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Purchaser:</U></I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CLOVER
    LEAF CAPITAL CORP.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Felipe MacLean</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Felipe
    MacLean</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>The
    Purchaser Representative:</U></I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>YNTEGRA
    CAPITAL INVESTMENTS, LLC</B>, solely in its capacity under the Merger Agreement as the Purchaser Representative</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Felipe MacLean</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Felipe
    MacLean</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manager</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Holder:</U></I></B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIGITAL
    ALLY, INC.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stanton E. Ross</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stanton
    E. Ross</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex10-3_001.jpg
<TEXT>
begin 644 ex10-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "( 00# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHEY+C3]1<!"QXBGZ _1NA]\4 SZ0HHHH$%%%% !1110 4444 %%%% !1110
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MD?X"N\ID4L<\*31.KQ2*&1U.0P/((/I6</$NA-((QK.GF0MM""Y3=GTQG.:
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MXR6 YV[E!SZ$^E=;XB\;Z/'X?N!I=Y%J=_<PM':6EDWFR2.PP.%S@<Y).,4
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; **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex10-3_002.jpg
<TEXT>
begin 644 ex10-3_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !' %0# 2(  A$! Q$!_\0
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MZ/\ ] FQ_P# =/\ "BB@ _L'1_\ H$V/_@,G^%']@Z/_ - FQ_\  =/\***
,+X    P!1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>dgly-20240624.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa6MGbP9z5Z8iekhvWB/bQnKnyAk5UbnUirWXraWQYMH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:DGLY="http://digitalallyinc.com/20240624" elementFormDefault="qualified" targetNamespace="http://digitalallyinc.com/20240624">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://digitalallyinc.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="dgly-20240624_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="dgly-20240624_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>dgly-20240624_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>dgly-20240624_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://digitalallyinc.com/role/Cover" xlink:href="dgly-20240624.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://digitalallyinc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140174185007504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 24, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 24,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DIGITAL
ALLY, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001342958<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-0064269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">14001
Marshall Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lenexa<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">66215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(913)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">814-7774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DGLY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !LA=Q8_EO]04\$  !T$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)V877/B-A2&[_,K-&ZGLSN3Q!^8KQ2882%):=@L#71WMIU>"%N )K;DE>5
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MF]3\<,,HO 7F OA^):5^&YB=:O%#P^!?4$L#!!0    ( &R%W%B?H!OPL0(
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( &R%W%@'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ ;(7<6(1X
M&Y_O    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ ;(7<6)E<G",0!@  G"<  !,              ( !S0$
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !LA=Q8_EO]04\$  !T
M$   &               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ ;(7<6)^@&_"Q @  X@P   T              ( !DPP
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !LA=Q8EXJ[',     3 @  "P
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52P4&      D "0 ^ @  YQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://digitalallyinc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>dgly-20240624.xsd</File>
    <File>dgly-20240624_lab.xml</File>
    <File>dgly-20240624_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "DGLY",
   "nsuri": "http://digitalallyinc.com/20240624",
   "dts": {
    "schema": {
     "local": [
      "dgly-20240624.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "dgly-20240624_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dgly-20240624_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://digitalallyinc.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-24",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-24",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://digitalallyinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001493152-24-025635-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-025635-xbrl.zip
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M:S?BV"VD**[D(B'*0SUD#^6.NK'2+[1A\G=F1M7V_5/NS-#F;:%%#_6EH%%
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MC]H9DJ"\TY4["=8#'S((5B]@:07K'>%POJSW=O*R/?0A@TCU(I8_$B!N3"&
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M01W;34*X,DQNXTOJ<_!##H  [;@AS&=VR'?=54P&470),&PG!6 5^P \QVB
M<"$#+F/0 TC%'HGCWNX_8YF'06EB _#E(5HA73<(-V'EZ'XRO\AU WL,6;<E
M"7'(K7C.,$UHU;H5JZ['<3Z3[_9I'?96\)Z0-A6Z?#P(+_PETF !:B^=ZA/_
M;C=T-'FA]V? 1N:>RF'7RV3[3:I"]/F:PO$1W,+_ =]+,>1V;13VG@I.!N:
M"L0('SR 1_2,0?QQS I65TF8S[I:PG_]\=^>/?WFV?/_GA2%+P4M>#9!"^X9
M6O!L@A9,T(()6O"5;M5OPEOUQ1>Y5?'A']6G; U7Y#D,*EMF.5*I_,3WY$%8
MZ,Z]?CYS[U^,W'J#IO%G6<93,/)A#]B(]K<#1@JE^T4W509F;S'H]O7ST*:P
MY0/'GI](9.!<#>?T]=+%F/5+2+\^(PE@@.0T3'A43*1A^,2F-(%_(?F\S[#Z
MR90FL*=7V,D=TP2FN-O>#-B(Q<EO0^1-DK(W S:2<OJ[=>!]FK6]%9/'([C-
MR59^X ,V H !O6Z0;4+O[H=VS3)P.WHW_AQPS!AKAA",>'5$L.X,DBG#6QAU
M,)_=*\GQ'AHY]\>L<=KE)(M>6L*@B6'C7W;(7]X/=VH9-LHEO%I9ZGG?<^9*
MAHP4_S-"U"DL0X&$?MT'1TW%%&=KW4Q>M0=_SK*L';/"JY#?2R5;4X4 6?TJ
M3* 5AK8:6:%B<WE!KS1!4S=8=JLPI</@NKSAJ!75^ '9P^"4Y<@R;4IAK1_-
M*\Y2K/P%U]TYE3"*31_,JQ=8JZ>(B+(*'=(#_&%&J+L]PL>]+G5QY5P84U$
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MHFP\>:S;FLHN^_1_ZZRNI=2T)X,&.D IK$62;4""NY73X3*.\6I%D6U@;+N
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M["QQWMC0U^.0*D-QW^/3 T6@H^,G!^G"YC* RB8:17-31ENM*J0.T(DVD<[
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M\VM@]'?8?,;O7?#Y;6/X6!)$*C01IOU@V-FX@)V];@NQ.GP<OLU5V'@,!L.
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MNK;KM4G[&B<%%6CF(,&45_'YANU:C' A9VW;]$CH7;3:9KQQ](>\F1([%JM
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MI\88&Z*TP3T6KKK<7&%<)O'\)-IU"#:H,1,X'FH3= V;;ET*Q>Z2"P@NN12
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MJ>^?H7J73E7K4 !1XB+9F"3M[G0(?[;H;6E6D-R>MIJ4NBZSU+B#TK)=TF6
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M]^S:2]#4!]+KEI"-T9!R)RJ[.$Y2!]Q-L&L,0,C>-EZU$X?QU6910=,P3K&
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MN?KU #*J/%2R1X*KAN?5D134=:@P\U- :7H84\%LE% IDYL;"$HU:':$!D4
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MY!2T<M(#14< /[?<J#7P%M[=S&#C#$KUF/!L05\I<N1H(#0C!/&M=)$BEW1
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MT;PHYQ?,T?L%WD;!M",<2Q/\B2/7;DB<2CET4=0PO.8QFOPH>MP9)D"T'PX
M9DYK/%N'1J-G)-J\NC)VX>+E&@03LEA_"CR"3M,I@'++URH#A>4;GYJX+",O
ML7)R,J+BF,F^6Y'*<* TS'+]7M&L)>1.M![3K\KK8UHO^YC6?<>T7O8QK3ZF
MU<>T[@)C>>8PECU84V@PG5B6,5J@>V&6L9$SN(TJUH[W*IK\79("GC?=*2?
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MW!F$+C3!!V%>^=P",1,]&)1R"\)H*MK%! C0A_'"%T]/KI>R6L-%N59NB R
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M;#39V52T@Z\D0]W%BRDY(TNM/S6)W:1.?_)@SO_CR1-P5\-X]CQXKR["%_"
M_Y0AK#E\,7CR1+!//[T^_2\_<F6F\PRG,TDS$%#SLY>QFGX,0&O" N9I',TP
M0'Z3,+T\#Y.S:I7#6/3?3*#;1O#]8+"-PS=$U_UUC\,Y?<.$M+U'-R$6]")6
MXYD_?0_KT[!4DRQ4'Y],0M#[,,(5K:\K,<]XR/=_9>J+X;WNFBOCR-KW*&PL
M7U_OX,DT'QHJ[OZG9;_.O?U#Q8;[+8UG-53(<  W6</'JO@/OMGI=EG0!_ &
MY+_!(!3_9HKI&+Y"1\$\2Y=! 8.D6PG_F\[[F^F!R-8_*K)U"FNU3"C$-1R\
M5UE1A3S=R$TX&A_T(K%M(O%CBTBL*438R\1CE(F]IS6A(">PS9%IOW2B;N^1
M$QP^H,U-Z?>BLW6B4\W%OTGS/*R:)3<+11[U$>DM%(3]BB"\CU4"9NL\>(V:
M()J4N+?W)E'Q-1;I8>QS-2'U/DLIB%?6#[V]%U;F0["CT[B<,2!-M5T4._PI
MD 6.%*9E$<31,BKH@PBF=YXH.7!Z;$Z!Q"@!Z5G29X>#%>:=TS*/UT$J@3QR
M>KQG\,T$#M(*+"""!"1!J%-M0>:.,K<9_ 1#>A'% LL5UCV4X# ='CP]QD<O
MR_A"%2;Q3F!:G7GOP'0?3XM=<M44O&/&J?6\7*UB>B<_#N?H#-[^NCFFR\@X
M3N[CD9S#[L(IHUG"@^"@X9@D^=_L^P73])(*,?#M+;O&Y1)XH"D]SA/@L"W^
MPHXRIS@MH0/-)$:!V7(845X\L:MOGV/? )L+DP!+ [XEI1T\N"R$V6&D$-=M
MAF:%1E>T?G(XB 2Y:(?37T!;IYBJ.5%'D"DI()+<D@OA@@D\#YP,F(/PX+F)
M$E$Y.VJ7) ]/,4E].OT(/YWP3_]468;G^6RA,D:*) &<]5*@NOA7'@CIB?!3
MF$T1/2)G3K[-Y^1]%C[YI:2C;WZ^H^ !2SJTB8-,N=9W$02L7TA:%[%.PX%6
MJZ#;5#;3*1@S,JMM:3:(*99ZJ)WI+GTTM\I!9IIF=N*D/VBR]%E<K2!?Q1%6
MJ$2(D$GP\Z"-2%7,'!MA!$.::M0SJQA4@3">6&4"<FK2<AC.ODAAC3S8U"BH
MXZ5H1"ZTJ"(B8I9,0PR4L?)HT8H[N"!NOHB_:=!1%MZU5%%2*(W4\B \+'<C
MG"5>0\.!2E)&#K7<CC;WYJ\#%Z#MXDH@F@FA6"C7)+EMSVI:R5S%=$_4%LF=
M.OAMLW *6P+SL[JZ#C*3)&'MDI,[H?T%:!4.!Q,L5P+Q@#L!)6RNW\#Q3S(B
MIJ#7.2%'DZ%GVA&UW55X<C>]/J"W6P,"_!AX;=-+Z>;?.SRD7<030H]VCL@D
MG*9+V'G0@!&^"?<(EAU6VD Q\33BU$1LV&-.,T^^2!KIPH+'K<3VH!%09+?,
M,OS6JIS$T=0U@[R'\I;H(8.Q)3OM?@:V5\%]'4UQ7791C#RC7 57&=I2:.*O
MP.N'-\1A0>G>U-V!$>9%89XYGL09S)ZM"+K&I]-P5="RB]R=@\+*X5(.CB]P
M"/IL*7H2?$MBWHXVI./,X#IGK>GI=0UE59+6<EAHF<"(<E$RX:?I0B47I)<I
M%TS;B;:855KT /EE=9.O8'((NM3:$%6O?O.(?AO >!,)M"_"V%ASQW,X^I'<
M/,Z&T\64@2)*$WC(VEQ*'IZ3/T@#H_4B.#P=X&E:)GD8ZP66S_;&S=89-T=5
M=,=-(G,H8"TN3#<"N0U8L6>.F /9:'X#>@[@MH"NTG9W%S[#^@#@ 7+%(6:K
M=MES<;V%3N?"WO MTX;WMK@>8$#1 WT?!.YDUPF!*SYDJHI<W[IWXYJ0JI6Y
M# ?-D^E/<S=@9/]%\&Y%ANQS?)'(VXO@OU1<XJ][/$F5 <-93+V,+X+S]0K>
M?PQV4C1]$;R%\\!+_3;%!=SW8!3Z6_B;'I?2XU)Z7,H6FAS/JO&4$KW"P[VC
M9B.#8Y][1PVAS^#:D4\R=]DKP\<)SM.)A$9XFN"2+A#!4,.NL+F.]Z5$"S)\
M"GE:%V7,]R9>UPQ,5;-TU3Q(\/TH#5%.X)9-,*,9K\4S7A(A!WJC3(I %@*8
M!\ZP^PMYZV2]"L(26=\_[)+U_<->UGM9WSI9KX+"SL(X)O /A;0%-OBO,LQ1
MA!(%WN'?R=H>],G\+921*DKL[.35<*#K'IIUXD[$:0&./<;K)^I2@5["F)N$
M"E$YI<B>=J$+*&RL2VLCT$'SN5%MMDS8"4WF!(;%'X"(YFW/X%1%%.TV:-Y>
M('MZHCNE)]K?$GJBLT48SV_&P>/&';4B\&?;4^ILG<9':%7P+B'%NLJBE+(X
M%'UUB@A'#8E.L$Y7F.1 94NE<"85Y>CCUMPC84HT=X8DPU*01X*0=*)1#+L5
M9EHIY\RQ44HN4<YY8P:04FL*82\"A^%0+%$NXA.& PQ<1TF9EGDP43E6 CKV
MO'9WQ\&):B>IJ,;3#5$#?.J7-%L&9T_VD))$_^- NPJPWT+F84GX8 0F?0@?
M*_.P,\:-N;^10\2A@5B744Y9?5AA&XH_8D8827RGG*K>*9.8$M2:[6(XF,$E
M/-4HI"*(0Y47P3^.OD63C_P5+*R4O9-TW6Z#;Z&-"X8)!@TH04.'6A2POK*(
MS &+C$])$GX:#E!N]_#3D@-H?XT8N8%CX^;N:W)9B8[7$0!Q'[]4YV6! ]]$
MS)*D.D]M-KZ2<$G4DG%G*M&C)4E!DRG,].AT=IBVFY_X79;CKT D/JTPO\KG
M=CC0MA;L84YD:V>^ #A8L#J9FG^X4< PPS'!/87C!*8])5>F"G_3>JJ%"DGG
M_2./!W@#KH^_Y*2$=F6=&J &[<""G/SR50%2H,!:! <VIT-CZY'GK-8*PXM:
M%CK5P@ 39+)1_&DE6563#6]@8!DYIZ=EV8:#CV&XZJ2TL0H'1GZ-B9;P\=@2
M#[%2C.,-$+[A8++N' 9:\A;]@(B'$:\4#R3-ZHK0(!_0X)9(!D$E]"9?IG&Y
M9*(A!8<I>Y+.GS#,!#5&%DT9:=3TX)OC(X(;PR-P&.WX"%\G.[ ("N'44_+-
M67=O<LHZ11Y\@FBKFO$3?Q<T4:/T]<6XD4EF=SP<G-<40Q'&X6J1)FB&QVOM
MBC6@FMHDC,%V1\^?/@U6X^4XV$%3Y:\T^QB\BHHUA;=VF13)(R\*ZD.)P$&<
M(6X"QD'L32XZ* \N(Q7,U91"9"1]L$/ADR4XIOJ2NOZ@44I,7,PEF:)SYPFA
MOSYPK.<1:EW_70VFTD@8"#P^)SK;LL:(748M7QMUQWEN6+81KL./SP^>!JIK
M^46\S$2M_G02XQHNV3&"$=N&L!41 @5LYKW97'1XT6"8.M8Z#GZ!;2LS$GS-
MU>7N-D,:X>@CH]G.GD\$I@?(#%]3I1'/E87,0%K,2]H&35S':*Y&,[M3DL_'
MF@=B8:E<93VERL8\_4&?DK_5E/Q!GY+O4_)]2OX!!6F0X/9M6N UAX[NS(9.
MG%LW!=OV0H#[;75TQ$E9N7;9&LY]0T9[%+IVJ,VS )L^Y82FPD!.&9L@@%C+
M^K[589,1^\(F9N/"H?$AX(^GR+*ZMO$9#LH@C53<5I'E>['2F@!N<N,.\B2]
MEB[:5!1?D QH[<)1_B&;1F+F"@HW)/M+>\-L)5@TXO5XM"I&3M4,]")C2_4I
M6I;+("F7$_2_YJW[8*FJV ]R%KCA)6X,BHK,<%&H'(,6R>9OX&'Z2<Y&L37<
M,I*63;Q^/.I%K3)!?'9_U+J !,0L2U<9(:@Y\"41H>N\[+"Q"F*EUDOA!XZC
M_V#*"A=VII:@^//-U+RX/*JPX509/G.%:7%I"KM@=)#/,.\C"N,,ODSNG2-X
M:G:93G&^34:T^,45S"B*]\;8:D-U \4>'.8S%S';%,9Y99UOV 9PWJ)\&J<Y
MVM6G&M3 (WJVMS]^^F-O&F_;570P#BHW$98MK45_F(-6#S0VGLNND^:%39PS
MVW2'<=IX./!8^N 2S.465(Z4:@?7:-6V\]"A5"E$@17#T;1$"(ZK[!%/X6C[
MQBMM1]IX5&[T2CB!>F7<L@: A0I@2RC$Z10 -R_!+@9F_4Q 8!(!H"XPE(4C
MI]I@"7@S@3=>HBU%=J/KK7[3FG<%+XF=G+XQ*Z<<6M^*QD1?5LG46T?=/+'_
MM13/WAA\L"PO1FR ^)<G;SO5<N%13YAOU"L%,R473$/ &HO"_,TB^,CZ?GVQ
MZZDB?E] <O;'N*V@A+M$IT4/92&FV0P#@U-YK6N^=\C5P3I'J?(EGCVN4,32
MS\K'EVJ-U:V.:AOI^U"[)'R]9&!]JT))#AK^9"5(R;RT !?#ZM R<11EY7VZ
MVM#)(>:[U&ZRE^\'(M\'&.J/LEL0;Y?D8*-@>Q\VU,Q&JBFE=7MB[;VM4:CO
MN3?Q102Z.]1^V(?:;S74?MB'VOM0>Q]J?S#QC5-)]3L-PJ9E,5%TXS@=WJIW
M+#;!=-E)#$)NCK_8.?)RT@+9,D 03$UCP(QH6[1'3QW=IE+/D[MML2HP,'A]
M6G"Z_[2E'1B''?/KA*?K,4!>$,.QX\^>G.XVN%@;+G14 6K1%*ZL_6%C.FXX
M!_G<..I:A==PF%5'.Q(N#<B]N.9%F&#[]I'7]*R-MZ [/#X<;(J/P^"P<JH+
MP4J,( AA;<Z$B#G4O5<C*LB2LK%[9OKT:J5BHQ^.AX/3^7."V%WG&'(G.$81
M\UDP^00\:E[OR,@CCJ$O>6>]M2V)CN K/+,FJ>CDQ8)TA3'",B%T4-K0R$^+
M*F&C*KDMIQ*,&V1&25!![2%REXPFU 0XG%FFKG(7J5E)653Q18U9%$NQ06A&
M6,GA((>OYM3BC\+2TYBPK+ =NP)*PR=YH'>-:O36%DY^IVZC-"BCX@AF/IV&
M<:CCPET@LS9JJ<-G>W^SV%3 47,";7G7D,S:8DC=J;H=)'>P>BM><VVJCOH*
M9@WS7H10I^XZV6Y;NTEF,ND*W@IYFD 5=8=)#87&"]/YE)-)\-M,ZHV#G3-'
MI@6YULYGV;[GBIAB&C@JZ52X[2'S59IX47)$4$M=VW! Y0;UI2)F4<Y&=D/K
M]+:B ;&S5VM/:A%[V,,R6M'C]-OQO9A!%<.#*XQ;MLR9H-NWE([R3*Z]KF&V
MH;A'-(*=Z+*#HDY?CKAX+DY@<R:3U>=U:.H(%(T_:NBN*2_9H*MWC%T2=>FJ
M8):&TM\3S1TW32/U+ZTI]8*8Z!0K)[C%/H:47IYB[#$:AV,T:]"2HFP'/7@>
M?4*^=?P,D?IA)J>N*@W6&XY$364&C1ISEX\7[EH=$QIL/E@=H@(6+_(NYE*?
MHW$7?.\@BV(;3)YMXP[\N\L\W(E619%TKT L-+)'&A?%RPF6!6S)?[/A_]ZE
M)>:[C@:>AS"N#KK!$4V7[%&N.,#=X .-A1S@?> 4_</M?0'_=W&!9)Z\]M@1
M-R2E<%15"CL,,D["<*;5:.M+=D$F2CIYN!5[^T^6L/@+G'^4SC!_*;$W#9M%
MB'5&\)I)B-\B)BLI=_&J7-K[5C)T8\YE!D@^D#.5'0F>KC/&VMY+D6:_>QL-
MAR&XZ126-Z\]+S!/LS=[PS.J/AMAT/7,\:;[A!UV,2S:^7SW!<[3&Q5VU]/!
M\:D__K)U].;YI 9:9$'>Q\ M4]8P<M]?V4<*YL*GZ[O8U&B0-RBAP+%FBM/T
M;.Q*D5.1>P8G1I!)^W@E)_07<'5L%4ZLK@C#1-+F[+KN,6A^1R*+BC%)D'XR
MYQ1\\_>T%>U6^]!O#;$KV+"F-@;$*[3QYQDU5K=%.;5GH/HL.=%3KZ14:U-T
MJ:,'L&C+M&2K<*KRQ8C+F1!O /=0 U1"X 2,-UB%B8J+]2B RUJ98A2XI68E
MFQ7[XZ??!F!1%A&%]_6E:-7(&9CETRPB\K3@F(>R4I%3020CK=J>[\MLNL D
M@>WL$9S.F\TIG#A5Q[1/J]HPQ*4B/-2,QMH2RC'N4;5^N(^W6K-XUT(7. 93
MO<A 0"P%1"M>U.G>T;=X6%"&RB4:PN!*X (@*B+,#$1/]DNW\:Y"1W#Q""7A
M2?&NG_<;H0>0E7CJ9K!(:VN8F?;R>K&&@R8A #4\*T,11#'><%B@"5=Q27$6
M_G%URB/Z+@U2%I5K1]JWAI22M_5<7RA82A9MG.U:]SC'"55R/_JB=W H*I![
MQC7=IR6WJ#<U%O<LVG'O*BJ.^C3/K:9YCOHT3Y_FZ=,\#R@>>X1VR7!@XOP2
M,;"A?5U?7 51\L\V>.R=N2+T8TS6H!(!Z(AI$+E%,^;=4A[12POUT4]-=#]5
MKP'SNZ5<B,F.$/X&^>#UJHP"FX.IQ@MY<MW=#CJB(P7UCT@,UYQCQ&!9*ENV
MK06Z-F'C%5"T,OSG;,9?)T#4VQK;=K:?-4/4T4FX,"8E?"U#?U H3X3X(V*7
M-4DEB2IE[XZ8HS'O&O<))3[@%[^9MKO*I?1W<-$,E/_#LGQXY 9^3EA8/$P0
MF!_2RV+/7W:G_&4'6\)?YM=;W(3&['V63L,9.)3$ C0.,&AU2N<MD=""F]7#
M(V^0%JW5EO:ZO]E8:M?G\YY/;;LO'RI2>(NQ0JJ:H0!]%P1(=[ RN>ZP@U-,
M!_GLHYL(+]P'#P?VR9Q1X68<3K)"0C VR^=U'>0 $3S,\C=QJ[1T6LKO$<V2
MEHC&K;2S,+TN*'1<_:U.DKA-+QJ35&@NS\LLB?)%-4XZ35=DP\YM9$L/C !&
MW#K*:7 "YY,CY?9C.TX9".-VFB>QJ6''KBE JM2X"6;"O\AS!.]HHYUIM2+"
M+<VC*26>DID46J68Q]"\0M11#L[?*J1#Z**'A-H(,01@.BLI2-99:(T=BQ+,
MWTJ=+JTOE2* Z@.9 G/((+UMS;/A*8(92&J:DD66ZLC9DA$GN1.*-"OW*5%R
MB<3"K#)-\GIA2(0IU5.'+S11_VAD3(=#D-E&,!VRGOO";EJZD,"RH'CP=0I/
MJG^G&<)ANKTU#;TW_9M2%@K$HJ7I#*/@Q:+B3OG2C]%N \#0TL-/$:" QA7X
ME&7-ZL9&Q/5L7*(O?<#"F7NF6JL:D<ZW0?-\SCO:E5+;)E&&%G=)"!BU>6UJ
M_AUEX6$@F1D,2=6#_[@DUUKDV9/6-("U%N4>(R!!FM" V%&-G-K!=2FU=W5X
M7$-P)!!A=7QQ!=IWO^/V& Y<-!A379'WG<RTD,Y3A,@$.X<_G?WQ_N=B\=/W
M^%]_][A84GO.#8E%66C"D\!9#F89;+AI>I13;[IZ_3C,1W(VO?/2';1_U@?M
M;S5H_ZP/VO=!^SYH_X!\J_TQ>@/8#O :Y-,^>/&Z;<:)H;/#__*A7L-!*:V5
MG?@!F2<T(I7KJDAC8.,+B ZV@QN[ ^1609>TM3'6R8LFHD]N<GC]%;1]'IL'
MG%LL*%K.3?40[82]FY"<(]=#8K^D9BRR8^:TS['&HG#>LI4IR%7GFXZ?NY-?
MBRV9.V%S Y_4>Y&Q6:6<V_34U#@)<BHTI^5( &+:/ZL4Q#A^@^$P%O24P?"*
M'39KA.]6:8TZ;7G?_]<>/XL)N2?7')Y7/)"5H:X3(*.[XJR#F2AS#ZFVAR:A
M$K>V1\^%MEQ"]ZVG9J?#DV)?+/Q$[<W)M7+:(]OXOT0D=(B @QH8AR^BHBQ"
MV]XS29,GC8V6L9^Z-J#EY;IU.N*<:2G6!(F+G6ZALDT.)ZH]X5+T9*BKFLZ0
M:*43W<(8?]A$:\6]M".7#::;+YII7=H$1]"A%8VD<8R>*W#=PV57  %*=)R7
M8;%(9_1A9_P&M%WE</-X[[I@Z7R O9Y;M7!!_9#W+LRVF0P'G.=WA+7I3KPF
M)1$" Q.F21:8;$[6LSZ9]@$Y4V_ WUS6 @I=>!TKHO8F&8R@;5!D'/JRJ7I7
M&V=J6F@LKT-M3[P-.F; $'?GS'I53RK9?.4W]N^HG$B8>B6.X2^05PWDKW-_
MRK;ME!U2T@,>ZY=/;"+WHD8!NBB!:Y&$I=P%EUK\/T/JL[2\6 0[E]BL0'=Q
M".FZP5/">&:,KH/PPYO+J<:>YV6.<7,2Q#(W<!M'X5L$-UF+<-> V4*7JAO*
MQ,JMW>N81$CR-J*P&"$.%+\3/)B=XUUX5)Q>C6Z2SY':!#RKNA!B[M##BYW+
MEQBL?IKL:@)Z.6VRQ*V1XZ:W5Z.":SW^*U1.JB&ZWFQ?8Y%$6V/U3L,N:LGD
M!#LO91 5<U%BYCZ?+7Q0TCQ8>*TS-<JO-920+&4B.FT';$L!;Z;*Q\K;C7GN
MK'(W<9T8B*]VJT8;K-"&_$:;'SNR"T-UN8QWFB)ECU-_1YZ5B<%SS6J](!$!
M[[9J8Q[.L(Z>O"P<37"!-T&"+X6?JA*,-4J.S+LB^)W[#1_U98H>96XD/$[&
MY-9>E)QD&'%)]F;3+(*;3T+6)H=+1!Q<42&4KFH$N&WN>"6$!9MK&,6%CZCX
MT!CM?,#0]("'Y> WT<>P0I!KA$;L:AB@(M=^V@5AP@1^D-<2H<ECX.E:.L\P
MP((2IXU"!F90N%RQ24XN7.4#_*+NB5(%J:(4(7WZW_"+?,:-849-RX _(0;+
MQ$EMVU7A1>%J";,H=DVH-HQ2MOJK0O8!&DKE.48U\9-HX]'"+M7'4%>D)R!>
MZ++E;O##UA:V.TO@8.H&7G-R-N!+N0D6149 ;1,OJ@_N, _K!\7+R[MY:NKN
MUI[%;LK$XU6('KQL2=57#;34250E%R6B/=6. S["\)T[;#Z3-B&?I^+"5^[-
MKH7P[W$*SYBO<@0.'N=4F8O3SYI-IFJ77O*\,N6YXOFFRX@.!JL,;U7H(Y7^
M7O2QF;N_7@QP21C=A?-:G=@4"&*,AJJ6V6F4P?(@FA%K?CF<9O+3:V8308%A
M>P*47APJ[K5%=\MEU"C]>'K1$7&.@M%N1CY <"[!5%F9FO.JDO HXWVD9!R%
MEZ&)@9KEXHB%L\6ZD9('LI;'C+!4'D]@5-#DY"O$-5/M.^?T@N(::XFE(ALL
M0YC!>A+%?JUC=>U^;W7,J+'%Q.K2K?6J\:<-P:912[2) JWU<).)!E6I\/7F
M:-/<(BG(L"7=4?+2D-&(O@Z\7G@_JF^HUD2:KU<^2TT:X4>9]%:DG:/2+VUB
M.5/JW;[N_/ /?7[X5O/#/_3YX3X__%6#-?<N2[SE8:BC<? ']JIM(J-3EVDT
M\]W$E/K-4SL!_!D&%=*)*5[2;%0JEJB-N&[D!\+&K<CY<'W"H.82=E(^688I
MMA6Z?:T=U]D*ZK[6;KNS54L-MWM;8B4PEU->N 'E8)DN^]+K+3P5S\;!+PR)
MI!2TA];5!4C3!0PP'%G>2HP%HB$(QAD#-BO,&1VA,?I0+9_LX"\0E=[@29-A
MB=C+,L8)H85IO<+K@[(;W5F_D:L)FEH^"XZ8LK_$V>)%-(EL5Z?J-P/_BRX^
MGE'DR-@4,8C# E_9]6\!D%.N5P+*U7[%VERV"]+(J^E79QH7)((E%D?#K>;4
M%OG)ZU^//P3Y.L>/:88+]%733._>KD<:9"<$Z[Q:K'.T-0@_VVN';=,./YA&
MX8:N_5J=PE$N)FM=IVC.B216:JGTNEYHKC/!U(W;I"T7/+7V6Z/F4BW36(>4
MR.9B:@?AT#14ZB6T8:@C2@&O"N>P7D273D12'/^F+D8'?5/8[3LI_QB#F$0I
M=^KF>.<&&@"G+=)H4VM!UU8U&#H0/#;R*&<P3=-5F.FV3]*3^GKGPR]=S#;;
MEAN_M+LIB^\P*-3Q 0XD,/=2'B_C$A[R<8WT2#9*Y!JIN5L\]$<2X3U*!DC.
M?,BV%-O)R<J][:;E1@:*2?KF)BM$&@"7:=?E/C00D^&@%7<)KYRQ\&A#0Q@=
MIH5D?#"MXX[<BQJ'+"I5-)?&+GG+9 JJ-JO CJ+#S8P/8A.XX6\ML\*Z':_I
MR,#$)V4>T9(T.!^8L\1B'%,"0_"77#^-VI 8'%DEV.L&XPOU23^^MBB([6M^
MB7XRD>91:9D,WE3B8^@_S"XC#I:O,-UD)U)[4Z_>MTV]_\A(,1]08;2WKWN]
M@B@L.5-3S"QP$5=(R4-"8R'(F@\4%72&,=(0<I =(W2D7MP>/*A VAQW3:1+
MSQ!>38RL)SDZ$+Z=T1YR8"_ >[NAS9[#8T85A\=P71C(99WB;Z3AI)B+R2)6
MAW%X@3T'1EKMB>KJ8$(USIRX.F&2ZIP06V46-T>@&LZNJ"47LYI3*+N"22?9
MR_XL=B<6_M$G%FXUL?"//K'0)Q;ZPK,'9!OL/1T/!W^L)%[6AB#"%#^X"+$.
M[3G>?JWE31->U/I$/MZC4!_1,(@2P@0RP8-K AN"&LLL *_(P3PU<!9T.&9(
M@2R,WZR2\J;</OJHN:U>-V4G*R1A+\H,^R?8KM[:0Z,5&-FZL@KVTX$F.D0B
M'0#&#1!!A3%*&Y'13!MM[":-L*B;AY%'MEZ.(D3"9*T]'_,6 V%24IG"(2)C
MNXW JXO8[VN;8Z(A;,YD"+YD<23$D?<9R*5;P2W!^MO(_:WCEFJDT1ZHU\8Z
M^#BXA ,=8'$8DW,B S5)+\,67'@%Q]R%"\<S6=TH'RON%'+XZ!O]XN:8J<]\
MTM5H:S@($SJ,QD-OAK>;#IUYN0QK-8<$M#;9OB;>E0ER2A11$;.PA)\PC,5#
M K^)]EVK,,OZ@%093ZO+?&TT%IXW%]C7VC^^DQW=[<HBPM[:6Y[@QKJ,3?!+
M7.L3/'O:W4^!J'3<A@K41T&'""HM%'JG9.N,@+UQ\$Y+$E5^7R>6*T6?7 \N
MG.B24,\PT:D]6]/ISV(9-7B]O7PZF7$4V*W]=&Y8F]_%ENB%8.:I!GGOA_W6
MYX[,%4>0Y]@[@3X/F+V$"61<R?HBP**IL-P]?+HBNF,T1DLQ6+!R!Y@RBVB.
M^6O&]!)\^UI%?UK%F>X\W/:&8QW(9!7QMN ",!<3O-(LH2X&5Z158SOO>A\9
M]YX52\"OGVD(W=/ _++=MM)$U*QX-SO="I4.!"M']S<'EBL!K";2XTU4Q[U"
MVSJ%MD^W_'#@7_-M[3P-M3.7,O#EC=>E6!M"P7Q R1()QPF*0!];AA*T4&OS
MD=F45.O%;.O$[* B9CHTB]QKC"CRDIC='&X<N08U:KT>2XVRJ0 ;9#H)YQ%?
MV'!C725AM8L\JW2IK-2=+*LX&WH7.L-P.:X( &0I",@()P_@,BTT),$H\4NA
MGD[C(+W4_._N$,?!:]MVBTU%![[O-&<L$]V"=AF&!=-'-G'2-A9M-"CXUCQN
MGL:8S9B$S,+B)%AM9T39KBJDWZ9J,4/1U'NRSK%+(?L17^,-MCPCF[+0]LK1
MC0KISJ_U2>;6>,:!*=(8W1<!>4A[)JGS6CN. L5X9.IHU_/<#0PKC)7S4'%M
MV*=J>/W(;<GC+@]LHY?0<5:DUW/=28L?^Z3%K28M?NR3%GW2HD]:]*T'-CWK
MKEH/'#[XU@,GG[#"@QL/( 7P.#A&.I]0W/=0?HTA%JJ_-%'.,".3P=:L<%0I
M,F'O&_<=\(B-*^P QJP!W9N$U=]J)@U,#*2,,?<0*S<9AQN_R(0.YCHP%@Y.
MUQ?.]BJ]T6JD#@-T>)&B38E@'+K_>#&DR+\YGD:E081^<<9*H;F;C$* _C2I
MG0T1O/K,6ZQI(6F_V4AN1#*_&Q 93,7%X,GD3&*@(X W&X7K;A'52\LK*NDK
M^T:43.UQ_,X]LW6Y]6=UZ;!.9)1S1B>.""=&X8S,K;=_M<O!/.^,NI%?\EUO
M-HHNF*P3U:-Z;UX,_]PZ@=(&\;K96!IE$5S<"9Q=20E2'3EW"-#A'F<DU3BG
MGL[-AN%!='./C:36;<SW:7>%_68%GC8MB3E(SMK<;#!-Y]0]GN95'O8.UZ9K
MB,AV>Y-1++$K;7)!C1C".%PML([+PQ[J,0E1S+6W[\:GE\@;B'BEDK6 ,R'!
MPPC3EHH2ZY&?[\TQ1IX3LX@XS?+)&ZOV"2$C";$XT^6-Z-;CA*=9V,0X84DS
M&A4M-<VXR2@X&O]>XD3P3N8;K1_0)N0^YA/+Y=(+Q1/JTT3W;S*4*D3%MP3&
MP:EE_VOB4.7L\0I>:ZALF,CH9J.("(@/5PHFEURSI\RR&IWRM5?"F]S-!E1;
MB8U7,.7O5:RRJ$%"W%8N-[][<0KI&B5/##_4&G%XP8Q5<O=2D^A2% 7C=>G]
M!NV3)"616<%FWMP8*1K-JTT;A/>AU#^UJ]X;'AV!UUL-$NI4IW+N?IN$0@GN
M[M[G"/ -+31):TRR]",;P#D(!(@ I8'95C%-34PW0%,F5L%5ZZJ*.184W608
M8JN>6\D/7NNJT!&]FV6%]L_P*TW3O#"7HJ0E?8>K[S;6^_AW[>,?;8F/?PI2
MMTR,;6D<]O[ ;'<R\@C;\S5NL2EOD9O"QFAJ.#@"*[K=99D4NLI@YI=.1_(Z
MQM@BM#98J&Q)U*\N(P,GP;7Q,'*;P"U#3&["7Q#IEM#?U 5K?;Z27._%_.AJ
MD7)U-)=&A^VL[X0'Q-C3"FDV75 +(?16<3B["#6B%E-_!#E,M94B !XEVXM0
MN;B:?]T=21\XSMO.+J,\E6YWUNK9T<DYNKF& VTXLQ,=S,MDRER@V!\##(!+
MQ.0509;&PA,HE RXR!3+X>1@0:P2M:T+* >D$WOT,9\ME'ZT2]643F'Z<L3_
MDG?A*DM>MUZ*M%/O=N>"4?>.6IC]81@&FOC49&E=K->NX7OKEA@7SUV7G\[U
M#SJ6?SCX8NOOLX_(4E/$3)@[#'O!O(QC0JY4"MBHGL^&8&)U-0I,UPEUH9 M
MVJO,C=.<_.1IK*(E+BQGH$?&@:7^)&Q8>6&#)G_! 0<JT.-9$JYS"=.1I;;K
MF]H[F.9BQ!JFC[T6<V]H7-4^<@1#TQ8Z_".+<NZJ6-+YI68LMH\&TCP[W)?L
MQX47L$K7P93;GAF=_/4^BIH!@LF:P4!<0NO ] 4ENXD?PGYR!?.)4.5F:^=1
M%!V7R0>-<Q<Z8Y<96*9N?U:?\M]F]S2?W6%-,!P88E,?;-Y"-O&YT/K="K2>
M2*?V>?<OHS26V\]9!O/3!MK@)GAF%8#J<=FZKAL=.?DE8E]Y8S3RE:>JVRBW
MN)A^*J0&>G'@Y\[=V^2 <7L$PH94?DY@$(SI,[E!]3SD4E$A[A[F+2846Q*8
M3+FB@ORFMC#NG>!1Z.C ; 7MY .30-E^PC)A8A02U)TIO+"MA$7MT2QJ>!.N
MD*EC5#+WGR9[8'C7N0F+]& IL@B6CH6F$XYZ11XZ$JL+X,:.'_0P^+_^Y"LP
MK/IDNW1-O0;C^BIE)T(" QP"B0_<E:E#=B##00IU,VKN ;H/QN1>( _A*"GV
M;!7.Z5W#[E;E,4YJ!62:@5IB6NM5Z,.-G;(5B@D_P>#DR%1Z5%:.'DF*GY!3
M<'&%NL!*AP,(XE0FE@G*Y;\Q=#:&ZD?EN@!GYKW)%5V]7BZ@.;_A*/1.UQ%Y
M?KMLA]:\,G'\[?'L4A/NVFB@LXK/Q@<M786CN=_#Q #/-<&\T/-*=!0YR$F?
MP7V<-3.TFZN(+ T,];0HMM9 9D-L$MYBFQ,[B$!U!=H(Z9SHU)._4:Q-)V*$
M[^*.H7U$%.E3S@QP^9VHJ5CSV%- VNW83(FUR9I[_\)Y@:?.'19?<:8P1\C6
MGZ4)SLOL$K?=3'.NA73=BCF49A9^O*K258K6SF[J#SUBKALQM_>TA\S=*F1N
M[VF/F>LQ<U\UB';OD'-;'A[<[PH/RC5D0X-N_WD)#>;8&(!"4W@!HNOU[S1*
M"G3BNT* 7OH9O1HGBF-".^"Y-L1K.@)1KGWPN4$H?)<7A:I7'$J/RX)8R>K#
MUE$FQ&>8().V'.J1G-Q0$'5$<F I-H9RP/1X(R$<+S3B.TKU6$'-G7O>'"JY
M7OV]'RMQT'+=T9+19@=&^H7<2E D^(R8"'-EW6I0)+AI3&0XN)V@"/K[-XD/
MD.SR]CM,"&YH  WRVMZ[OGB>-@<!*DY-)2;@N\6FCY EQ&KGS&CPD,D_O?&\
MFR,*XH)78@CN9TW.6S;[3,J^SFQT.O@75O_ AQ.%U6&"'-L0B""E]#4#$6ZG
MIUN-)N@&5KNCIMUCH=I(5-N&B; X+#K;E2(\.,\7U&2+W[,4TAEIY#E#BS+3
M/]:7PHK]WCS82<)"D\*9F/9*1;5BNY::9PJY>_K)HY0X,O>-&0"OA"X2<U^!
M:VW##<3*X>JME5HSQPO&Y\VU5-?L]F3OVM;;E=G@92&TK)LIB-W&8>['*@=7
M.(4S'+P.VT55X\3&0'LG>-M,S@-M<KY*DUF)URK(3<7\='O^6?/SM!9MLM!]
MXKUQHE.AG^,2:]&E<[$1(Q.''PYVX+Q[R:=3)]+S7F7%NIZ'(A&M?4[&9D)J
M3KA-!D,6'-BO2V<H$9:?XDQ@*/C1QK&LR7AL&HQ']ZMU1OUK,C8JVJ7X(MD4
M:!7E2)7#&B^<HQH3HPO+,%S&_U!,6VT%:O"L@\QF7@F%UK&Y6^NKI =IF6U(
MB=; >'CAMZ/Q9+"!&6N=Q%<G\,78JH\$AGB!83NWB9EE_,VXN1MKNX85;4C.
M@"PZF5.OT*,E8T.9:+1%=INR&U%AY)T[2J#7I5O):?Y6V(A,=F2Y"NG+'NFP
M4/CX'>B$&]@A&X++.F3\)=AL!;-^H4&QZYA%LJ)@!UEIT@:S^(/"P<;<L/\&
MX9F&;3+9*W([8__5K)>W0;D?P]7<I@CKRH8U"-AA1!H<&AWB4DR[F85$[!<,
MU$4K_(9IIU@Y_9.2G<5F/+OXX?PR<X/H3D 65MRBU[%A(HZ!'"X,9CPG=$&S
M5&._P%P7J?B93S3$^!Q5!SFBA/5FU8T'$!,0^HII5."6MKZ^EK(#UU#>+6O1
MO%7<Z.F IX"$Q3/>-7&;FC9WQZ=9BF!@X*G:+^YJ\S& @[MH&T[[C<>WH9XH
MCJ+Y.M+)([,0TM23U9X3$,!>07$T)55KVG*"'HVCCR%O!?4:U74>U)9:OY[<
M<FI[(#38XDK>9$(401!R:Y5S04G+0SPNP88G6;'$5>&+)D0P3MYU2NOGI6WE
M.P79=.1T50.B\6IR+*?;K(F#,&H\YN !+E,F">16[[4I=)S]ZICA]."@=SF1
MVCF;"7N:NER$T/Q%$=N 68/X<TX2=DQ#J="6P$V!"UP3\H]T+9\FZ/=>62:.
MT.)3%F$LC)^Q6H>S<? V;1VW+?E@KQ93SY6W5Q<EPGB@;+!D5)NGJGO%.;.-
M$MM76:=VFVTR3/*2"B!*$8H<T](YKQ&]@*Q?R!QG&,RH>3/V]NK2Y1Q$1>R;
MC0TD H +#/,*'6"QC4 !%,*XX^_A_;9?#@[&/QRM[G-FI]U>J1A"=VS#7+LY
ME'=1M.B@YDO&N>PZ'Z"O*7$"NAP@![O D#<F)A93@U3HK*9U**X':Y*$F;2:
MQL-.';(+C=2P4:A=;>ACA2&&MMI\NDKZ0>=A0)=4"9&TCA%O2VOXRH/=NT3[
M=7)3=5WBQBS*PFA)I9YM-]%<=W=?I0;6TFR9N8!:L8J0DI?]/7P,*[,V:RD/
M[M!MXS9-K7Z;4+M6.&TKD;5M83?\4NIL \!DKP>8W"[ 9*\'F/0 DVTF97I
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MGYT5<L+:W+I(^;QQY,ZZW/T>2?QF!G\)A6#[(_"7\5NV"W1#OZTJ?-WUIT%
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M""UX$GQ6JZ"^4] V%G7VO>[[B_8S2/"]T/MP$"87()\S#2YLOX*SC()7<Q,
MXR!^;J/X*??,0=QB04U5*0DX#OQ7TM.R<!HB*30V?H_RW/0.G44YP1AS*8]K
M&]%.FO%%"S=^!3PY+1PHMVFTJTM&R)LV%_C(OL9\8G<X0*C4DH?!+4 M\F&$
MZ/ 1QO+"%;7ZR4-Z2[$@@!5X[F![<]"0.GG"5?_>7/4CTZ9323/0A,8Y7;M1
M1.HAB>D3? DS::A@"I( ^YNMG4H:NWC<XW4)5K\%=_UR^O;#,9M'^WO[>R^X
M 6KE_2Y@W1F!0LG\2.UNN4APEEY=YR6/S99Y0/,[!8&;IF!+L 28/!PAC^LU
ML%3[R?6L.3=^CI)1MP:ARQ2_E3;&SOF5DXIZ,MIF'B4@=A$(:B2=I'7 '2L^
M\/DHVV66!*S12/]8*$+#%$S+7/"<:8IF5*@.I/:#)H>M8O.\7$HGWYNY*3P(
M/'S2;QN?F'LCP?[8<8J#* M=\4O?,J.@AM9Q2@7KNMZX.A]450UY5;TL.$!=
M]N*]_CJ3<O:.TQG.SFS:Q&##'CJ]NMT"7Q@ HL_PEG FR=LM786Y2[LLZ]HT
MI/8OA.ZW^_<!_&M.U=6Z,_?*T=W\:G=G:R_;)*]R]]$VN &;RKN"';Q8S$W"
M)=/:(86/9^$<NP[S )SEW^WU[];.KST HND&ZJ>*;!P-GZ ^]I=I?,DML'4%
M?$5)2"W^# G79V+=2'2#HA.8_X2G2S2#F]R+HER&*J'4Z+PI>,)=YKWK@_$8
M; .>)OS/\%*:L:]=VT_;@W3PZL>*[P&9K5X.."[SJ- $"%(B4]?RVJ[3%NZR
M<0G,W'&"[L!<FW0X: L=29O[)OX">#>L#5B(]#*GE3@KYR*8I? ,-/FHT23^
M1O>*1%V280F0X<>'GTA'=%@%>-,(M!_HP6D1K_E&UO\:\0[0.L''<9%26PY0
MO3IZM;&U\R.UH44JRO7-.&-O# Y9F!4*SN9<<Y*$GU9ADI/Y ]N?6<_// 1N
MK9GQ7T(_=EH[7VP\R'>'@P5Y7B"N- #L*+I,8,;MAJ&Z4'@_FG&"&93C?*>Q
MBI;PWYE:4MMT'#HX'A,LJ"7'#889ET19XOR83\=PT'!"'ZX(/'01_Q,DW,K4
MQS!<U>RE$,RV*9F*H*<CKNP.519'[/#O1+NV'V\;L8U<"W"1@&AVA4/X4D13
MW3L:**'.+U1&P\43!9<R^ YDV"JX(;,GZ?P)W59QM,3R<+IH)F@8JIS/F$YJ
MC,P3^232V5Y*8(/%W%PG=(\UN.CDX^!)AV^MRDD<3>4^<K,A)HO2GAQQTRM8
M-$:6,TP@5C 2W@#\T$X$BZWBN.$JI@MN$B(]#RYQEP&<?M:0B,U+QB0RP?I)
MK /7CT!" %@P&DF:Q&N#V.)-)2\ ?:YHBNIRIJ-=9!"(!1;-K;KE0=K$ZW"0
M4^&_\\I87;$AA#TR<>TI'*05'WT\'[G&3#OK$\HJF@QZ F428Z0(755GE>U,
MR'[Z3PEGE""S&!6C-XAEY^2+>=2TLM4D6OTR,,^<\@]< 87]-%DP#CWE&&!
MV0SYH/0J>6OG]P=?LX[<<!DI%ZM?(-Z:E)H]NB<:_ @'=^3:I3K^+*+HE:R*
M"JD?!RW_<-;+&&SA,"USK%*SH1]A-ENJCZB^T3V^U >_P#-.BD:;.*!#E_ Z
M4O(F9.Q.+L1!30EF 2N2SI#H#=0 ^/@\\@]FSL'O8).OX#.9?CAZ$YA/TT#2
MZBPK*J'54C(:JYS\6\;N#!%TYV4D+LN<XR+NDC/1TJ)MGRB 1YOE&E;>K)Q
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M-4WZ5^]P@=_^\YO]SUC-NSY@IS^??)J&JT+BIK46\6S*1GEP"G9K<,A6L]M
M-,I-BP>WU6V&K;%U.PAN?(OA8#B>>>O!)092C9Y6295E%.STDJ*CJS*#OR6%
M;DGZ7H=UW:[RITTG_,N[DGVQY@-TBONN.ENS55M3 XS^DTU>'2_3$A0<*$A2
MBJX:M%H64TVZCW>+J=-S+_=CO2=JKI>@GGNYE[%>QN[#;!YVP/TGC&[427(>
MU 2OPP74!_JNO9Q'7S_0]R&,*4>& ;Z<\5).<.#1\5T]N)A=<_G05@3'&N)B
MHR )(W+-J@&Q),THS@6^6U3D%@X)+TKA[U/XH,8*IAD!"5=9E$RCE8J#\#]E
M5*P#]MWR8(<"9Q0G._H6_URFF0$ORF?KX31G,+N4Q\;VJ8P]3/.(TM!I)F/!
MO]%'%'^"O<TE##?#,%[FG,G:D83A933%51;.PFF8YS(?.^7=8 :# Y>4T)<J
MQSAA%H;!.E19?M=!.B_T=H?5:Y5(66\S?HF@V%T6(S[._2-HBHY K8.0-!^>
M?= ?67@7@:1^#^_W&7R(6_5 W-9^,Q_09C[(& 2:=J</. 9Q:PV.;G%^\L,H
M06SJ\^#@8/S#T2US]R.JU?5VJ"2*2J96&;@%6/Z4I%+:Y63V.?5O_(HH45-P
M6]24W)8LF"Y4<A&: J\H 4]K29X'/O8RFL&;T JAWZL"'K0>#E)\1)"7DYS@
MA 8.,,/:,_PTOK6@%Q<PJ^!J$<5^J94/R05O9ZDBL'?"^1R!PI?A"_/V$;^W
MZNOE"X6M6A$ 015CX)(AW@$&TKX(>JXRVJ1<3A@<X7ARY+&AD^:F]]P7B^=E
M/:WQ8Y/$QWG^7H+<HPB@3RUQB*IH3,%DIQ)%?1RB?!JG>6DC!^[Q@D\7(/3V
M?.'_4+*2_ I##_ 01/[DP1ZZ[FEYL0B.,$,]'/"3IG&94T0!Y+><+KQGRVEN
M.6V8YL9?4XP!W@]'+5_!N2MS+M^$HZ+@@S-3;YF7JU4LY9<8I@B+=#P<G%>F
M;ZLR<SZSM6%=17',QS5&]'ZY@I]-_*,:T<(D4BY@ A^K+%PIF0C&.?3P0!?-
M[WRJCTW4'^<!/WT['/QY>O[VY.PL^/.WDP\G[WZIGO 12JLJBT6:80!P5L*=
M>P&W%3P<0WE357(9=91+/U 2,J\GMY0XAY_@RD&!Q _,X#AP&V\.; X'< JD
M6AE$$MZ)>H'>)B__;[K_O6*61[)+6Q><;PB/ZLI1O9KD-_UMC^DU*+CGP==R
MU^ZW1[M]\& +ON?Q$@+_>?#_=?[?W8?T#[[M#N?+QPZ?F<_=Q9^WA*_=__8^
MA%)N/.RC[1SVX>%7'/<=AN\>3$SOWHSUY;J;,W6K@X^]0&Z?0%)-[:T,]?97
ML/_SR__9G^?M/L_G41'?VP/=)5P/,E]UKR(8#SV.=LO0T?=O3H[/3H:#D]^/
M3]\$Q\'X_>M?P*]^_U?P[I?@_+<3^/OO\)GSD]?!\=O7P<G_>_+J#_S'VW?G
MIZ].Z&?_^N/D[/STW=NWQZ<?3H+S=S"TX[?C#^_.SO[7Z]-?3\^/WQR_>?/7
M&!XT"OX\/?\-WD(O@$^^?GW\]MU_G9Z_^NU_G?WQYLWI?QV_?7/\)WYT_'AA
MV!OX70Y>!.\87?0\>(.XP)[DY1J7T#TG>3GXFR0O7X)RI?5\\-I^L2J%[U^^
M>_T7X==_.__]S<__/U!+ P04    " !LA=Q8/[TN_68Z  #3F0$ "@   &5X
M,3 M,RYH=&WM??MOW,:RYN\"]#]PO?<$$C"2);^2V#X&9$O.\5W']MK*602+
MQ8)#]DB,.>2$#\ESL7_\UJM?)$=RCR1;(\\]N$DTPR&;W=7555]5??7\7\>_
MOWVQN?'\7T<'A_#O"/_O^?&;X[='+Y[?YW_#M_?EZ^<OWQ_^&7TZ_O/MT3_O
M3<JB>1KM[\V:Z#B;JCIZI\ZCC^4T+D;\P2CZI*IL<@]^"#_]$/J[9]$TKDZR
MXFF$EYK_?Q8UZDNS$^?9"7Q592>GS;T7/Q7C>O;L^?T/W^!9SU^^./IRFHVS
M!FZ\^_#Y_9<OOLV#K^LE=YIR1L\S'XS+IBFG\IG[Y$05C:K@G=_\_EOTZ>.K
M?]Y37_;W=A[^W[V]_=V_9B?WHH.WQ_^\=V_%9N"KEOGU^W?'[@-V)O$TR^=/
M+WL$75MG_Z5X1/=>_&=;J,V-!X]&T8.]!X^>W\<;?Z,)N[Z7T%/_+0;_5ULW
MV61^G<.'3?O\CQ<?CCY^>O_NX.WFQL&[P^C5^W>OWQP>O3M^<_#V^?T_7O!.
M7MT7U$NTPF_Q>[6[N?&IB8NF+**C7?A5#5>_.LW4)#KZHI*VR<Y4]'XRR1)5
MK>Q;'F8G61/G((5Y/A]%;XID=V7?9?\1' 6;&[_'57T:YWET6,$*K>S;O%6%
M^A*/-C?^QZ?HR9,'^X]7]DW^*+)&I;29&E7?U&O<_ ES?/#R[5'TZNCMVT\?
M#EZ]>??;/^_MW:._/QP<'NJ_@]_F/$N;4[QT[Q_/HG%9I:K:2<H\CV<U#$C_
MUSTRB9\??PQ_P)FJFBR)<[W$8'/=$P/[^?'AT@/>VWV<%=_B,/FHGGHGR?'A
M54;_34[WP]_>_LEC_'_1AS<?CO"<@!\4)_AW'B=J"M9L='#"_ZP4_=T[^.%%
MX1\?>>7OD_B]N,8=LW#]Y,.L2!4^8(>N7%L(O;-3Q14<-Q7;!D]7]CV^@SW=
MD;!K%[#C4W!S9FTU*VL5E9.H.<WJ:&8V7GS"_Y2-%VW]E*=_M^4SWKR]#?E3
M1=]N1W"3IHS*MLFS N[;5LX]X&EU"]8B7G%^FB6GT8$ZR>K-C5?Q#$VLZ%59
MS7:[C\)+>H\YS\!ZB1,8(3SO5/4&#@9I',E]QJIN(C69E%53RPVB<5S#2+,"
M#H^B4$F3E<7FQGG6G/+=JA*G)>THIBW\SAN<452] 8[GD1B.D;4;HRT\J_!Q
M9PH_HP=F31W5[;C.TBRN,@73$1=I%(/5G&=H#8RBWF-?E=-97,Q[#X5EI+N=
MQA7( OR5E-,I3$7=E,EG>%Q<53#]=80/F%5J9]*"=*7V<W]XFQN]!W\"H[[*
MFDSU5F0W.D8!,H(1U0INB'-^&H'UW\0\UVF&4\TCB.NZG<[X[W8&PV29P(?:
M P#% X8ZS6 Y\!DJDI>/U!?XO*[S.<C!YZ(\SU5ZHN3.. H4C+AA$?NIJG&4
M,"=CV&0Q/_-450HG $2T4BPQE8KKLHC'N;I >#8W6'K* I\-CZ/GX+ 5.SUP
M*[VA['RD)8RH*!N<!=C@3=LH>" N4-;0!2 Q-%;<';!3DM,8-B;>U4XZ/4W?
M:'-#%75;\35UFR0P&9,V=[8"#<+[?0GO"E,W@[?!438X!7 5?.S<!'_'(R'Y
MA$F>@4S@L&JZ$^P$O$F)OXXF61$7"7RVN0$W'"MP*R;ZP;)2_K+!ZT^R:BJK
M \.LYK /X>:=^<)7A=F9Y<I.J"L8-#8]3% &.+5C6+_D%$92\>C.06JBLZS,
M81^Y(QH4!QB"?:U97#5SG)=*_=UF,,DT;?$<'TV7PER=NM?N1J_U+,:?4:%N
M;B0Y[.<&MCE?ZSQJ&N,[)WF;JFC<-CQV%>79%-T 4J#.U2*C!4S6"6@W>GN8
ME495HX[>2^96VX[X=^>X\K@ZSA=Q>I;59>5=3! 4SC(L#DA\I29M'>>@>^(L
MCR9*.2.*]/3:W^]&HL+A@('Q*[.^N+-:U*3RFK V9F%2!<(#7Z$0@G9@C_0T
M/N.EFJJX@('7T0EHH\),.=\[*[J2_4'O&"M!6W V^,_8_K:>^TT?X==LE2R#
M-%^?O7O-;]%_AQM_@Y<O]A\^>KRY<0#RVBJML0ZF<'T"HOC3?__UR<^_/J,[
M_EE6<![K_S)?[>_M[SV^5H/_>\[&UH/]!]N;&[_L/]S!%S-O^3K^$M%W$7_U
MZ&?SU>]J.@:]\OK-NX\'<.\W'U[U9N,.;EEXJ?^VLQ.]SE2>/HT^@"9_!C?X
MNP6%CC^,=G:T-W_XYM]Z&)?MV2?XF6 E^K.7<%I\CO9W'\/[UV6>I?!J%K)Q
M(9HNA",/78B]=#":OCA85&8 :_&7(E<3^H5!+OJ2ZCW.SJI& S02\/P^3-C
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M2E[%L=O<\ $E<NS67MWJ;1B6K'VR",N9J43+JDJ=E8D47W$G.Y(9D:)CG>7
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M::AN%&9YQ<S?-XT_BY.N-W.MKS702&ZJPM"QSBH0(F:ZD3G?W&"_C]3G.9+
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MTG ,6 "A R32B?3(+0+ *8!%"ZMT_ ?@3+,2-X"@G49^EA&7.%<X1"4T9<*
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M3:.9_>Z>X=;SH <^5Z E^^DEO*NO9\3AV0]E+(\&V1I4+R$!"3+YZGB^+O
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M+UB7*[U_-^U[?+?KE/X4A?W;%/0G+/X+4$L#!!0    ( &R%W%CAGCYYK@L
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MDDP"]>F6%V1$A:P_TNZK/]*NVA\P]^@7&)[@5\YVU7?0XE?5_A]02P,$%
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M!W1S-JH"L*3_Y]&CZ%6:S*??1^_B\^0'&. _JX04I2?1HT?BS?WQX/ 7,XW
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M-BUQCS%XDS)QR5 KB1WA=XX)IWUR!#A:$$/@KL^N4U;#+2G1)@@8MF&1RHP
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M5/EY0LFV-I&?<V^'556D8X9!?8=P:4E)<H[SA4#;,)ATAA_@(\3AX"X9:!/
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M[-OBBR>7=(AA2I.7B31VZQ.<1>HKIV8HF)+X_4?5^$O90Q@<@V5A-]>2DM?
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M9X_V\;-]_1,_Q&Y"=*W7(8@V>H#FS7V5/? JRH^5:GSL9>F:+!O;:ZW"95L
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MYK";L'TX+F65.2VN#4:?':/;)3;^$&U5G\Z&VCI/2\I=[-JS9!&*C-)D-;@
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MTA\T3J3UW).WG]PTF0]$VX1ZXF?,Z&69=@MJ^B7W.V/O?F.2J8E+@*&7B]>
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M;!)^@(W"NYWAT4'TZ_#PEW4Y7(UI6VO2]R7_G,HJF%FN8JH "ML)X(,H";F
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MRX0J*FA3$_3S>5Y$*@D=8P<Y!D-(*W$Q$8H'B3:JX[7NOO,8>U7I;22W0+.
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ME9ZSD*FJV94;K.DF_Q3KK?Q6]J(A<DHYX\'AY$TU1N2*,21]CMPNMEVB.-)
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M2X4;V;-UA)#*AS0W#3$01\QBG;$EB]?*']4VHPD%WX/C7],00;N_ C@LGO;
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MX,G &.>,_3Y;@3$GD(:U^1"8)GXT,LU3>13I [P1#-<+O(#Y+4$796\A\0[
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MH!.OFNI]>?QZY",0B#.? QMXO!7F!**>KC%TOMMRBLQZ-[0@"(2!8U P8R?
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M@GV"VOG4C!9TJ[.G_K4@RU2CE>MT)+@9_@J*A=[#"W*6@&7+T?4HG(.14:A
M,QQ@^'>PB,$<+.]X">GF_MM>;W=WMV8-K6&[A[4S#E&.,O;)?ON]?Z9$P$DF
MR-_YQIQZ/H^Y@&4=X$;XV]XN)O:<JP>=75QSDH0L^-M^]2/R'O EP$3IO,RC
MILO+F9]>:CC$,,*N69#JEVGZ-1LDJ3?Z<\UY-I<P/%KD _X&4AT5OM!=H#9Q
MMYH<E6*!J5EUX/#7TU@V-?X FUG$A5I<3V]18J3V\[[S08D2XQ2T6]Y<4&&
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M.]+$8 .TD;!%!])YQ(7-WVNE?NV4IDMT:\,-_&))MB+L(1QEDR6[K34D^V3
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M#TZ1<%A8P2<,-9%8D<(46$W Q)MV^%,K$\VQ O*&"$&=B T7X41#,VS$CZU
M&S$D-UD9,Y,01W_T <%?6@U!,&6DG\UX,<T?.W7CTRJC(&JO!Z]50 CX-4;U
MKR@&&"K4I!?((2.HS)<\0,R\(OI#71(?L2Q6,+GF9M&WA[$.PE7P*9F=#C[C
M"O:H(Q/^"14DM5['2<382E=TI.&CU4FBZYBT1)UM*,:<#BSZBLCZ4X/).$%>
ML#LQVR0*2FS\/;W74GT%CY*&W46O7@YJ0HX]AS;8RQ)INB<WB:X$Q6?0Y]BP
MV46B>[I>%YZ,ELT6@Y/]0@'TI(Z0'8[8F38P6O@0C3-?,!Z0;[F0;BLB2W/
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M1DQSCLS"?GE#,FS8&*K:'OHG/B4X&G3HAU;?M1,CJW+4?P=))^2M<]<5#GI
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MC(Q_,^K! -\NDE+E(.A]8B*K-0!#Z2#C2CCX[;LPA6F7*-VJ1 8MT,B:,]N
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M8>=BU>_4@'(0#DT"WVXAXFJ"?,2F887579Y>0U'F."%I0?3_=[O_I38,VTW
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M><[MEIO#<LAHF0NUCI+Q*48_MS;E!EKA@ZL52%CJ'!$K*XV>ZBH'E1 .TMH
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M^=O+7^@7 IGGGY,IG,."C):TW=IP>M:,IE0ZQ4-)S9YQS7'0,"NJ&<!NQ?
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M9<!8!.SG NR#:1EL)-DPG9,2B<MSG:"6+P^5%(E8>=. 6@^64)I"-TA?1HL
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MOA"6.-(^>XZEVM.N28OX?%C+LG12;M>+Y9)#G\S1G+SM[L%HWNOV*;M=7U1
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M]*A)U0++V2.!#SON8GCMX/1B!&]0Y)\\'72#R<DP,5'Q_UO%BW3QZ6LR[B0
MY(4;N56\:\9),;7B2IHW+&3B%HZ=._X+R]C&6!]LI'*L7DT%".K!LF9G:BWN
MA-2:Z%I"WR);I)2^-<-%\?R#D>L:XBWL1RXL\>:Z.#$2B6Y.\6LV;"!FX0II
MP1 TB&R1V-UN9^/S9M.,,HN=7B/FO['!='K&AS"9?&&4JOU-':CC2:_1Y92Y
M%9M&MJ=X!"NC\BZ%ILZF%)@B^]XL71!&<M</!#1AM>U9NHY*ATNIV91R"FEU
M._I8&;;/BK&B3 1+80H^=C@W" _7&X# >:3!(3\:=KJ0$*/#9F=#^K"/*F5,
M0)V8(+-*OBKZ%BG*S-UQZ0CM&@(X!5>PG>'/ULG#E9-J%/86A?F(& !XF6=Y
M(5G,P@]%KBM>--OS8B\!\0&R#T\ZULB"FI>U8[7A<$SZ)\</G,C-'H](5+3'
M'LSX6[:H!?@W3@*!"E]&'O-AQ;<+QJ#21 )<).[,WC$YWPMKV2W_V';PGHI&
M1M!&'"IT@G394$XZG82>D:T?-9]7I!G;Y6 %WCWY%3D,Y'ZL^U61]C>>SJIX
MY 3N6R:(:W]EQF\'2X.BDE^]ZK:G+NY@%T,):G&9)I)ILE.:4ZB)U1GOOYH\
MA,O&Y4ZC$)"93([?.%R6$BIB!Z4K.PI$R63B9:4BP\/(H&!HUR,WXZ*N!Q!X
MQ-OU,OG$*T=:A^5*LEX;*E>."01-%=R&YC+-RY)<YW8HDD=!2 WMES+DOUK[
MI?L_MM49/#I)["DT264[;^$TI-&U,-+@W%*9'+D.0HT?,3"1$,D1XB&F#6"G
M&4XQ['9F<8$<TPP#RD8_4HO_I.I#!)V! S1NBSHX 8NQT>[D_*GCWK)CG62=
M6EC3OB/\BBF<A'/7I:&_%7WZ"9L)+Y29<)QW.^\+UNNPQJWLD"(X'Q;)S*C\
MQWDP-H^5^K$2'S-T\GCHZL_IRTCNB28(/EX<=OI(3U?(5>V)VDDZ=TVGY!O)
M DZY_$U:Q(HCVKHJ'7\VR&KMT*9[*F6U1^L4*#(EA<SB*G3E&37/E,NZ[\U$
MP_RD>D:4N43,@@9E %%J^9S\Z>H(9K!7A!6+IF9]#!_)L/ 8OM36.BS=A%!'
M%]%G@5KTI0Z:97=;R,C&=#$IVZ!OG2$UZZEY"HK".KM=2K2*/FNS$B_I(44F
MB*>5$W?J][8-UFR +(0J^TH.K!Z<+O*VK+9;R!P135 (7Z1( #2+?!H5N9DY
M(APQA!/_2Q615>P:+K=AY4,:WV!-!Q6;Q46 U8%/+O-KY%ZE#P)FJ?:X5T%V
M-  W&&!LNAM)=TP0MWD H1LJNP93%Z=$0FD2A:KK_>@(P4FTD)H]HN0F@?6^
MI9H%<15S00OM'GE)]2S<BAO<8K?C);XIY1#G590&SM8WZ7;X'+Y-I55J5!V(
M]CGFJHU!&TK$]0/:VW0 .D>,2I?:M\YV-9N4+ ]LN0D*3F([37WO$M4<U-H-
ME<2$^=\:$3E4CI5VA1*JA3!=JEAS.WS*NAT?LJV[PD7@><%!M05],BEQ^H=I
M'%'NW="4&PY$'22-7FI6ZE*4FRU]IMNJR#-4)Y>'3;^36V)Y7/&G=5SQ?N.*
M/ZWCBNNXXEKS:]+\?M*:7YIS;2:0T^_R_%/9G-%$ 3MT,S*9%=HF)1KO F,>
MX"\Y+X:+BR3L?>1D%=&^P$9##:74\)JT3H:O21+"M;'_^'(BM5GO^[BTQG)D
MTI66I<[A3ENA9 ([Y"/76Z@K#3BA9>-?L@HDU-MK#W8[ :]0;4J84:UT<\A-
M/*S2>V5D:SN%'[)Z4R)F&/6HZE+!0)>"RYW\A(TJG\2DT.FPB!<PT@059:AK
MX[ *R,4ID%*D8F<UZLD3L._1MF]N5=67:$XN-*^2I"!Y@X>O[E55D0P8@WO*
MM"9^1 T!](K4)XM1(:>J6\CA@%[.SZ@9:\^M?B(XN09A4UXF,VN;.>2G5/YL
MDSWZ=A:' VW6'FPI#'YC2,+O8RTWC4*RE3-!^%'#1&BL'CIP8RLB0O*YY?TK
MLAXUYS!QA%AJMO.,)8J!A4LP0@^E6S#QV"V.L=PX+=Q^"S<3YA3Y68BZS >&
M'*P*(<UG%:,)-\R[V:W>[,,739.O\YE,SPJT'$&Q*JW0G=TYS <"LXB>J=S.
MFI-F\>"ZX00K<MOBJM=M.%/;UP%#L,4$=T[%="+KUP$3@.C.%W;4*TKS23Y7
M1J/]*TR8XOBN1"]N-\W=SHWSC.5!J9"0(_L217OK!Y)"%[BNMH$'17H16AVE
M;I(D$(<J;D#0C(>8JR7NCQ:JI-V]C9&.<#E)7,K)4,Q3V2N%3OXJ'=Z>RHK/
M)!4?)I"OAKJI5B[(CXP+P9#CU_:#I:KP@!J7'%T*EV.\LV5L.L#2.#@#$0'C
M$14T%!A82TEE*=,=C5X;F@6O$A(L?&UV:3*P&W#/VW>F1:K3N/MH/S2L,]^.
ML61HN)*+''VQ>+1L6C8=\24)M$%^Q%2P29C073NF#=O<O11Q'FZ6YYN<3ZW\
MCRVB+$"]U^Z@\2[RH<"U"$9).2SB)KR!6CPJ/ULJ4=64K%>+RPOM0.TR1P?.
MGYS9X"XFEN'[?V9F[?Z1JQ03XSA3Q<K864&3"+DO=9@/*9LU(BCDLQHOY 8A
M^!.I=D.8BFBXT/YJ9YH=:!L':NU%P&2WG!58UM,073(G3S*>FQA./<D?AI-9
M2\V-W(O@HSSE!LG7I&0U2NTDTQVL5Z.TT_B:U8S0RO1@MV^JLRAOTP['F<<I
M.^*A4T(C40MO3_.2X30ZQ2\9\A68852-J=F['1:%6G_>UVBLD',6)5F*(P A
MD41$T'81Z[;GL)V&V&P."@:G%'K@'227V/=_YP(C="3/^DU5ASEBVB+%3NDJ
M7DF]LZ9TFY-[\&?J[6@L%30=!*.@2R>R(@K^&5I2^E,='VPO%8KVC%[4="LN
MZWFWHS!$V$.[_X?LKC#5<F^U=9I.6HLQ2!9%BU:&/6[3%.U2>Z[%6M/%5M-U
MRX2X3^D.I1S#T@A3#E;=9@:NK:($;,^[N,GEDM4S_RR=[?GVJU?_B8$+0>6H
M>#@5==4@++N.AAT0Q"55^6=A\ K;TA+N-ON[V[&A3NTKZT8C_XRQ9H.@9.CJ
M/+NHFY DB.25QXRMDW^O8APWE+.M2V@W/]1MMMMI;#?!_DI 4G"D//]?,OW!
MS;//&WF%Z5]N(E_&:9/MSG;)C3.E4&YX%R?9G$*NJ*PNMH->9BV2*'4WK8UV
MN0YBB\/(U!1_N?OV_./ISV7U]D?\+U6\,:CO;D<AXY:5V+YH'IDN:6Q$&Q94
MK8JY $P3!$/BE:1BR>+H-0 820O& L-% FN$4ASCB=6BC4.Y-IV$C2P*6F&W
M5QMNG5-Q"F_Z&>%JSG)&$Z 94Y*[3O<@01,3M_9-BR&VL#%/6.),D7*3526&
M(\UG,C%@P,7HIL+4?3J595)PL26$ Q4YJ XI5VGV787&&N+UL1B>&LPC?ZEH
MPS%7![2&/8"WVV0C]Y;<N9+;_,&#KG]=!UWO-^CZUW70]9$%71^>^G-=A-$I
MGWC'H<6][6^]'H2$HF$NH^2691!Z&@5;UBE7[[@,@E.M]-:E$;Y]@,*W5[-U
MSU"RDO[>[1PDE( Q8D?4^2Q-VC.A0X<+")3#-*YY!RT[@RMKSHC9CM$-7#(7
MB>SMX"]I?>B91)>LL:Q1R[/^+JDZ5XMQ4UB1'4G:R/6_K'0PRQ^@4EF2>JO*
MK[%!^B_'2Z*K/!DI8VB4SP=5:,7'58!1'#!MAFH]7VRI_81A6XJ?E?,!SURY
MBO, E'"*7"%6N*A9AJ$P70[SZ0 T7[]TP'5$OE2$EB!.L^1=4N*^V+S%R\LI
M4JHTO9UJWUUM\GP0M2M8)&E4EDP8(T[GYM;95VN^&T:S!/',O+E\#P^YI1P'
M=0,$WP"M-5J?G2%VFH))3X#QQ$54H07D\$3=:']O<+"7_$UHMLZ+A9X2E4W:
M9J-+JC*G.9 /P/;5B],ISG)R;.<6R^(=> ;,2TU<Q#3I%6/H=I;[ PPX' PV
MMC7E7:K\%Y?^5GZ15JZLYH8YX TF/5N06-T!'0568@>AZ5T@E&\I@XC4_21V
M2>,KJ,\.A]F)Z72D*,%J833&&AAT5]E8BIRC%Y9\=(0A56*\3:_,]]0Q5 .T
MDUS0V213V(7.PB!2<K>(M]PC>7>F[;=W)WX'E[ZF$SN?#TJR("O%>A*<P$9!
MM'JYE _"G*$E!"9[BGJ!19JE*]A7WD3\QWP!P.$H*(^\I*?;8!FT*[G#=OI7
MR2&K:^V4MAW^A2E/- -5F'( L#Y81(-"/@'R, U0^E4$QX#[)4VU2UL.MCJT
MX@"G@[%,T%>^M_Y4]=;EF6F@.U"!-W)5>BEOT5#R+W2V';O[+'";\GAY+PP]
M6>I]74^^&R+&J-NA.*R\=N0E:E]&(_;NKG3%<"/&34^ "A"1[3?%AJ!WD%EM
M@D2@L@]MYYU]T[#'TH[J-,%_5G 3;S;=O!1E8K)/E:0?J>V!Y.>@OV9:]D\X
MCF2<YP5S:Z@(=6UU,!H#LYO)ZGGM"BZ#8TITE9CUJN_0M@70"4M62*VAPS?V
M-MA0T0O0325U2J5--4 X&U"-)CU;4=+2]<2J<_V- GB#08%^IES]L@DY$J)9
M &_"&_CGS-+?_?12MVM-W3+<QS3:#6*4,5$<#9C2$]D>)H_4Z)KGW'O5IJG*
MO+Q+AB. #BI.\2!>T)94*R_S8#$4H[2FW<@+BZ2WE5XSR2OC%6$\U;)562FT
MM;E6+1[Q /<,H=IID8-.@;?K@6VU&ZWB@(O.ZVU6XYIVO0>A7[B$3^L(C<5"
M*G=(?;::5P&$M>-)8, JW-LQ2C!'E9#[S7I@LU4]"$@[N%':AF)'D[ 6ZAC+
M6'5<'ZL 5OVQ,*=[J3P?/B8L- H/?CL36)&Q[2,]8=#*#%$B8[@Y?2L\M$H^
M@,&*2S2A2%Q(>$5.:[4^MKHB^8T6N]5FC?K)WB0UC8CX@!I(I]U2,C9J T6[
M0:,)CK.M^,!-HM[NFP8(8%9FR]UF\^=8[0E\"UJ]&]U)K.O5E:?@_G2G%F'>
MHCQIHO1ENE-MZE?2C$0OL^$V=Z<9F<44$$:MCU]!'W)>]ZUH0TZG&G0AY6]H
MPI K2^H6&M&2UVT:2(G!K#8<8WWZ6[4A[JM7ZNMNE2.$)3=K1\W&B(?Q5IO(
M*Y/#:Q8SG[?D%11:3EA9@2,AXX:U$3;NAD/''%8NNYHS_W]N)NW)N(Q*JV_W
M@Z7X]I2F+T!9O%JC+.X79?%JC;)XE"B+1W*ZG]( ]PPI\?MY-HJF0M=B%7ZQ
M \BW#!J'NC:\CN,QG0]?:LA+R'^1MH_X=K0$&:]/V1IPMYF.E!('8>?R-*:(
M**>0D,2+[$O.Y.9CZG AH<S,SNX-37TV*P$ _X.>]00TW\+J,/FV[1[;G4$O
M6PCGC*R4-!DB?1+J%(K3)]3$."&G'2Z4-Y$[!%:AKDN."A4QL=;MU0"IV"SK
MUTQ:!#9C(<AXF3O;9-.!8FL-[!4(+9[+,?6R4L5 QCS)L4IZH4^ZG0V5\51/
MH7!GF6K;*/7%92ED#=]2ZVO*O%0?9=45 PNF8Z9+I)PFFD%QW&A&$RM<;L4/
M4-'490FC(>9<FHB^U:<7._^I=Z7L+3O(ZD:TX<&&YZ]RRL:8@46A>9B'_#N%
M;_"BW114OY]S4W<-@,%83*(L^;<5,A3_AOZLJ? ;GQ5<VGE:YBH$;G:*6FJR
MNHTUYP$I3'"3R&A5KC"=5VN11RNN*V,2VF:O=HB;I\\Y.B1?YM,IIS(:5PV/
M5I\;*H/E^DX&\Q)!&:43D;6<1,S77&<@=1<DK"T'>WJVR--CQ&"C(V=3Y0W:
M1Q*?YAPY>%AX"* O:/2HVE/-CXM_K;SI4+0C>VXX'3K_=MGQ"#;(+^3YH*SK
M*VBXO90[ZHW.V @#Q\2G-WR@V53V)5&Z(+0_J>;HE@A:WJ$\5N3185-?16:7
ML'/4K/4:+P?&RPA/8 HY>O3VK83/)CSG4D^[M,16:E".N9=%;+,%MBD$N@I4
M$\'WS?XJ/'.U=(:\QCGJ@:?8TKT9_\)],>A^E%*T:WT.M[RH2=T$7<NJ '(Y
M+ZXXD<;ZE9 ><A"=@^I12GL$=I0T7(\9]U*P:Q < Z^RGJP5]^;5IJ5K\INT
M[#[R!D=>S=0;)\I0IB]+66[<+LL[<S_K7\^8U2XUERNV#M99AA.+9GAO%(D'
M7%*Y27JT+2L8."52#=MUR^.@NZFCZ9)UXA7$UTD=@;=TN@V,RPVL0._%YU,?
M/6S?:2XNJ[9Q4=H2E\.E[DH&D^0 *X<7)[.#V+E"=X9:E%&"&B+*/E0-8&B9
MJ>;6\K[M;N=PO%01Q%P@24.]S*ET@:;G6*KEL3=8$_S3N)9*<?9T^D$&?KV.
M'-3ZT#J/NKA :6Z'5E>_*?+,26HM'5U2WKE6U]EA/Z5PT;+1U^T@$:/=3A]]
MR(L&PB"ORJ#G$.<K(G2$BFU"0D_YWD'5%L=$^ILD/._M8-Z>E)F7&T K8];-
MTS(D3HT%H8XZ76%!+^1G34GD>:V"<4OC&->R*A+:JUCD4_M"!.D\BQ;U=&Q#
M.2UA0$,]3=YD<NB=#Y$]NF2'8=/LJTJDFA]H%7J@IJ+-_L0N$SM-2A13ENA
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M72\_H0;31G^I,V8?5C(,,0DO;)1D-QUEQ$WG([QGEQSJ]<E;(;#V?!U8N^?
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M;]E.WXE,UW3=N>-9#<L?TKO-+7@?3Y@T[3U#X/]>14[DRKU7Z_QOX]501J;
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M Q#$,J3GR%QW0Y*: (X@4;@[(,YI]]UY71^4QBRT5]3C"'C#ZY70&8Y<B?Q
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MB[$KZQ_,/LGOM"29.G8T0/":_UK)/.CZ :"6@3EP3>M:=& %H>\Z]DNA'FK
M^'FKL9F\@:NNA\X_(#5;HRC!#>Z3^F<*O/4,?#\;>^'(]-+SUWOFT'%!VMX
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M'61BGOXES<52#*O\("(ETIE KS.H& Z\@RYB-Q[--H"J>V/79<TH3Z3)D2H
M! J8@ZW( _IWB <-]<)>I**.> $&@S'P78Q'[Z-:"-Q0K&;CC*A@Y>==PTBE
MWT4M5=HU,3 GJ-T(LKQ-MPP7,4>OQH1)AQD?;0J\DB-,0>NB?8_!2_2(Q^!'
M UAJFDLS2*P8E:Z-N%J7A^ [2@(M)Q0; OU.'/=Z++R((^408O"+'#T@%?$"
MXW%A6N\OL+"UN-J3^CK GBGY<J%^IHU+V0C%3<C,:>3GI$ N"88B=JKFL&#+
M@'1"P!%PQ3"$@X8<.6#]MR<#M)V008(F"_##W-R@$U]QG2$HJ@1*29Y5)PDK
M=SK[J+$/QRYJ$'9U^G@<L"XWFN"5E 8,M#&DP$R-!*]I@ RR0$O R M.2P(A
M\M<RQ^;@NQX;)S3N=")R&L=]F(/(, >6P$:U!$:-CE::WH,JS*1D=%(%E!R;
MD+;;MV!_8)Y=?8(,PD]<XFPBV>")"M+GA3I\TT&Q_ F?"([(T:MH/ $(FMIS
M-(NQNJZ4'L!GN282J(P/*QH\[28I@*H9DQ%Q?29LVSRLY<Y'#"4IP[$=#6)H
M+D()(*0/70Z,4IJO(FV#+'(=-X3U98$462 3Q2N:2A<>TS5%K&C#A_A2;D=H
M7U$KLI6.7KJS1OI@)?I6<JB F+C7 Z"AEEDA<6!_BIMNFR!7Q50B^T'K /8/
M P%Z"3%YXR?E9&C88V:"681DD1".NW_#K@KMM['(0G=]/U!G9[/97G!VTDL]
MH:\^(&#)6E%E-9!!$N,;#S4J4R^SV3(T9\YP/+Q9O:7-IUAPJ3K)^U=RW/RQ
M:QM=6;"SLEZ:S=K.]E:MN;.II\?1.K7M%\W:B^UM]6,-C]!(FUU97PJ>&P(Q
M,J_A] !>>P[RO+(#:I0<T(+(*AP)'X7)P'1[^?.4]9C=(#DS-+I WJ5D@1OZ
M64]?XE]*@+B]!^I#CO 7@I$UF;D=(R$VQ= J>!_"@))]"G^ ?=ENKF7.0$KF
MH)^&:C<S=KN1LMO)I+EQ1@8/I5[,,C40 R= (#8 " M&P.R$,DZCBDB)SX#<
MK6EUB&]Y0ZHE>439#Z!S*R\@FN6P-]00,4R3#((=YS4D#:JS*L#Q8;+7/:>'
M8&[FP30JP?PYIMIWML 6!N';RR#\,@C_% C[&1[,Y^X:R9DQR+]O5(P2JV/D
MI]PD635U/^MJ2:M_-JZ/Y!<-T!M'XP#L#,=EY5DKORQ-R+&+7MZNX['X(]$4
M-L2G@?3@OX."10=SA5;@C.AM%!ED7KH^*CUA*8SD_$B".^PIS+C-0YP";8B0
M3,H,/M@8("\U<$M3IQ0J338M^G!O3K5NGU%@!7G$07_UE'H,(OCKV'0-I;/D
M]@DU>Q+Y&1\6/$,SUV?_+<%-8),1!G(5-1P[,2[THU5N# $ZAL]JO(+V2.^(
M!CF)F<(77F9JQC[-6_BL5K8"'B%>1JS)!!BHY-X7B(LA9E@R*M)V"Y*GH3U'
M1:R2ZT0YA9294S!P& QENN"+FU4FG#9K5'T(*6Y>;'4:BNX+RQ:KA X&=Y08
M( J[!^AHOR02R9DR6O>[VT$T;CJ("8ZQ'8D?4!2:-X].),9"QV0\*R]38KT4
MG1VE$_BL.V:M5QVTG"90X%IH_],!588ND$,,E(\]UB%!BXD3:F.X\IA3GZ)7
M!1:'!\F@@Y0S_QKB% @*Q#T=4$5,"3,*!1K0 "VF_7;!2JIA8G'&A93C,]EU
MDH.*_2?,(VBA1CARG0CM.""[4,=OU(_\!R@"L#[/UG^G>5T@53C9^<?4CCH.
MT(<.,'TSR$2V'6_BNQ--SQD3?14= ;7D;#/Z#E-3'4]D+J1"U%!TK%1\BCR4
M#S.ZR]+Z?OY]@]]/^RIBFE]\6I,07G((4B>X\IRF#W.*:^6,###07=!4R0JN
M6"-YCQ%6R42KQD<K9@!63#18JYI+5,UE+)PK+3WX9^X3E9,>J_$I4<GP-VX2
MY1=H>8%^/G\D/6V3JB6HU8WBGNB<)$&["^I%$<]W19L_QM.VVDGAS;@MWA9/
MQKR7"6(Q-8K]1!_AV\#CP*P!V$KD\HU"3.-%L2E*QK@%.O7OKDG>N+A54_'<
M%""]C61%AP'B8A,=)"G:+$C<U>XXPN\\7UG_ "984Z&TUS2W) 0;:0HL$58Y
M1G\W;3$!*YZ]2BKE=5>=J42,F#QC-<VL3<K,X:0Q+MI@\2UY"AV/R0Y82[E7
MTOI'42P:BCMY)6+AEN(OD7,U,0 >.$'H:<WI'6& $O^,(B":'EV.K&N4"K]?
MQJKY!8VXPB$B#RIWG4<S"KV(J-M($RTM3!:3E!"3S]0H92?Q(8BU1#@'ZD!D
MM'$5B5G,C50L9"TU,_.1DO!H,4:="F&9H68A.D:B'Q*O;!@?1YKS\>K5VWFF
MD?,-%Y)&OIVY&?=A;@4XOY6Y&?=E;N+;F=OC83Y+1O--C$:[1(H1&K.82UP:
M DH2>O?[_,_2A&G*CZT1D=DBFS*>R4Y@JX0S;6E";IHI PS65Z;3BFPZ[;UR
MFA-<Q-/"&=6@8,AUD)JP)U/G[$6CV?R7YA&<S<VOZS1HL/HD !PSPF(V-&>\
MX8P4BHZSM?65$SJ]N+7]$C38/LR+C"&4+C J[5J)3[IRLF 8=K-9:S:;Q9!9
MY;;5=#J)H51;@&;*_0?9G>(EV:EQ["X;8],I$361CZJ'S@R#0UO-M7P C;*'
MDO"E2XRND&P8RY$%B?IK@DMR>\A1T<%78\=9+3:UI\@$=0(-^=&<<,2J/5"H
M YL5@9E"Z>GZKQJU7(4-=Z)YRFCEC*: O0.IK!W?HR )\G<Z3+2C21H+_<G^
M$/J;=KQL[)?D]*)H)98RFV-,-X/QNA1 H]3?^:+@96Q<JZA=( '/9'DQ%1"6
ME(UXSP4:W[A =.Q9J@Y$<1Y]!CE1'R?W@)Y9]>"* ^WPB760N7;:L>,$*08]
MQEVF&?0?2_6 B(.=B2AY_=[CD65+1?I!EZM9GA%K@@NX1EF6 *:/ ?O"? U,
M$!M**B<A/I9DEP%%L<S"G"02HUVI'09 N./D0R/WX9I^+4[7&@5(ONP,(74L
ME]16;/U2MI"\U<^LE6Q(XK]&&?_5"0SI><IK=D@LC /%,%4^)WY:EG*7^+ZS
MJ VY_Z1!"312U0EA64(&LUGY39HR<34E!D)SB-D_\$) Z8:8_T*N5/@-% *"
MF#SC(>P+\P&+A/)LGN*36"*%GR8?U<W1R$<^8_/+&AP&?>*S;]@)A(8><_S,
M"2<^Z3EHUH;XI+(W0'JNM@#M7=!<//1 %5,WC%OM064Z2Y(F?WQ((2>)":">
MB<55N27#@0@P&2$L[*AQXXXVQ(FJZ;H]3:JD2* ^D/UK.EM.UX9EQ#TM+U'%
ML*H J0(8N&,[)IERZ:C'P.E2X@J-I?R@>$0#%BB)'>6E1$I&<"0&4*X@SH_;
MK!<@J [@P,29OX]!Z$TP#28JS1>^29&AO-ET^ #FX_*=B(776BI$8(H_ 3QB
M'A>X,ZD2W+O/O92*SW2Y:.DDH6%6DT;IRP9ND"[%THM:B8\EGT59*TLJ-%+#
MXDFOM$DPR(&VEM-SF'[Q!* 6&$C0*+NH H,>*TE%9%E/*6Z(2+TJNI5A\=(,
M>H>NC"TN43\K+C7WY"#W9'$R9<FR,U@!^3>:QU>\H;N*= W A]+_L?L;,<%0
M=!JM&ORCC?_8J,%VX]_PSS;- O^QD<T^K3&RL*1U' 0X_X7$*#)ZAA!T R^Q
MR&9[XN-L6-OQ+!\D1T!VO2KQ2F_(X^$C/S/A;V.9\+=,^'L*"7.OG'B]CZAI
MQP.O<!_KDJ@*'QC@.QGT4;W53/<Y+_P1;NV/**C'5'>^;<EV0NZH4(M;*K3(
M"PVB,=69!&]]!DD+G')>]Z<>!764^@]2\RU #M;&,?(*M)185'.G$R4IRUY)
M<NVR?G:OJ Z0+J8(,RV \[2:B.(NVTKF$',B#UTL"1%GTNQENU6@0G$D77.*
M>4Q:;G,V?Z;8F@T>5:T'R-5%]<FXR<R'9QK2RW&7T8#3G,N)::/ZDDS"!:05
M:#7R/N6:^ ^@J1^8\1).J;L*9W:=G1VF%\.UCC"@"_:/XZ*?T2KI"A /CIH.
M!A$]K(^<I-(@R_<VY\.@O+.RP$*V*0F,,1RYI!@ITS*_?QE;OF:D]TU/605R
M/EAS!M9F_>.HHDZG\#1)TR(;5IT$ T_"+Z.Q/5^V]U)T097L!SX8,:CZ^<$N
M&@Z1+&O8E**ZVD*2*_KR,C082U5Q[C=$2UMB>9HW%C&T9)"XC4,A<E7]#8-/
MS7YD.GK('6+IX?MQA#G=1DG1>.G@:^Q9^GT,PJ/=9I3AD/OC/FRDV&@^MGX\
MRS/S\&?F>&;)4628(;M0;9U-O)@:A>W#])C#/#2O);D:5:(O"+T("!JY.,?(
MPBK:7M+5<Z:K?4-[=VZ@I-C=HS2-2I<-W3N:^(1$N]%B+TU8YJ@QTHZ:A+LO
M] XNAO*V3CIN_;"D[B>V--W<=:/1;(N/GNZ7@H7#V',/:>28H_R)I_7YMCU]
ME(U=?T3XP/'XT@?*-\F6V."Y1Q(1U/]77SFBF%2>"V5X K,D[HA0U9[,2]H]
MJ2P8U0&O(M%K<5!2\[N4U19FS3;B4]TDH8F3ZV.BY[N8<Q/M8]F 0ZDV#A?E
MQ:GH0^:DI%%FDG;B6H\NG1SZK;-JKJVVUTJB,ON<=;N._7MD?^QR*<%1IH5/
MDE6Z9+)/;&F:R;[ $_2>-,9C+I!]5(QFN9MW=C<_*L?K,]Z_9^]<:6M[L>#7
M,Q9Z_6[C7EGP495_A>O-^*$,,(AF]BF3Z$(UI$,%<6'?/)IT/"KX75XT_R5(
MT$=3;"BV#7\BFN!GW2 Y3@9"143ET^F&4)P&;>C$KX!ZV%!EAO3"L:IK$"'@
M/^PIKZV2MCH3"[0!55V<Z#DPG);1VXWVJERK,HT>C^1=IM#\?$?1@G-U'T]1
M8;C'0VU+ROK>KJ)%M'1O7U&KV>@\L+/H!CB7WJ*?2^"5U/:@QLR^:M!ANL9I
MRG% QCQUV ".=@(G2IQ&/\_ ^0&H> *L[(?@X=0SRGPU<6)\.MU9*W[YR'A9
MF#X3\#[0HZ6Z+:1R%F@X@X;#KILJE[*L-*"JNDHST<MZ)W<M  RQGDGZO-0?
M92LB5:I^IKZ-6>V:5FY3!=\WI/-C-V"<T>F.54&W+EI )UHV;X.R6]*W+&"+
MR/R6E'VCBC9,S>+CX@U50T"5$<"Z2[]-UW70#"H552LT>L>,="</W !=TA%%
M^*F9*^WB&HEJG%.GL"FV"C:Q<2_"3-..P_)B."6ZC%2Q6\;3"']4)??DUUGE
ME2RCS8;8CTMQBLLQXN4L;*ZLLDR J#*&)[LOAZ8#.&!*<U2SF P943IPO@2G
M(0[XNJ$A%:53101LLZJQ<.*,' 3'">E^HN02)&HYQ'B<5]!C:H<=LG>I'T%L
M8F(_;3"JE)5ILLI!<!N94XJ^T&1G:UQ"J%6-4&L0G($4:]>V;XWY>49AX@(:
M"^;&)/*YOMF"*WYB#66*%?'PV]SH2CA+H+5/ ,%\L9*D0DUZRKA'IS+=%C5$
M!8S:TZ4E81>;MU=11JQI::3DSDN&BHS3Q<C'&C4N[P'[6F)GJI&3%!DOX#'K
MJ7.#(U>34>I-8Y6P%&-F+;7;E<C_V+ALB/LWH,WQ'Q@2I%E_0%[ZJ>R&(,SP
M*'C<!3YU9-!Y,(BBT>[Z^G0Z;0#J&GU_0D7#W;FJ"N8J&UTZ%?D@TCJ;37$0
M.-8ULIC]B?2PT/ARC-.T.NUF3;QS0$[6Q,F9V-AH;;2>?*_;ZK#7P@SXSC(#
M?ID!_[3I^YG<-O]L#2S8.5#)IV9@U\]\G]256&_ZB6D(2]/RAYF65P,G- +V
M<BF=*XROZNPIVG"9-A*-)4Q:[(-N(,VX:6*B8(1F3X+J'8 L48H&Q^Q#RAG(
ME6HGRHMQ!O_JLQIW@>Q\F%RCL[E)N0ZA7 28,@#CGBRI.WTRN>/:_*B5V5Y&
ME<4<&RW8;<;B8<N-,ZYG!WVI5$.]BY5>,WA-N85BXYK UCTAN](#_3**,5LV
M:TUU6 "Y[(PXY\$9IG:N^AO0PEU'V@9>*QC;LN6)_VKM>--JR/8AZXRE_@>M
MJ ^IAQ]U!5!F/&SY"/M(2W5WS*+-P)8(?U//5=5'&_=B[%)_;-!D0HYE@16H
M2+,+.KN<R)JF2_6S&B7_,^]T_M<$B_J)OKL6+UP=IG[77_"]K_E?R5Z5_7G^
M=UY(_E=_A <5R]D+'XQ<..TY4,!V*<PWP*M9\K^BR57XK>I%H+72GY%].*C,
MYZ"@AZYSC8U,>6/BS\GB4DU\ <_PE-D#74Q'^&)#EODB\$G>RNKCWQ GV6=&
MZL3@J#"'S?=] 6&I'><I8SLK_079F8JHN.<Z1T-QJ*ZI[IFU5+ @PQ/(<,9+
M>,B]3QR%;_C2.,BWA,>+RIP>J,PP4N"$USP$-O$A@F=#%N>V<&-$;#!C_QYL
MF:)H'H>R'?++#-7U\=A 5E\JS#!*.SDB[_Q0EWPC9X71R!;&/LZ<^9_K/[20
M<=Y\5I%* I_OK./.SSU8-(!"O;QX=V 7%1BT8#3!>;EJJ;D-6;1@D5]P+980
M!G9]01 PC*BKH=!"U5T<<1=$TG&[C(\C:"K+#:NG7!FQC\VD;MD A^JU@ETI
ML"6EJ_V4U/K&IG[8[MPPN;<&\\YLD^=,@1TBK=15&,O/U'5@MP??R(!?X8XL
M]3;;TK1=^+E&FX&-E[ERA(?)N\9J^@HP7*=/3:EP-TW'Q<L/L"<6.UKHXDEX
M'*8"8PNGQXE#=%I$.>A?PHP3GE!-0T>-\A?8CQ'G*V@W$5(H'-MA+.>J16,B
ME^D<VGXFE&=FTB9'JD9QJ&H4;ZA/-)2;)>,$SCH" 9MJ:=1PG2-_NBO9A(2Q
M\@'%#=,M)[#&0PR06S+-3/KHE0JHQQMK+ZDNHD9%K@9.[Q10&^_@/-VF.N"D
M2[RUW%1-<4)R"CD!,_@8Y[(:W0;,ITD;FP..])7D8T^YV9$=$R.@TV]ZO&CT
M LZYKQX YL+2/%-?;Q#7'J:005Y5U%L6^Y\9'MWP5?695CNONJ_I;FPC/!&>
M-5]$32A(%FJ<\0%@)SP@;.",PIH!:A(Y1N,8<_RBNI4=VU:L.C,&%&93U9[D
M'[9\$#K_R()B>#MU,F9E=-6;ZGL/)["FJFH9_V@H]$-JE3Z2D9/QT&I@M#L5
M9%$]?<!U22H "X;0E+[CKE/T=T1]HP!0-8[!X2?V' /TUQ*. O U?RZ)-0(2
M\.9[A4,FO>KEK<[4[H(@)(>U.ES<3%)UJL2U)6**VMJ" AAA3,DP^VA.1>6Z
M+_8]2FG_N1;O&0K2ON8%%@5!J\!-[;#VVY(SUW5"W8UML1#1"=CG9FB;7S,M
M\A=,7IP=S09>@J9) ]E@2%TNI66&D=+NF5"R^E/29XTE4XJSWH )"C]HA9$I
M B^/D/'%%Z9K))HT"\V9%A,D-;&3LC_U0,M0FIPBSM!)Z#4P1XZM.:PRA0=.
M?^#.$TJG['X;=C^8)[9-&348B;6S.IODY;<MAP@$LK#%D3093!R\-$B1HFY_
M; M[+/FBPGR[]Z2K,^C@?5D/\08Z(Z2K48!46,7"LTMZ:(P,ZH\'ML24 2YH
M',3_6;V)T["<&QA<AJ\1[P4-;:Y;DDH5H(ECME0% *S=TU&:6)T2*75*$Q[>
MLN<!CW2H#:Q.463B8+T9V[B-U-5%:E7J]M=D6:FEG.(:/!D!<&8 NRJ]/BHB
MIMOWX1 -A@K:N6<.'2NL\=5)Z3=A(21I^)8'(EQL6)K,P$8Q]<^EZW]1=T;Y
MQ+?P"@\;UQ*% 8OD.PY H*$R?0M"<2(5)X*EJ]LX:\0Q8^%1C1J#4%.ZY7GJ
M0M,/R(@&1.8)1$5G/I*F0A!68/@4IF8M@"Q(OKZ)3B@K01*W#&-L$8:-=,]_
M W>=8<0)4]1^Q_-"YW^67U IUW8XZY#[D*?X*U_L,2#%BO 8<.04D3@:JP0
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M2P$"% ,4    " !LA=Q85X5=[/X*  " A@  %0              @ %; P
M9&=L>2TR,#(T,#8R-%]L86(N>&UL4$L! A0#%     @ ;(7<6)/(B[1;!P
MX5<  !4              ( !C X  &1G;'DM,C R-# V,C1?<')E+GAM;%!+
M 0(4 Q0    ( &R%W%CU]L(.6+L  "08!0 *              "  1H6  !E
M>#$P+3$N:'1M4$L! A0#%     @ ;(7<6#RFZTES7P  TRT#  H
M     ( !FM$  &5X,3 M,BYH=&U02P$"% ,4    " !LA=Q8/[TN_68Z  #3
MF0$ "@              @ $U,0$ 97@Q,"TS+FAT;5!+ 0(4 Q0    ( &R%
MW%B%/@KI60P  ,EB   *              "  <-K 0!E>#$P+30N:'1M4$L!
M A0#%     @ ;(7<6.&>/GFN"P  L78   D              ( !1'@! &5X
M,BTQ+FAT;5!+ 0(4 Q0    ( &R%W%CDZ2Q@KGH  $4- P )
M  "  1F$ 0!E>#0M,2YH=&U02P$"% ,4    " !LA=Q8/V\=P$=B   ]@ (
M"0              @ 'N_@$ 97@T+3(N:'1M4$L! A0#%     @ ;(7<6+/3
M#F_L5@  +#("  D              ( !7&$" &5X-"TS+FAT;5!+ 0(4 Q0
M   ( &R%W%@@,:<@E#(  !). 0 +              "  6^X @!F;W)M."UK
:+FAT;5!+!08     #  , +H"   LZP(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dgly-20240624.xsd" xlink:type="simple"/>
    <context id="AsOf2024-06-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001342958</identifier>
        </entity>
        <period>
            <startDate>2024-06-24</startDate>
            <endDate>2024-06-24</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-06-24" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-06-24" id="Fact000004">0001342958</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-06-24" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-06-24" id="Fact000010">2024-06-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-06-24" id="Fact000011">DIGITAL ALLY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-06-24" id="Fact000012">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-06-24" id="Fact000013">001-33899</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-06-24" id="Fact000014">20-0064269</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-06-24" id="Fact000015">14001 Marshall Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-06-24" id="Fact000016">Lenexa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-06-24" id="Fact000017">KS</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-06-24" id="Fact000018">66215</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-06-24" id="Fact000019">(913)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-06-24" id="Fact000020">814-7774</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="AsOf2024-06-24" id="Fact000021">Common     stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-06-24" id="Fact000022">DGLY</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-06-24" id="Fact000023">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="AsOf2024-06-24" id="Fact000024">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-06-24" id="Fact000025">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-06-24" id="Fact000026">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-06-24" id="Fact000027">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-06-24" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
